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ABSTRACT 
 
 
The colony-forming green microalga Botryococcus braunii is a potential source 
of biofuel feedstocks as it produces large amount of liquid hydrocarbon oils that can be 
converted into combustion engine fuels. There are three different races of B. braunii 
based on the hydrocarbons it synthesizes. Race A produces fatty acid derived alkadienes 
and alkatrienes, race B produces the triterpenoid hydrocarbons tetramethylsqualene and 
botryococcenes, and race L, the focus of this study, produces the C40 tetraterpenoid 
hydrocarbon lycopadiene via a previously uncharacterized biosynthetic pathway. 
Structural similarities suggest this pathway follows a biosynthetic mechanism analogous 
to that of C30 squalene. Confirming this hypothesis, the studies presented here identified 
C20 geranylgeranyl diphosphate (GGPP) as a precursor for lycopaoctaene biosynthesis, 
the first committed intermediate in the production of lycopadiene. Two squalene 
synthase (SS)-like cDNAs were identified in race L with one encoding a true SS, and the 
other an enzyme with lycopaoctaene synthase (LOS) activity. Interestingly, LOS utilizes 
alternative C15 and C20 prenyl diphosphate substrates to produce combinatorial hybrid 
hydrocarbons, but almost exclusively utilizes GGPP in vivo. This discovery highlights 
how SS enzyme diversification resulted in the production of specialized tetraterpenoid 
oils in race L of B. braunii. 
To understand LOS substrate and product specificity, rational mutagenesis 
experiments were conducted based on sequence alignments with several SS proteins as 
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well as a structural comparison with the human SS (HSS) crystal structure. 
Characterization of the LOS mutants in vitro identified Ser276 and Ala288 in the LOS 
active site as key amino acids responsible for controlling substrate binding, and thus the 
promiscuity of this enzyme. Mutating these residues to those found in HSS largely 
converted LOS from lycopaoctaene production to C30 squalene production. Furthermore, 
these studies were confirmed in vivo by expressing LOS in E. coli cells metabolically 
engineered to produce high FPP and GGPP levels. These studies also offer insights into 
tetraterpenoid hydrocarbon metabolism in B. braunii and provide a foundation for 
engineering LOS for robust production of specific hydrocarbons of a desired chain 
length. 
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
1.1 Microalgae as a source of biofuel 
Microalgae are a promising next-generation resource for biofuel feedstock 
production, which could ultimately serve as an alternative to petroleum-based 
transportation fuels1. Microalgae are considered superior to oil crops for biofuel 
production as they provide higher biomass and oil productivity, do not compete with 
food sources, have shorter life cycle, do not require rich nutrients for growth, and have 
potential to meet fuel demand without land resource limitation as they can be easily 
cultivated on a non-arable land1, 2. Microalgae can be used to produce fuels in several 
distinct forms such as conversion of algal biomass by biochemical and thermochemical 
process to produce bioethanol, biomethane and biohydrogen; use of biomass as a solid 
fuel to produce heat, steam and electricity; transesterification of crude oils to produce 
biodiesel; and use of liquid hydrocarbons as feedstocks to produce transportation fuels 
such as gasoline, diesel and kerosene2-4. Depending on the microalgae species, oil types 
vary from triacylglycerols (TAGs) to hydrocarbons2, 5, 6. These oils are carbon rich, their 
energy content is comparable to that of petroleum, and the fuels derived from these oils 
have been successfully tested in combustion engines making them a direct substitute for 
petroleum2, 7, 8. 
 
This dissertation follows the style of the journal Biochemistry 
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1.2 Challenges to commercial production of algal biofuels 
Despite the great potential of microalgae as a source of biofuel, and the extensive 
amount of research conducted at the laboratory scale, key challenges remain for the 
sustainable large scale production and commercialization of algal biofuels2, 9. 
Microalgae are photosynthetic organisms that utilize sunlight, water, carbon dioxide 
(CO2) and minerals to produce biomass and biomolecules2, 9. This means a steady and 
sufficient supply of water, CO2 and minerals is required when photosynthetic organisms 
such as microalgae are used as a production host for biofuel feedstocks2, 9. Freely 
available concentrated CO2 is required for feasible production of algal biofuel10. 
However, current pilot scale experiments conducted in the laboratory utilizes purchased 
CO210. Although researchers have suggested the use of concentrated CO2 produced from 
coal plants and cement factories for culturing algae, the amount of available CO2 from 
these industries is not sufficient to grow enough algae to meet the demand of current 
transportation fuels2. In case of minerals, algae utilize phosphorus and nitrogen as the 
principal nutrients for their growth2. The current supply of phosphorus is limited, and the 
nitrogen fixation process from the atmosphere requires large amounts of energy which at 
present accounts for 1.2% of global energy consumption for making nitrogen fertilizers2, 
11, 12. The use of existing nitrogen and phosphorus supplies for large scale production of 
algal biofuel will divert these resources from agricultural crops raising a concerns of 
food versus fuel2. 
Another major challenge for algal biofuel production is the supply of freshwater2. 
Although the use of marine algae are suggested for large scale  algal culture, freshwater 
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is still required to compensate for evaporative losses and for washing salts from the 
biomass prior to oil extraction from these cultures2. Large scale production of algal 
biomass to replace petroleum suffers from technology development as currently utilized 
high scale culture platforms such as raceway ponds have very low productivity10. Closed 
culture systems such as photobioreactors have potential to overcome this problem as 
they have much higher productivity for algal biomass than raceway ponds, but are costly 
and require large amounts of energy for operation2, 13. This suggests that improved, low 
cost and energy efficient biomass production technology needs to be developed in the 
near future2, 13. Fossil fuels are cheap and their reserve may not run out anytime soon6. 
Assuming the carbon footprint (the measure of amount of carbon released during 
production and burning of material) of algal derived biofuel is smaller than petroleum 
fuel, the price of algal fuel still needs to be comparable with fossil fuels, to make it 
commercially viable2, 14. Unfortunately, the major impediments for commercialization of 
algal biofuel at present are the sustainable production of a large quantity of algal 
biomass and at a cheaper price than conventianl petroleum fuels2. Despite these 
problems, the quest for sustainable production of algal biofuel must continue and the 
challenges must be overcome by continued research2, 6, 10. 
1.3 Approaches for sustainable production of algal biofuels 
Sustainable and commercially viable production of algal biofuel may be within 
reach in the near future assuming algal biology can be exploited to its full potential2, 9. 
To achieve this goal, extensive research on the biology of microalgae is desired as many 
of the challenges in the field of algal biofuel can be overcome by utilizing the tools of 
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molecular biology, synthetic biology, and genetic and metabolic engineering2, 9. Some of 
the proof-of-concept experiments have already been tested and many more remain to be 
conducted9. The challenge of increasing algal biomass productivity may be resolved by 
utilizing our knowledge from agricultural productivity9. As we know, the ancestors of 
present day agricultural crops had very low yields, but this problem has been overcome 
by millennia of crop plant domestication9. Domestication of crops included several 
factors such as the identification and characterization of genes, understanding the 
interaction and regulation of genetic networks, and selection of specific traits over time 
to produce sets of genes and genetic networks that resulted in a desired phenotype9. Over 
a few decades, we have observed a tremendous increase in agricultural productivity such 
that we might able to sustain the current global population9. Although algae are ancestral 
organisms when compared to crop plants, very little knowledge is available about their 
domestication process9. There is a great need for accelerating this process so the high-
biomass-yielding algae species, which has the ability to make meaningful impact on the 
global carbon cycle and energy production, can be achieved in the near future9. Targets 
of the domestication process can include several aspects of algal biology but not limited 
to manipulation of genes, genetic networks and pathways involved in production of 
primary and secondary metabolites, photosynthesis, carbon capture, light capture, stress 
tolerance and nutrients absorption9, 15, 16. 
Rapid advancements in genome sequencing technology have accelerated 
sequencing and assembly of algal genomes from multiple algal species9. This is 
important as it will unravel the genetic basis of unique traits observed in individual algae 
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species9. Further understanding of genes and genetic networks responsible for specific 
traits or phenotypes will be required to improve the productivity of desired algal 
species9. The current approach for increasing the production of lipids in microalgae 
depends on the redirection of metabolic flux to TAG biosynthesis, and is achieved by 
applying physiological stress such as nitrogen limitation, temperature change or salinity 
increase to the algal cultures2, 17-19. Lipids found in algae species are not limited to only 
TAGs but includes diverse carbon rich molecules such as terpenoid hydrocarbons2, 5. 
Detailed characterization and elucidation of various lipid biosynthetic pathways must be 
pursued as it provides the foundation for manipulation of these pathways to enhance 
lipid production2, 17, 20. For example, engineered versions of lipid biosynthetic enzymes 
with better catalytic properties can be used, and the enzymes involved in rate limiting 
steps of pathways can be overexpressed for robust production of the desired lipid 
molecule2, 17, 21. 
Carbon dioxide supplementation in culture medium increases the biomass 
production in algae, but sufficient supply of free CO2 to algae cultures still remains a 
challenge and may be partially overcome by genetic modifications2. Organisms such as 
cyanobacteria are known to have the mechanism that allows concentrating CO2 into the 
cell from their culture medium providing us with the opportunity to engineer this 
mechanism into the desired algae species22, 23,24. Although carbon capture by algae can 
be enhanced using genetic modifications, technology for efficient transfer of CO2 from 
the atmosphere into the culture medium must be developed to increase productivity2, 25. 
Like terrestrial crops, biomass productivity in algae can be enhanced by improving 
  6 
photosynthetic efficiency21, 26. Rubisco and other enzymes of the Calvin cycle that are 
superior in enzymatic properties can be first explored from several different organisms, 
and then overexpressed in the desired algal host to improve the photosynthetic 
conversion efficiency2, 21. Another genetic engineering strategy to boost productivity in 
microalgae can be done by improving light-harvesting efficiency, which means 
increasing the rate of conversion of light energy into chemical energy27. Most 
microalgae use chlorophyll a and b for light capture and are able to only absorb the 
visible portion of light (400-700 nm). This light absorption range can be expanded to 
750 nm by coexpression of chlorophyll d along with chlorophyll a and b, thus increasing 
the number of photons available for photosynthesis27. 
Nutrient limitation for large scale algal culture may be resolved by recycling 
processes6. Since the target biofuel feedstocks are carbon rich molecules, major nutrients 
such as phosphorus and nitrogen can be recycled once the biomass has been used for 
extraction of oils6. There are other alternative ways to supply the demand of nitrogen and 
phosphorus2. An ideal and sustainable approach to provide nitrogen to microalgae is to 
engineer them with the capacity to fix atmospheric nitrogen2. This is possible and worth 
pursuing in microalgae as there are examples of nitrogen fixing photosynthetic organism 
such as cyanobacteria species28. Furthermore, nitrogen fixation efficiency in 
cyanobacteria has been successfully enhanced by utilizing genetic engineering 
approaches29. The current supply of phosphorus can be enhanced by its recovery from 
animal fecal matter, which means more phosphorus available for algae culture2. 
Recovery of phosphorus and nitrogen from municipal waste water system can also be an 
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important source of nutrients for algal biomass production30, 31. Despite many 
challenges, economically viable production of algal biofuel could be possible when 
disciplines such as genetics, molecular biology, synthetic biology, metabolic 
engineering, technology development and many others are integrated to address the 
challenges we face today in realizing sustainable production of algal biofuel. 
1.4 Biofuel feedstocks from microalgae 
Oils produced by microalgae range from TAGs to hydrocarbon molecules, with 
most of the species accumulating TAGs at a high concentration32. The majority of algal 
biofuel research over the past few decades has focused extensively on the selection of 
microalgae species accumulating TAGs molecules32. TAGs are formed as a result of an 
ester bond formation between three fatty acids (composition could vary) and a glycerol 
molecule, and are widespread in plants and animal as they are used as storage lipids by 
these organisms32. In the case of algae, TAG accumulation can be further enhanced 
when grown under nitrogen starvation conditions17, 32. TAGs are transesterified with 
methanol in the presence of an alkali catalyst to produce fatty acid methyl esters 
(FAMEs) and glycerol as a byproduct of the reaction3. FAMEs are also commonly 
known as biodiesel. Fatty acid composition affects the oil quality of FAMEs as the 
properties of saturated and unsaturated fatty acids at room temperature are solid and 
liquid, respectively32. Fluidity is desired for biodiesel, and can be achieved by changing 
the fatty acid composition of TAGs at the cellular level32, 33. Unfortunately, unsaturated 
fatty acids are prone to oxidization, can form viscous polymers and produce oxygen 
radicals33. Due to the inherent problems of low oxidative stability and cold weather 
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performance, FAMEs are not considered an ideal substitute for fossil derived diesel 
fuels32. Hydrocarbon fuels are preferred over biodiesel and other biofuels as they are 
highly compatible with existing petroleum infrastructures and possess superior fuel 
properties such as high-energy content, low freezing temperature and high ignition 
stability32, 34. In recent years, researchers have shown renewed interest on microalgae 
species producing hydrocarbons, or perform metabolic engineering in microorganisms 
for the production of hydrocarbon fuels34. In the case of microbial hydrocarbon fuel 
production, researchers have successfully manipulated fatty acid and isoprenoid 
pathways to produce short-chain (C5-C12) and long-chain (C10-C23) hydrocarbons34. 
These are proof-of-concept experiments and large scale feasibility still needs to tested34. 
The approach of using microorganisms such as E. coli and yeast as hydrocarbon biofuel 
production hosts is flawed as these organisms do not have CO2 fixation capacity and rely 
on organic carbon for their growth. Thus, renewable production of hydrocarbon biofuel 
must be pursued in photosynthetic organisms such as microalgae, which either naturally 
produce hydrocarbons or use metabolic engineering techniques to engineer hydrocarbon 
production pathways into microalgal host that have the capacity to accumulate large 
amounts of lipids. As mentioned earlier, only a few hydrocarbon producing algae species 
have been reported32. Green algae such as Chlorella kessleri, Chlorella vulgaris, 
Scenedesmus acutus, Scenedesmus acuminatus, Scenedesmus obliquus were reported to 
produce hydrocarbons such as heptadecane, hexacosane and 1-heptadecene35. However, 
the total hydrocarbon content in these species is very low, ranging from 0.001 to 0.31 % 
of total dry biomass, making them unrealistic hosts for biofuel production32, 35. The 
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green microalga Botryococcus braunii is a promising candidate for the production of 
renewable fuels mainly due to its ability to produce and accumulate large amounts of 
liquid hydrocarbon oils5, 32, 36. 
1.5 Botryococcus braunii 
Botryococcus braunii is a colony forming green microalga where individual 
cells of the colony are embedded in an extracellular matrix (Figure 1)37, 38. It is 
cosmopolitan in nature and is found in fresh water, brackish lakes, reservoirs, and ponds 
of all continents except in Antarctica36. The climatic regions where B. braunii is found 
include continental, temperate, tropical and alpine zones36. Based on the nature of the 
hydrocarbons synthesized, B. braunii is classified into three different races A, B and L 
(Figure 2)36. Race A produces fatty acid derived C23-C33 alkadienes and alkatrienes; race 
B produces triterpenoid hydrocarbons C34 tetramethylsqualene as a minor product and 
C30-C37 botryococcenes as a major product; race L, the focus of this study, produces the 
C40 tetraterpene lycopadiene as a predominant hydrocarbon (Figure 2)5, 39-43. Recent 
ultrastructure studies of B. braunii show several unique features of this alga when 
compared to other eukaryotic cells37, 44. About 90-95% of the hydrocarbons produced by 
this alga are secreted into the extracellular matrix that holds the cells of the colony 
together, and the rest of the hydrocarbons are stored as intracellular oil bodies (Figures 
1A & 1B)44. The extracellular matrix is a resistant biopolymer made of ether linked 
hydrocarbon polymers specific to each race, and serves as a depository for the secreted 
hydrocarbons (Figure 1A)45-47. This unique feature may serve a special purpose  
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Figure 1. Model and image of Botryococcus braunii. A. Model of B. braunii colony 
focused on a single cell (Figure adapted from Weiss TL et al., 2012 Eukaryotic cell. 
11:1424-1440). B. Transmitted microscopic image B. braunii colony when pressure 
was applied to release oils from extracellular matrix (Figure adapted from Weiss TL et 
al., 2010 J. Biol. Chem. 285:32458-32466). 
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Figure 2. Hydrocarbons produced by three races of Botryococcus braunii. 
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in its natural habitat by allowing the colonies to float and increase exposure to light for a 
higher rate of photosynthesis37, 48, 49. The hydrocarbons stored in the extracellular matrix 
are sequestered by a retaining wall that surrounds the entire colony (Figure 1A)37. The 
retaining wall can also for a drape that is hypothesized to penetrate into the interior of 
biopolymer matrix to divide the mother colony into two daughter colonies (Figure 1A)37. 
A polysaccharide colony sheath extends from the retaining wall out toward the growth 
medium (Figure 1A)37. This alga also possesses a unique fenestrated endoplasmic 
reticulum (ER) that is contiguous to the cell membrane (Figure 1A)37. The fenestrae in 
the ER may act as a secretory pore for the delivery of hydrocarbons to the cell 
membrane, cell wall and finally to the extracellular matrix37. 
B. braunii has been considered a potential host for the production of renewable 
fuel for several reasons. First, geochemical evidences show the contribution of all three  
races of B. braunii in the existing coal deposits and oil shales50-54. Second, this alga 
produces prodigious amount of hydrocarbons as liquid oils, the majority of which is 
secreted into the extracellular matrix44. Third, catalytic hydrocracking of hydrocarbons 
from B. braunii can result in fuels that are highly compatible with the existing petroleum 
infrastructure4. For instance, under standard hydrocracking and distillation, C34 
botryococcene results in 67% gasoline, 15% aviation fuel, 15% diesel fuel and 3% 
residual oils4. 
Despite the aforementioned advantages of B. braunii, its use for the production 
of biofuel feedstocks faces several challenges. B. braunii is a photosynthetic microalgae 
and requires light, water, CO2 and inorganic nutrients for its growth. Several studies on 
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culture conditions show that the hydrocarbon production in this alga is directly related to 
its growth rather than the requirements for special nutrients5. It is a very slow growing 
alga with a doubling time of 6-7 days, probably due to the commitment of most of its 
cellular energy to the synthesis of energetically expensive hydrocarbon molecules55. To 
overcome the slow growing nature of this alga, genetic manipulation and use of 
molecular biology techniques are necessary. Biolistic transformation and preparation of 
protoplasts by cell wall digestion has not been successful due to the colony organization 
and presence of the extensive extracellular hydrocarbon matrix56. Recently, isolation of 
single cells from this alga was accomplished by the use of chemical treatments such as 
glycerol56. However, the survival of single cells remains a real challenge as these cells 
can remain in vital condition for a week only if maintained at a higher concentration (>2 
×107cells/mL)56. Another aspect of B. braunii research is to determine genes involved in 
the biosynthesis of the above-mentioned hydrocarbons, and to introduce these genes into 
faster growing heterologous hosts such as the green microalgae Chlamydomnas 
reinhardtii or tobacco plants for the large-scale production of hydrocarbons for biofuel 
purposes48, 57-60. 
1.6 The isoprenoid pathway 
With over more than 55,000 members, isoprenoids (a.k.a. terpenoids) are one of 
the largest and most structurally diverse family of natural products found in all kingdoms 
of life, with the majority of isopreonids produced in plant species61. Depending on the 
function, isoprenoids and their derivatives are classified as primary and secondary 
metabolites62. These metabolites play important roles in photosynthesis, respiration, 
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membrane fluidity, regulation of growth and development, plant-pathogen interactions, 
and many other cellular functions62. They are also used as essential oils, drugs, flavors, 
colorants, and agrochemicals62. A common precursor for the biosynthesis of these 
isoprenoids is C5 isopentyl diphosphate (IPP), which contains one isoprene unit61. The 
five-carbon isoprene unit is the building block of isoprenoid compounds, which are 
made by repetitive joining of several isoprene units63. Based on the number of isoprene 
units present, isoprenoids are classified as monoterpenes (C10), sesquiterpenes (C15), 
diterpenes (C20), triterpenes (C30), sesterterpenes (C35) or tetraterpenes (C40)64. Isopentyl 
diphosphate (IPP) biosynthesis in living organisms occurs via two different pathways: 
the mevalonate pathway (MVA) or the 2-C-methyl-D-erythritol 4-phosphate (MEP) 
pathway61-63, 65. The cytosolic localized MVA pathway is present in plants, animals, 
fungi, archaea and some gram-positive bacteria, whereas the MEP pathway is present in 
green algae and plants, and is compartmentalized into the plastid63. The MEP pathway is 
also utilized by eubacteria for isoprenoid production, and is localized into their cytosol66. 
Like other green algae, B. braunii also utilizes the MEP pathway for 
biosynthesis of isoprenoids and derivatives67. The first step of the MEP pathway begins 
with condensation of pyruvate and glyceraldehyde-3-phosphate by the 1-deoxy-D-
xylulose 5-phosphate synthase (DXS) enzyme to produce 1-deoxy-D-xylulose-5-
phosphate (DXP), and is considered a rate limiting step of the pathway (Figure 3)61. The 
DXP molecule is rearranged and reduced to 2-C-methyl-D-erythritol 4-phosphate (MEP) 
by the DXP reductoisomerase (DXR) enzyme (Figure 3)61. MEP then undergoes  
 
  15 
 
 
 
 
 
Figure 3. MEP pathway of isoprenoid biosynthesis. DXS = 1-deoxy-D-xylulose 5-
phosphate (DXP) synthase, DXR = DXP reductoisomerase, IPPI = Isopentyl 
diphosphate Δ-isomerase, GPPS = Geranyl diphosphate synthase, FPPS = Farnesyl 
diphosphate synthase and GGPPS = Geranylgeranyl diphosphate synthase.  
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conversion in several enzymatic steps to produce a mixture of IPP and dimethylallyl 
diphosphate (DMAPP)61. Equilibrium between IPP and DMAPP is controlled by the IPP 
Δ-isomerase (IPPI) enzyme (Figure 3)61. DMAPP is primarily used as a chemically 
active substrate for addition to IPP to synthesize higher carbon numbered prenyl 
diphosphate molecules such as C10 geranyl diphosphate (GPP), C15 farnesyl diphosphate 
(FPP) and C20 geranylgeranyl diphosphate (GGPP)63. DMAPP is also used as a substrate 
for cytokinin synthesis, and isoprene biosynthesis in plants63. Although the reactions of 
MEP pathway yielding IPP and DMAPP are localized in the plastid of green algae, these 
molecules or GPP, FPP and GGPP must be exported from the plastid for the biosynthesis 
of cytosolic isoprenoids such as sterols from FPP63. To date, there is a limited 
information available on the export of prenyl diphosphate precursors from the plastid63. 
GPP is synthesized by GPP synthase (GPPS) as a result of the condensation between 
DMAPP and IPP molecules (Figure 3). GPP is used as a precursor for monoterpenes 
such as menthol, camphor and limonene63. FPP synthase (FPPS) produces FPP by either 
utilizing IPP and GPP or two IPP molecules and DMAPP as precursor molecules (Figure 
3). FPP is at a major branch point of the isoprenoid pathway and is used as a precursor 
for the biosynthesis of sesquiterpenes, triterpenes, brassinosteroids, dolichols, 
oligoprenols and polyprenols63. In the case of GGPP synthase, it can utilize all three 
prenyl diphosphates, FPP, GPP and DMAPP, as substrates to produce the GGPP 
molecule (Figure 3). Organisms such as plants use GGPP for the production of a variety 
of isoprenoid molecules such as the tail for chlorophylls, carotenoids, phylloquinone, 
  17 
plastoquinone, tocopheorols, gibberellins, diterpenes and abscisic acid63. Furthermore, 
FPP and GGPP are also used for protein prenylation63. 
1.7 Squalene synthase 
1.7a Squalene 
The two chapters (II & III) of this thesis will involve study of squalene synthase 
(SS)-like genes/enzymes. Thus background on SS is provided in section 1.7 of this 
chapter. Squalene (C30H50), a triterpenoid hydrocarbon, is widely distributed among 
several different organisms for use as an intermediate in the biosynthesis of cholesterol 
in mammals, hopanoids in bacteria, ergosterol in fungi, and phytosterols in plants68. 
Squalene is also used as a precursor for the biosynthesis of a wide varieties of triterpene 
molecules49. In addition, squalene has other critical roles such as regulation of 
membrane fluidity, formation of membrane rafts, and protection against pathogens in 
host organisms49, 69. Squalene was first isolated in 1916 from liver oils of sharks 
belonging to the family Squalidae, and the formal name squalene was given later in 
192070, 71. It was characterized as a highly unsaturated hydrocarbon which is colorless, 
odorless and an oily liquid with a strong ability to reflect light71. The absolute amount of 
squalene varies between organisms, and is found in large quantities in shark liver, oils of 
human skin, plant seeds, wheat germ, rice bran and plant oils such as olive oil68, 69, 72. 
Currently, squalene is utilized for wide range of applications in food, cosmetics and the 
pharmaceutical industry73. Squalene acts as a natural antioxidant, and is proven to have 
radioprotective and cardioprotective functions68. Squalene also has anti-carcinogenic 
properties as it successfully inhibits chemically induced tumorigenesis in the colon,  
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Figure 4. Two pathways for squalene biosynthesis. A. Conversion of two farnesyl 
diphosphate (FPP) molecules into squalene in a two-step reaction catalyzed by single 
squalene synthase (SS) enzyme. B. A novel three-step squalene pathway catalyzed by 
three separate enzymes in bacteria.   
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lungs and skin68. Due to its potential for increasing immune responses, squalene has 
been widely used as a component of flu vaccines68. It is also used as a moisturizer in 
cosmetics and a surfactant in dry cleaning69. Because of its highly branched structure, 
squalene is currently being explored as a potential biofuel feedstock molecule for 
production of high-octane gasoline74, 75. In fact, the catalytic cracking of the squalene 
molecule resulted in gasoline range molecules with an octane number of 9875. 
1.7b Squalene biosynthesis 
Several studies involving squalene biosynthesis in plants, algae, animals, fungi 
and a few bacteria show a single squalene synthase (SS) enzyme catalyzing a two step 
reaction57, 76-79. The first step of the SS reaction involves condensation of two molecules 
of C15 FPP to form the stable cyclopropyl intermediate presqualene diphosphate (PSPP), 
and in the second step PSPP undergoes reductive rearrangement in the presence of the 
cofactor NADPH to form a 1-1’ linkage between the two FPP to yield C30 squalene 
(Figure 4A)48, 80. The PSPP intermediate is not released from the active site of SS during 
the two-step reaction. Squalene synthases from several different organisms have been 
cloned and characterized57, 76-79. Consistent with the two-step squalene formation 
reaction, extensive sequence conservation exists among SS enzymes at the amino acid 
level, with five conserved domains proposed to play an important role in catalysis57, 79, 81. 
Except for bacteria, all eukaryotic SS enzymes contain a C-terminal membrane spanning 
domain57, 78. Experiments with rat hepatic SS using analytical subcellular fractionation, 
immunodetection with a monospecific antibody, and immunoelectron microscopy show 
that the SS protein and its enzyme activity is localized in the ER82. Furthermore, deletion 
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of the C-terminal transmembrane domain resulted in a soluble and active SS enzyme 
suggesting the C-terminal residues are dispensable for SS activity83. These studies 
suggested the C-terminal transmembrane domain of the SS protein is used for anchoring 
it to the ER membrane and the remaining large N-terminal region containing the 
catalytic site is on the cytoplasmic face of the ER79. This structure orientation of SS 
would allow it to take the water soluble substrate FPP and co-factor NADPH from the 
cytosol, and release the hydrophobic reaction product squalene iinto the membrane of 
the ER84. In another study investigating the localization of the SS protein, the C-terminal 
transmembrane domain of yeast SS was fused to a reporter gene encoding for the green 
fluorescent protein85. Fluorescence microscopy showed that the fusion construct was 
localized to the ER, a result that is consistent with the role of the C-terminal 
transmembrane domain of SS as a signal peptide for targeting the ER membrane85. In 
addition, the fluorescent signal from the fusion construct was also observed in the lipid 
droplets connecting to the ER85. 
Recently, a new and unanticipated pathway for squalene biosynthesis from 
farnesyl diphosphate was discovered in the bacterial species Zymomonas mobilis and 
Rhodopseudomonas palustris (Figure 4B)49. Three genes from the hopanoid biosynthetic 
gene cluster encoding for HpnC, HpnD and HpnE enzymes were found to constitute a 
new squalene biosynthetic pathway (Figure 4B)49. HpnC and HpnD are squalene 
synthase-like proteins whereas HpnE encodes for a putative flavoprotein in the amine 
oxidoreductase family49. HpnD is a PSPP synthase and catalyzes the first step of the 
pathway where two molecules of FPP are converted to PSPP (Figure 4B)49. HpnC takes 
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PSPP as substrate and catalyzes the hydrolytic rearrangement reaction to produce 
hydroxysqualene (HSQ) in the second step of the pathway (Figure 4B). The third 
enzyme, HpnE, catalyzes the unusual reduction reaction where the hydroxyl group of 
HSQ is displaced in an FAD-dependent manner to produce squalene (Figure 4B)49. Until 
now, the squalene biosynthetic enzyme(s) from few bacteria have been characterized49. 
The discovery of a three-step squalene biosynthetic pathway and the conservation of 
these three genes encoding for HpnC, HpnD and HpnE in the genomes of many Gram 
positive and Gram negative species suggests the novel squalene pathway might be 
widespread in bacteria49. 
1.7c Regulation of squalene synthase 
Squalene formation is a critical branch point of the isoprenoid pathway where 
carbon flux from the central pathway is taken towards the biosynthesis of sterols in all 
eukaryotic organisms and hapanoids in prokaryotes49, 86. Sterols are essential to all 
eukaryotes as they play important roles in a wide range of cellular functions87. They are 
known to maintain the fluidity and permeability of cellular membranes, regulate the 
activity of membrane bound enzymes, serve as a precursor for steroid hormones such as 
testosterone and estrogen in mammals, dysteroids in insects, and brassinosteroids in 
plants87, 88. As the SS reaction is the first committed step in sterol biosynthesis, and the 
FPP substrate is used for production of non-sterol isoprenoid derivatives, SS is 
considered a potential target for regulation of steroid metabolism84. Studies investigating 
SS regulation in plants shows that SS enzyme activity was found to correlate with in vivo 
biosynthesis of sterols in tobacco89. Sterol accumulation in tobacco cell suspension 
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cultures increased parallel to the fresh weight gain, and was maximal during the rapid 
growth phase of the culture cycle89. When SS activity was measured, it was found to be 
highest (4- fold increase) during the exponential phase corroborating the carbon 
committed role of SS in sterol biosynthesis89. In another study, sterol accumulation as 
well as SS enzyme activity rapidly declined when plant cells were treated with fungal 
elicitors90. This rapid inhibition was due to channeling of FPP away from SS and 
towards the biosynthesis of sesquiterpenoid phytoalexins90. 
Follow-up experiments involving fungal elicitor treatment of tobacco cell 
suspension cultures showed that SS is regulated at transcriptional, translational and post-
translational levels88. In this study, time course experiments over 72-hrs were conducted 
during the rapid growth phase (4-days after subculturing) of tobacco cell suspension 
cultures88. In a control culture, the SS mRNA level was transiently induced 3-fold and 
remained maximum at 12-hr after the start of the experiment88. Induction of mRNA 
levels corresponded to a 2-fold increase in the level of SS protein and SS enzyme 
activity by 48-hr88. In a parallel experiment where cell cultures were treated with fungal 
elicitor, SS enzyme activity declined by 70% and  the SS mRNA level declined by 80% 
within the first 14-hr of elicitor treatment, and then remained constant during the rest of 
72-hr time course88. On the contrary, the SS protein level did not change until 36-hr 
post-elicitor treatment but started to rapidly decline to undetectable levels by 48-hr88. 
These results suggest that decrease of SS activity after elicitor treatment is not due to the 
decrease in the level of protein but rather by some post-translational modification of the 
SS protein88. The rapid decline of SS protein after 48-hr could be due to selective 
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degradation of SS protein in response to elicitor88. In the case of mRNA, its regulation in 
elicitor treated cells could be due to decreased transcription rate of SS gene or post-
transcriptional control such as destabilization of SS mRNA88. Expression of the tobacco 
SS promoter fused with the β-glucuronidase (GUS) reporter gene in transgenic plants 
showed a high-level of GUS reporter expression in shoot meristems and significantly 
lower expression in other tissues88. This suggests the SS gene is primarily expressed in 
the meristematic regions of the stems88. This data was further supported by a 
significantly higher level of SS protein and enzymatic activity present in the apical 
meristem and stem when compared to that of root and leaf tissues88. 
Mammalian SS is highly regulated by sterols and cytokines84, 91. The level of 
SS enzymatic activity, protein and mRNA increased rapidly in a cholesterol deficient 
condition but decreases to very low levels in the presence of excess cholesterol84. When 
hamsters were treated with lipopolysaccharides and cytokines to mimic infection and 
inflammation, mRNA, protein and enzymatic activity of SS declined rapidly whereas the 
hydroxymethylglutaryl CoA reductase (HMGR) enzyme activity increased rapidly91. 
The HMGR enzyme catalyzes the rate limiting step of the MVA pathway used for 
cholesterol biosynthesis91. Opposite and rapid changes in SS and HMGR expression 
support the flux diversion hypothesis where the limited FPP produced by the cells is 
taken away from squalene biosynthesis towards a non-sterol pathways such as protein 
prenylation required for signaling during the acute phase response of cells to infection 
and inflammatory stimuli84, 91. Cholesterol homeostasis genes are regulated by binding of 
the sterol regulatory element binding protein (SREBP) family of transcription factors, 
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SREBP-1a, SREBP-1c/ADD-1 and SREBP-2, and one or more accessory transcription 
factor to the promoter of the gene of interest84. Analysis of the human SS promoter 
showed the presence of three SRE-like sequences, HSS-SRE-1, Inv-SRE-3 and SRE-
1(8/10), and the binding sites for three of the accessory factors that co-operate with 
SREBPs in other genes84. Characterization of SS promoter elements showed a 50-fold 
induction of SS promoter activity when cells were deprived of sterols84. Rapid promoter 
activation was a result of the additive effect of HSS-SRE-1 and Inv-SRE-3 whereas 
SRE-1(8/10) contributed very little to SS promoter activity84. When the role of 
transcription factors was investigated, SREBP-1a activated SS gene transcription by 
additive interactions with HSS-SRE-1 and Inv-SRE-3, while SREBP-2 activated 
transcription by binding to all three SRE sequences present in the HSS promoter84. 
Additional experiments found a critical role for SREBP-1a than SREBP-2 in mediating 
SS gene transcription during sterol deprivation conditions84. 
1.7d Structure-function of squalene synthase 
Squalene synthase enzyme catalyzes Mg2+ dependent dimerization of two FPP 
molecules to produce PSPP as an intermediate and squalene as the final product of the 
reaction (Figure 4A)79. Because of its critical role in the biosynthesis of sterol and sterol-
like molecules in living organisms, SS is considered a potential therapeutic target to 
reduce cholesterol related diseases in humans and control infections caused by fungi and 
parasites92-94. Structure-function studies to elucidate the mechanism of the SS reaction 
have primarily utilized squalene synthase enzymes from yeast, rat and human81, 92, 95. 
Amino acid sequence alignments of eukaryotic SS proteins from mammals (human and  
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Figure 5. Amino acid sequence alignment of eukaryotic squalene synthase. 
Conserved domains and regions found in a typical squalene synthase are highlighted in 
bold and labeled. Transmembrane domain predicted by TMpred for each protein are 
underlined.  HSS = Human SS, RSS = Rat SS, AtSS = SS from Arabidopsis thaliana, 
BSS = SS from Botryococcus braunii race B, and YSS = SS from Saccharomyces 
cerevisae.  
FLAP
Domain I Domain II
Domain III Domain IV
Domain V JK loop
HSS      ME----FVKCLGHPEEFYNLVRFRIGG--KRKVMPKMDQDSLSSSLKTCYKYLNQTSRSF 54 
RSS      ME----FVKCLGHPEEFYNLLRFRMGG--RRNFIPKMDRNSLSNSLKTCYKYLDQTSRSF 54 
AtSS     MGSL---GTMLRYPDDIYPLLKMKRAIEKAEKQIPP------EPHWGFCYSMLHKVSRSF 51 
BSS      MGMLRWGVESLQNPDELIPVLRMIYA-DKFGKIKPK------DEDRGFCYEILNLVSRSF 53 
YSS      MGKL---LQLALHPVEMKAALKLKFCR----TPLFSIYDQSTSPYLLHCFELLNLTSRSF 53 
         *            * ::   :::        .          .     *:. *. .**** 
 
HSS      AAVIQALDGEMRNAVCIFYLVLRALDTLEDDMTISVEKKVPLLHNFHSFLYQPDWRFMES 114 
RSS      AAVIQALDGDIRHAVCVFYLILRAMDTVEDDMAISVEKKIPLLRNFHTFLYEPEWRFTES 114 
AtSS     SLVIQQLNTELRNAVCVFYLVLRALDTVEDDTSIPTDEKVPILIAFHRHIYDTDWHYSCG 111 
BSS      AIVIQQLPAQLRDPVCIFYLVLRALDTVEDDMKIAATTKIPLLRDFYEKISDRSFRMTAG 113 
YSS      AAVIRELHPELRNCVTLFYLILRALDTIEDDMSIEHDLKIDLLRHFHEKLLLTKWSFDGN 113 
         : **: *  ::*. * :***:***:**:***  *    *: :*  *:  :   .:    . 
 
HSS      KE-KD-RQVLEDFPTISLEFRNLAEKYQTVIADICRRMGIGMAEFLDKHV------TSEQ 166 
RSS      KE-KH-RVVLEDFPTISLEFRNLAEKYQTVIADICHRMGCGMAEFLNKDV------TSKQ 166 
AtSS     T--KEYKILMDQFHHVSAAFLELEKGYQEAIEEITRRMGAGMAKFICQEV------ETVD 163 
BSS      DQ-KDYIRLLDQYPKVTSVFLKLTPREQEIIADITKRMGNGMADFVHKGV-----PDTVG 167 
YSS      APDVKDRAVLTDFESILIEFHKLKPEYQEVIKEITEKMGNGMADYILDENYNLNGLQTVH 173 
             .   :: ::  :   * :*    *  * :* .:** ***.:: .         :   
 
HSS      EWDKYCHYVAGLVGIGLSRLFSASEFEDPLVGEDTERANSMGLFLQKTNIIRDYLEDQQ- 225 
RSS      DWDKYCHYVAGLVGIGLSRLFSASEFEDPIVGEDTECANSMGLFLQKTNIIRDYLEDQQ- 225 
AtSS     DYDEYCHYVAGLVGLGLSKLFLAAGSEVLT-PDWEAISNSMGLFLQKTNIIRDYLEDINE 222 
BSS      DYDLYCHYVAGVVGLGLSQLFVASGLQSPSLTRSEDLSNHMGLFLQKTNIIRDYFEDINE 227 
YSS      DYDVYCHYVAGLVGDGLTRLIVIAKFANESLYSNEQLYESMGLFLQKTNIIRDYNEDLV- 232 
         ::* *******:** **::*:  :              : ************** **    
 
HSS      --GGREFWPQEVWSRYVKKLGDFAKPENIDLAVQCLNELITNALHHIPDVITYLSRLRNQ 283 
RSS      --EGRQFWPQEVWGKYVKKLEDFVKPENVDVAVKCLNELITNALQHIPDVITYLSRLRNQ 283 
AtSS     IPKSRMFWPREIWGKYADKLEDLKYEENTNKSVQCLNEMVTNALMHIEDCLKYMVSLRDP 282 
BSS      LPAPRMFWPREIWGKYANNLAEFKDPANKAAAMCCLNEMVTDALRHAVYCLQYMSMIEDP 287 
YSS      --DGRSFWPKEIWSQYAPQLKDFMKPENEQLGLDCINHLVLNALSHVIDVLTYLASIHEQ 290 
             * ***:*:*.:*. :* ::    *   .: *:*.:: :** *    : *:  :.:  
 
HSS      SVFNFCAIPQVMAIATLAACYNNQQVFKG---AVKIRKGQAVTLMMDATNMPAVKAIIYQ 340 
RSS      SVFNFCAIPQVMAIATLAACYNNHQVFKG---VVKIRKGQAVTLMMDATNMPAVKAIIYQ 340 
AtSS     SIFRFCAIPQIMAIGTLALCYNNEQVFRG---VVKLRRGLTAKVIDRTKTMADVYGAFYD 339 
BSS      QIFNFCAIPQTMAFGTLSLCYNNYTIFTGPKAAVKLRRGTTAKLMYTSNNMFAMYRHFLN 347 
YSS      STFQFCAIPQVMAIATLALVFNNREVLHG---NVKIRKGTTCYLILKSRTLRGCVEIFDY 347 
         . *.****** **:.**:  :**  :: *    **:*:* :  ::  : .:      :   
 
HSS      YMEEIYHRIPD---SDPSSSKTRQIISTIRTQNL-------PNC----------QLISRS 380 
RSS      YIEEIYHRVPN---SDPSASKAKQLISNIRTQSL-------PNC----------QLISRS 380 
AtSS     FSCMLKTKVDK---NDPNASKTLNRLEAVQKLCR-------DAG----------VLQNRK 379 
BSS      FAEKLEVRCNTETSEDPSVTTTLEHLHKIKAACK-------AGL----------ARTKDD 390 
YSS      YLRDIKSKLAV---QDPNFLKLNIQISKIEQFMEEMYQDKLPPNVKPNETPIFLKVKERS 404 
         :   :  :      .**.  .    :  :.                           . . 
 
HSS      HY-------------SPIYLSFVMLLAALSWQY--LTTLSQV-TEDYVQTGEH------- 417 
RSS      HY-------------SPIYLSFIMLLAALSWQY--LSTLSQV-TEDYVQREH-------- 416 
AtSS     SYVNDK----G----QPNSVFIIMVVILLAIVFAYLRAN--------------------- 410 
BSS      TFDELR----S----R--LLALTGGSFYLAWTYNFLDLRGPGDLPTFLSVTQHWWSILIF 440 
YSS      RYDDELVPTQQEEEYKFNMVLSIILSVLLGFYYIYTLHRA-------------------- 444 
          :                 :        *.  :                            
 
HSS      --------------------- 417 
RSS      --------------------- 416 
AtSS     --------------------- 410 
BSS      LISIAVFFIPSRPSPRPTLSA 461 
YSS      --------------------- 444	
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rat), plants (Arabidopsis thaliana), green algae (Botryococcus braunii), and fungi 
(Saccharomyces cerevisae) show conservation of five functional domains (domain I to 
domain V), a FLAP domain, a JK loop region and the C-terminal transmembrane 
domain (Figure 5)76-78, 81, 94. Site-directed mutagenesis (SDM) experiments, biochemical 
assays and crystal structures of SS enzymes have shown the importance of all these 
conserved regions in the two-step SS reaction81, 92, 94. Crystal structures of human 
squalene synthase (HSS) bound to substrate analogs of FPP and the PSPP intermediate, 
as well as several SS inhibitors have been successfully determined92-94. 
HSS is an α-helical and monomeric protein with a centrally located active site 
surrounded by the five conserved domains, the FLAP domain and the JK loop region94. 
The crystal structure of HSS with farnesyl thiodiphosphate (FSPP), an analog of FPP, 
shows two binding sites (S1 and S2) for each FPP substrate molecule (Figure 6A)94. The 
S2 FSPP binds to serine residues (Ser51 and Ser53) of the FLAP domain via hydrogen 
bonding whereas the S1 FSPP binds to two conserved aspartic acid (Asp) rich motifs, 
80DxxED84 of domain II and 219DxxED223 of domain IV, and to the conserved Tyr171 
residue found in domain III (Figure 6A)94. Kinetic experiments have suggested a 
sequential binding mechanism for the two FPP substrates; the acceptor FPP first binds to 
the S2 site (nonactivating binding site) followed by binding of the donor FPP to the S1 
site (activating binding site) (Figure 6A)95. Three Mg2+ divalent metal ions coordinate 
the binding of S1 FSPP to the aspartate-rich motifs (Figure 6A)94. SDM experiments to 
mutate Asp219 and Asp223 to shorter residues, neutral residues and positive residues 
resulted in total loss of SS activity (Figure 5)81. Furthermore, change of these two  
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Figure 6. X-ray crystal structures of human squalene synthase (HSS). A. Structure 
of HSS bound to substrate analog farnesyl thioldiphosphate (FSPP) in the presence of 
Mg2+ metal ion. B. Structure of mutant HSS (Y73A) bound to presqualene diphosphate 
(PSPP) intermediate in the presence of Mg2+. C. Structure of HSS bound to PSPP 
intermediate in the presence of Mn2+. Diphosphate group of FSPP or PSPP is colored in 
red. Figure A, B and C are adapted from Liu et al., 2014 Acta Crys. D70:231-241. 
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aspartic acid residues to either glutamic acid and asparagine did not rescue the enzyme 
activity suggesting that both the size and acidic nature of Asp219 and Asp223 is  
essential for SS reaction81. When the SS assay was conducted without Mg2+in the 
reaction buffer, no enzyme activity was observed94. This result is consistent with the 
critical role of Mg2+ in initiating the condensation reaction by ionizing the diphosphate 
moiety from the S1 FPP substrate to produce an allylic carbocation and diphosphate 
ion94. Tyrosine (Tyr171) found in domain III also interacts with S1 FPP and is found to be 
highly conserved in all SS proteins (Figures 5 and 6A)94. When Tyr171 was mutated to 
phenylalanine, serine, and tryptophan, complete loss of PSPP formation, and squalene 
formation from PSPP was observed81. This suggested an essential role for the phenol 
group of Tyr171 in both steps of the SS reaction81. It is hypothesized that the hydroxyl 
group of Tyr171 promotes ionization of diphosphate from S1 FPP and the resulting 
carbocation is stabilized by the π electrons present in the aromatic ring of tyrosine 
(Tyr171)81. In addition, the allylic carbocation could also be stabilized by electrostatic 
interactions with a magnesium bound diphosphate ion and via the side chain of a 
glutamine residue (Gln212) present in domain IV (Figures 5 and 6A)94. When Gln212 was 
mutated to leucine and asparagine residues, both mutants completely lost SS activity 
suggesting the critical role of Gln212 in SS catalysis94. The highly unstable allylic 
carbocation then undergoes nucleophilic attack by the 2,3-π bond of S2 FPP to produce 
the cyclopropyl ring containing PSPP intermediate (Figure 4A)94. 
PSPP is converted to squalene without dissociating from the SS enzyme 
suggesting that the synthesis of PSPP from FPP, and squalene from PSPP takes place in 
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the same active site of the enzyme94. The structure of HSS with PSPP and Mg2+ showed 
the binding of the diphosphate to the serine residues (Ser51 and Ser53) of the FLAP 
domain, and the position of the two hydrophobic tails of PSPP is the same as previously 
seen for S1 FSPP and S2 FSPP (Figure 6B)94. Furthermore, the salt-bridge interaction 
observed between the α-phosphate group of PSPP and arginine (Arg77) may provide 
electrostatic interaction to initiate the cleavage of the diphosphate moiety from PSPP 
(Figure 6B)94. However, a structure-function study of dehydrosqualene synthase (CrtM) 
with PSPP has suggested switching of the diphosphate from the nonactivating site (S2 
site) to the activating site (S1 site) in order to initiate the cleavage of diphosphate from 
PSPP, and subsequent reactions to form the final product (Figures 6A and 6B)96. CrtM is 
an SS-like enzyme that utilizes FPP in a two-step reaction to produce dehydrosqualene, a 
molecule similar to squalene except for the presence of cis double bond at 1-1’ linkage 
between the two FPP molecules, and is used as an intermediate for carotenoid 
biosynthesis in bacteria96. In the CrtM reaction, two FPP molecules are condensed to 
PSPP in the first step96. PSPP then undergoes an NADPH independent rearrangement in 
the second step to produce dehydrosqualene96. As mentioned earlier, opening of the 
cyclopropyl ring of PSPP in the second step to produce squalene requires NADPH as a 
reducing cofactor. It was suggested that the SS enzyme undergoes a conformational 
change in the presence of NADPH to position the diphosphate of PSPP towards the 
activating site (Figures 6B and 6C)93, 94. Mutation of tyrosine (Tyr73) to alanine was 
made in HSS to allow it tolerate the movement of ligands such as NADPH94. The crystal 
structure of mutant HSS with PSPP and Mn2+, an analogue of biological cofactor Mg2+, 
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showed the binding of the diphosphate moiety of PSPP to the two-conserved Asp rich 
motifs, 80DxxED84 of domain II and 219DxxED223 of domain IV, via a trio of Mn2+ 
bridges (Figure 6C)94. The diphosphate moiety of PSPP is indeed bound to the same 
binding site as that of S1 FSPP, thus allowing its ionization to initiate the second half 
reaction (Figures 6A and 6C)94. The highly unstable cyclopropylcarbinyl cation formed 
after cleavage of diphosphate group from PSPP could be stabilized by the π electrons 
present in the aromatic ring of Phe288 found in domain V (Figures 5 and 6C)94. Squalene 
synthase activity was completely lost when Phe288 was mutated to either tyrosine, 
tryptophan, leucine, aspartic acid or arginine residues, suggesting its critical role in 
catalysis81. The crystal structure of HSS showed that Phe288 acts as a floor for the S1 site 
(Figures 6A, 6B and 6C). Furthermore, the crystal structure of HSS (F288A)/PSPP 
complex showed the movement of the S1 hydrocarbon tail downwards by 4.5Å, and 
results in the misorientation of the diphosphate group suggesting a stabilization as well 
structural role for Phe288 in the second half reaction94. Besides Phe288, residues Phe286, 
Gln283 and Gln293 found in or near domain V are also involved in the conversion of PSPP 
to squalene81. Substitution of these three residues with amino acids of different 
properties retained only partial activity in the second step of the SS reaction (Figure 5)81. 
Reduction of PSPP to squalene in the second step involves hydride transfer from 
NADPH to the cationic intermediate of PSPP (Figure 4A)97. Although not required in 
the first half reaction, NADPH was shown to stimulate PSPP synthesis by 40-fold95. The 
SS enzyme is unique when compared to other NADPH-dependent enzymes as it does not 
contain any dinucleotide binding motifs and its structure does not show the presence of a 
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Rossmann-fold (Figure 6A)94. This suggested the SS enzyme might have a unique 
mechanism for binding NADPH94. Positive residues Arg52, Arg218, Lys315, Arg317 and 
Lys318 found in FLAP domain, domain II, domain IV and the J-K loop have been 
identified as critical residues for NADPH binding (Figure 5)94. The binding of NADPH 
by these residues most likely occurs through interaction of the positive charge present on 
their side chains to the negatively charged phosphate groups of NADPH94. Mutation of 
Arg52 to Gln almost completely lost SS activity, and this defect was not rescued in the 
presence of increasing concentrations of NADPH (Figure 5)94. Mutation of Arg218 also 
drastically decreased SS activity but the inhibitory effect was overcome by high 
concentrations of NADPH (Figure 5)94. The double mutants K315E/R317E and 
K315E/K318E showed a synergistic effect resulting in complete loss of SS activity 
(Figure 5)94. Although the crystal structure of HSS with PSPP and NADPH has not been 
determined, it seems likely that NADPH binds to the active site via positive residues 
such that it orients itself to facilitate the hydride transfer to the cationic intermediate of 
the PSPP molecule94.  
1.8 Hydrocarbon biosynthesis in race A of B. braunii 
Race A of B. braunii produces odd-carbon-numbered n-alkadiene and n-
alkatriene hydrocarbons ranging from C23-C33 as its predominant hydrocarbons, and are 
the products of the fatty acid biosynthetic pathway (Figure 2)36, 41. Depending on the 
strain, total hydrocarbons in race A range from 0.4% to 61% of their dry weight36. The 
structural backbone of n-alkadiene and n-alkatriene shows similarity to the backbone of 
the fatty acid C18 oleic acid (18:1, cis-ω9) (Figure 7)98. Radioactive feeding experiments  
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Figure 7. Possible biosynthetic pathways for C27 alkadiene in race A. Oleic acid or 
elaidic acid is elongated to produce C28 fatty acid. In possibility one, the elongated C28 
fatty acid is decarboxylated by fatty acyl decarboxylase enzyme to produce C27 
alkadiene. In possibility two, the elongated C28 fatty acid is first reduced by fatty acyl 
reductase enzyme to produce aldehyde which is further decarbonylated by fatty acid 
decarbonylase enzyme to produce C27 alkadiene.  
Oleic Acid, 18:1 cis-Δ9
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indeed show oleic acid as the direct precursor for biosynthesis of 
alkadienes/alkatrienes98. Furthermore, the intracellular concentration of oleic acid 
decreases as the alkadienes/alkatrienes production increases and vice-versa98. A 
decarboxylation-elongation mechanism for alkadiene/alkatriene production has been 
proposed as one of the possible biosynthetic routes and needs to be experimentally 
verified (Figure 7; possibility 1)98-101. The C18 oleic acid could be first elongated via the 
fatty acid elongation pathway to produce an elongated fatty acid of desired length which 
is then decarboxylated by a putative fatty acyl decarboxylase enzyme to produce cis 
double containing alkadienes/alkatrienes (Figure 7)98-100. Isomerase activity for 
conversion of C18 oleic acid (18:1, cis-ω9) to C18 elaidic acid (18:1, trans-ω9) exists in 
some strains of race A, and race A can utilize elaidic acid as a precursor to produce 
trans-alkadienes (Figure7)100. For simplification, possible biosynthetic pathways for only 
C27 alkadiene is shown in figure 7. In the case of alkatrienes, the additional double bond 
could be due to direct desaturation of precursors oleic acid and elaidic acid or from the 
desaturation of intermediates during the fatty acid elongation process (Figure 2 and 7)5, 
100. 
An aternative mechanism for alkadiene/alkatriene production is also possible 
based on studies conducted with microsomes of race A (Figure 7; possibility 2)101-104. A 
fatty acyl-CoA reductase enzyme was purified from the microsomes, and the enzyme 
assays showed its ability to produce fatty acid aldehyde when fatty acyl-CoA (palmitoyl-
CoA) substrate and NADH cofactor was provided in the reaction104. Similarly, a 
decarbonylase enzyme was also isolated from the race A microsomes102. Incubation of 
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the purified enzyme with aldehyde (octadecanal) substrate showed decarbonylase 
activity and resulted in the production of an alkane (heptadecane)102. However, the fatty 
acyl-CoA and octadecanal substrates used for reductase and decarbonylase activity, 
respectively, are not considered natural substrates or intermediates of the 
alkadiene/alkatriene biosynthetic pathway36, 102, 104. According to the alternative 
mechanism, an elongated fatty acid obtained from oleic acid or elaidic acid could be 
reduced by the fatty acyl reductase enzyme to produce the corresponding aldehyde 
intermediate (Figure 7; possibility 2)101-104. The aldehyde then undergoes a 
decarbonylation reaction by fatty acyl decarbonylase to produce cis or trans double bond 
containing alkadiene/alkatrine (Figure 7; possibility 2)101-104. 
1.9 Hydrocarbon biosynthesis in race B of B. braunii 
Among the three races of B. braunii, hydrocarbon biosynthesis in race B has 
been extensively studied and the biosynthetic pathways have been mostly elucidated48, 58. 
Race B produces large amounts of liquid hydrocarbons ranging from 30 to 86% of its 
cellular dry weight36. These hydrocarbons are the product of the MEP pathway, and are 
the triterpenoids squalene, C31-C34 methylated squalene, and C30-C37 botryococcene 
(Figure 8)5, 36, 67. Hydrocarbon composition in race B varies depending on the strain 
characterized and the culture conditions used for growth36. The majority of 
botryococcenes and squalenes produced in race B are methylated homologues C32 
botryococcene, C34 botryococcene and C34 tetramethylsqualene whereas C31 
botryococcene, C33 botryococcenes, and C31-C33 methylsqualenes account for minor 
components of the total hydrocarbon pool48. Due to the structural similarity of C30  
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Figure 8. Triterpenoid hydrocarbon biosynthetic pathway in race B. Carbon 
numbers shown in green indicates the methylation position for the hydrocarbon molecule 
and the numbering system is different from farnesyl diphosphate molecule. BSS = race 
B squalene synthase, SSL = squalene synthase-like and TMT = triterpene methyl 
transferase. Dashed arrow indicated multiple reactions.   
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botryococcene to C30 squalene, its biosynthesis has long been hypothesized to occur via 
a single SS enzyme or SS-like enzyme(s) (Figure 8)105. Extensive in vitro and in vivo 
studies have now identified one SS (SS from race B; BSS) and three SS-like (SSL-1, 
SSL-2 and SSL-3) enzymes involved in the biosynthesis of C30 squalene and C30 
botryococcene, and show a unique mechanism of triterpene production in this alga 
(Figure 8)57, 58. BSS is a typical SS enzyme and catalyzes the two-step reaction for 
squalene formation discussed in the sections above (Figure 8)57, 58. An additional 
mechanism for squalene formation is observed in race B and the reaction is catalyzed by 
two SS-like enzymes SSL-1 and SSL-2 ( Figure 8)58. The SSL-1 enzyme condenses two 
molecules of FPP into PSPP, which is then utilized by SSL-2 as a substrate and 
rearranged in the presence of NADPH to produce C30 squalene (Figure 8)58. C30 
botryococcene biosynthesis also utilizes two enzymes, SSL-1 and SSL-3 (Figure 8)58. 
The PSPP product formed by SSL-1 is utilized as a substrate by SSL-3 to carry out an 
alternative rearrangement reaction in the presence of NADPH to form a 1-3’ linkage 
between the two FPP molecules to produce C30 botryococcene (Figure 8)58. Amino acid 
sequence analysis of the four triterpene synthases (BSS, SSL-1, SSL-2 & SSL-3) from 
race B showed conservation of all five domains, the FLAP domain and the J-K loop 
region found in a typical squalene synthase58. Except for BSS and SSL-2, SSL-1 and 
SSL-3 do not contain a transmembrane domain57, 58. However, the localization of 
botryococcene synthase activity in the membrane fraction of race B suggests that SSL-1 
and SSL-3 could be loosely associated to the membrane via interaction with other 
membrane bound proteins58, 105. As shown in Figure 8, there are two mechanisms of 
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squalene production in race B and each may serve a specific purpose 48, 105. It has been 
proposed that squalene produced by conventional squalene synthase (BSS) is involved in 
housekeeping functions such as sterol biogenesis, whereas the squalene produced using 
SSL-1 and SSL-2 may be used to synthesize polymethylenesqualene diols that create a 
cross-linked hydrocarbon network of the extracellular matrix48, 58, 105. Three S-adenosyl 
methionine (SAM) dependent triterpene methyl transferases (TMTs) were identified that 
are involved in the methylation of C30 squalene and C30 botryococcene (Figure 8)48. 
TMT-1 and TMT-2 catalyze the methylation of C30 squalene at carbon positions 3 and 22 
to yield C32 dimethylsqualene, whereas TMT3 is responsible for two successive 
methylations of C30 botryococcene at carbon positions 3 and 20 to produce C32 
botryococcene (Figure 8)48. Additional TMTs responsible for further methylation of C32 
squalene and C32 botryococcene into their tetramethylated derivatives remain to be 
identified (Figure 8). 
1.10 Hydrocarbon biosynthesis in race L of B. braunii 
Race L of B. braunii produces tetraterpenoid hydrocarbons derived from the 
MEP pathway, and total hydrocarbon composition can range from 0.1% to 10% of the 
cellular dry weight36, 59, 101. The C40 lycopadiene is the predominant hydrocarbon 
produced by race L42, 59. The biosynthetic pathway for lycopadiene was not known until 
the recent studies detailed in this thesis59, and extensive characterization of the 
lycopadiene pathway is described in chapter II of this thesis. 
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CHAPTER II  
A SQUALENE SYNTHASE-LIKE ENZYME INITIATES PRODUCTION OF 
TETRATERPENOID HYDROCARBONS IN BOTRYOCOCCUS BRAUNII RACE L 
 
2.1 Background and rationale 
Microalgae are a promising next-generation source of feedstocks for biofuel 
production with the potential to serve as a practical alternative to petroleum-based 
transportation fuels1. Depending on the microalgal species, the oils produced vary from 
triacylglycerols to hydrocarbons2, 5. Hydrocarbon-based fuels are preferred over other 
biofuels as they are highly compatible with existing petroleum infrastructures and 
possess superior fuel properties32, 34. The colony-forming green microalga Botryococcus 
braunii is an exciting candidate for biofuel feedstock production as it produces up to 
61% of its dry weight as liquid hydrocarbon oil36. These hydrocarbons are produced 
inside the cells of the colony, seen as intracellular oil bodies, and secreted into the 
colony extracellular matrix (ECM) where the majority of the hydrocarbons are stored36 
(Figure 9A). Most importantly, catalytic hydrocracking of hydrocarbons from this alga 
results in petroleum-equivalent fuels of gasoline, kerosene and diesel4. Intriguingly, 
 
Portions of this chapter have been reprinted as per Creative Commons Attribution 4.0 
International License of59: (1) Hem R. Thapa, Mandar T. Naik, Shigeru Okada, 
Kentaro Takada, István Molnár, Yuquan Xu, Timothy P. Devarenne (2016). A 
squalene synthase-like enzyme initiates production of tetraterpenoid hydrocarbons in 
Botryococcus braunii Race L. Nature Commun. 7:11198. 
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geologic evidence also shows a direct contribution of this alga to the formation of 
currently utilized fossil fuel deposits around the globe50-54. Despite the aforementioned 
advantages of B. braunii, its use for biofuel feedstock production is hindered by a slow 
growth rate, and the lack of transformation systems to achieve targeted genetic 
modification5. Thus, the identification of B. braunii hydrocarbon biosynthetic pathways 
and associated genes/enzymes can provide options for metabolically engineering these 
pathways into heterologous hosts with better growth characteristics and the ability to be 
genetically manipulated. This would then allow the development of improved versions 
of hydrocarbon biosynthetic enzymes in order to direct production towards the most 
commercially desirable products106. 
There are three different races of B. braunii based on the hydrocarbons 
synthesized. Race A produces fatty acid-derived C23-C33 alkadienes and alkatrienes. 
Races B and L produce isoprenoid-derived hydrocarbons: methylsqualenes and C30-C37 
botryococcene triterpenoids in race B, and the C40 tetraterpenoid lycopadiene, the focus 
of this study, in race L (Figure 2)36. Green algae have been shown to possess only the 
plastid-localized methyl erythritol phosphate (MEP) pathway to supply isoprenoid 
precursors for terpene production67, 107, and thus lycopadiene is predicted to be generated 
from C5 precursors via this route (Figure 3). However, the exact mechanism of 
lycopadiene biosynthesis from C20 prenyl diphosphate intermediates has been a mystery 
and two possible biosynthetic routes have been suggested (Figure 9B)42. The first entails 
C20 geranylgeranyl diphosphate (GGPP) reduction by GGPP reductase (GGR) to 
produce C20 phytyl diphosphate (PPP; Figure 9B). Two molecules of PPP would then 
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Figure 9. Background information on lycopadiene biosynthesis in race L. A. 
Confocal microscopy image of an L race colony of B. braunii. Shown are hydrocarbon 
oils stained using the neutral lipid-binding stain Nile red (false colored green), and 
chlorophyll autofluorescence (red). Indicated are intracellular hydrocarbon oil bodies, 
hydrocarbon oil in the ECM, and an individual cell as defined by chlorophyll 
autofluorescence from the single chloroplast in each cell. Image is an overlay of Nile red 
signal, chlorophyll autofluorescence signal, and a bright-field image. Scale bar = 20 µm. 
B. Two possible pathways for lycopadiene biosynthesis. Possibility 1: GGPP reduction 
to PPP followed by condensation of two PPP molecules to directly produce lycopadiene. 
Possibility 2: condensation of two molecules of GGPP to form lycopaoctaene, which 
would then be reduced to lycopadiene. C. Two step reaction catalyzed by single SS 
enzyme: two molecules of FPP are condensed to squalene through the PSPP 
intermediate. In (B), and (C) enzyme names are colored blue. 
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undergo head-to-head condensation (1-1’ linkage) to produce lycopadiene (Figure 9B). 
The second possibility is the head-to-head condensation of two GGPP molecules to 
produce lycopaoctaene, followed by stepwise enzymatic reduction to produce 
lycopadiene (Figure 9B). 
Using either proposed route, the condensation of PPP or GGPP is predicted to 
proceed in a reaction mechanism similar to that carried out by the enzyme squalene 
synthase (SS), which forms C30 squalene, a precursor required for sterol biosynthesis in 
eukaryotes79 and hopanoids in some prokaryotes108. SS enzymes catalyze a two-step 
reaction. First, the condensation of two C15 farnesyl diphosphate (FPP) molecules yields 
the cyclopropyl intermediate presqualene diphosphate (PSPP; Figure 9C). Second, PSPP 
undergoes NADPH-dependent reductive rearrangement to form squalene with a 1-1’ 
linkage between the two FPP molecules (Figure 9C)80. Herein we report the elucidation 
of the first committed step in the lycopadiene hydrocarbon biosynthetic pathway in B. 
braunii race L, which is catalyzed by a new SS-like enzyme. 
2.2 Results 
2.2a L race hydrocarbon content and related enzyme activity 
Previous studies reported trans,trans-lycopadiene as the predominant 
hydrocarbon (98% of total hydrocarbons) produced by race L, with a small amount of 
lycopatriene also documented42, 43, 109. However, the lycopatriene structure was not 
determined. Thus, we first set out to ascertain and refine the hydrocarbon profile of B. 
braunii race L to provide a baseline for our biosynthetic models. Analysis of purified 
hydrocarbons by GC-MS showed that lycopadiene accounts for 95% of the total 
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hydrocarbon pool (Figure 10, panel I), with six other minor compounds constituting the 
remaining 5%: lycopatriene, lycopatetraene, lycopapentaene, lycopapentaene isomer, 
lycopahexaene, and a C35H64 molecule (Figure 10, panels II-VII; Figures 11-14). 
Ozonolysis experiments suggested lycopatriene and lycopapentaene share an identical 
reduced C20 moiety with lycopadiene (Figures 15-17). NMR spectroscopy was used to 
confirm identity and structure, including double bond positions, of each molecule 
(Figure 10, Table 1, Figures 18-25). This is the first report of lycopatetraene, 
lycopapentaene, and lycopahexaene hydrocarbons from B. braunii, race L. The lack of 
detectable amounts of lycopaoctaene and lycopaheptaene in the total hydrocarbon 
fraction could be due to rapid conversion of these metabolites into more highly saturated 
homologues. Interestingly, the unique C35H64 isoprenoid hydrocarbon detected contains 
seven isoprene units, and thus is assigned to the recently named C35 terpene class 
“sesquarterpenes”110. 
In order to gain more insight into the mechanism of lycopadiene biosynthesis and 
assess the validity of the two possible lycopadiene biosynthetic routes (Figure 9B), a 
cell-free in vitro enzyme assay was developed using total, soluble, and microsomal 
protein fractions with 3H-labeled PPP and GGPP substrates for potential incorporation 
into lycopadiene and lycopaoctaene, respectively. Squalene production by SS enzyme 
activity with 3H-labeled FPP as substrate was used as a control105. Lycopadiene 
production from PPP was not detected in any protein fraction tested, while 
lycopaoctaene biosynthesis from GGPP was easily observed, mainly in the microsomal 
fraction (Figure 26A). This indicates a lycopaoctaene synthase (LOS) activity is 
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Figure 10. Hydrocarbon composition in B. braunii race L. Representative GC-MS 
profiles of purified hydrocarbons and their corresponding names and structures (panels I 
- VII). Structures of hydrocarbons were determined by 13C-NMR. Lycopadiene carbon 
numbering (panel I) is used for numbering all C40 hydrocarbons of race L. Percentage 
next to the name of each hydrocarbon corresponds to its average amount present in total 
hydrocarbons pool from three independent culture cycles (n = 3). 
 
 
 
  
32 33 34 35
2 4 6 8 10 12 14 16 18 20 22 24 26 28
29 30 31
1 3 5 7 9 11 13 15 17 19 21 23 25 27
1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31
2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32
33 34 35 36
37 38 39 40
To
ta
l I
on
 C
ou
nt
s 
(1
09
)
Retention time (min)
15 20 25 30
I
II
III
IV
V
VI
VII
3.0
2.0
1.0
3.0
2.0
1.0
3.0
2.0
1.0
3.0
2.0
1.0
3.0
2.0
1.0
3.0
2.0
1.0
3.0
2.0
1.0
Lycopadiene, 95.0%
Lycopatriene, 1.5%
Lycopatetraene, 0.12%
Lycopapentaene, 3.0%
C35H64, 0.15%
Lycopapentaene Isomer; 0.15%
Lycopahexaene, 0.08%
  44 
 
 
Figure 11. Analysis of lycopadiene and lycopatriene by GC-MS. The mass spectra 
from GC-MS and structures of lycopadiene and lycopatriene are shown in panel I and 
panel II, respectively. Molecular ion in box corresponds to the parent ion of each 
hydrocarbon molecule. 
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Figure 12. Analysis of lycopatetraene and lycopapentaene by GC-MS. The mass 
spectra from GC-MS and structures of lycopatetraene and lycopapentaene are shown in 
panel I and panel II, respectively. Molecular ion in box corresponds to the parent ion of 
each hydrocarbon molecule. 
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Figure 13. Analysis of lycopahexaene and lycopaoctaene by GC-MS. The mass 
spectra from GC-MS and structures of lycopahexaene and lycopaoctaene are shown in 
panel I and panel II, respectively. Molecular ion in box corresponds to the parent ion of 
each hydrocarbon molecule. 
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Figure 14. Analysis of lycopapentaene isomer and C35H64 by GC-MS. The mass 
spectra from GC-MS and structures of lycopapentaene isomer and C35H64 are shown in 
panel I and panel II, respectively. Molecular ion in box corresponds to the parent ion of 
each hydrocarbon molecule. 
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Figure 15. Ozonolysis analysis of lycopadiene. A. Expected ozonolysis products from 
lycopadiene. B. GC-MS analysis of crude ozonolysis products from lycopadiene showed 
a predominant peak (Peak 1) at 20.04 min. C. The mass spectra of Peak 1 showed a 
parent ion of m/z = 268 (in box) and was identified as the expected molecule 6,10,14-
trimethylpentadecan-2-one by the Shimadzu mass spectrum database. 
 
  
Ozonolysis
O
O
MW = 86
O
MW = 268
Lycopadiene
MW = 268
O
 
Peak 1
To
ta
l I
on
 C
ou
nt
s 
(1
09
)
Retention time (min)
 50 100 150 200 250 300 350 400 450 500 550 600
0
25
50
75
100
%
43
85 109
250165137
21039 268 309 546355 514 578490432 462336 394 600
m/z
R
el
at
iv
e 
ab
un
da
nc
e 
%
B
A
C
6,10,14-trimethylpentadecan-2-one6,10,14-trimethylpentadecan-2-one
  49 
 
Figure 16. Ozonolysis analysis of lycopatriene. A. Expected ozonolysis products from 
lycopatriene. B. GC-MS analysis of crude ozonolysis products from lycopatriene 
showed a predominant peak (Peak 1) at 20.04 min. C. The mass spectra of Peak 1 
showed a parent ion of m/z = 268 (in box) and was identified as the expected molecule 
6,10,14-trimethylpentadecan-2-one by the Shimadzu mass spectrum database. 
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Figure 17. Ozonolysis analysis of lycopapentaene. A. Expected ozonolysis products 
from lycopapentaene. B. GC-MS analysis of crude ozonolysis products from 
lycopapentaene showed a predominant peak (Peak 1) at 20.04 min. C. The mass spectra 
of Peak 1 showed a parent ion of m/z = 268 (ion in box) and was identified as the 
expected molecule 6,10,14-trimethylpentadecan-2-one by the Shimadzu mass spectrum 
database. 
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Table 1. NMR assignments for hydrocarbons from race L. 13C and 1H (in 
parentheses) chemical shifts determined for hydrocarbons from race L. Carbon 
numbering from 1 to 40 and 1 to 35 is the same as shown for lycopadiene and C35H64 in 
Figure 10, panel I and VII, respectively. 
 
 
 
 
 
	
 δ 13C (δ 1H) chemical shifts 
Carbon Lycopadiene Lycopatriene Lycopatetraene Lycopapentaene Lycopapentaene 
Isomer 
Lycopahexaene Lycopaoctaene C35H64 
1 22.7 (0.89) 25.7 (1.71) 25.7 (1.71) 25.7 (1.71) 25.7 (1.71) 25.7 (1.71) 25.7 (1.71) 26.0 (1.68) 
2 28.0 (1.54) 131.1 131.1 131.1 131.1 131.1 131.1 131.4 
3 39.4 (1.16) 125.1 (5.12) 125.2 (5.12) 124.2 (5.15) 124.8 (5.10) 124.3 (5.15) 124.3 (5.15) 124.8 (5.13) 
4 24.7 (1.29) 25.6 (1.98) 25.5 (1.99) 26.7 (2.09) 25.5 (1.99) 26.8 (2.06) 27.2 (2.03) 26.3 (2.01) 
5 37.4(1.08, 1.28) 37.1 (1.13, 1.34) 37.1 (1.13, 1.34) 39.8 (2.00) 37.1 (1.13, 1.34) 39.8 (1.99) 39.8 (2.00) 40.0 (1.98) 
6 32.8 (1.40) 32.7 (1.40) 32.7 (1.40) 135.9 32.7 (1.40) 135.9 135.9 135.1 
7 37.4 (1.08, 1.28) 37.4 (1.08, 1.28) 37.4 (1.08, 1.28) 124.2 (5.15) 36.6 (1.08, 1.28) 124.3 (5.15) 124.3 (5.15) 124.8 (5.13) 
8 24.5 (1.20, 1.34) 24.5 (1.20, 1.34) 24.5 (1.20, 1.34) 26.7 (2.09) 24.5 (1.20, 1.34) 26.8 (2.06) 27.2 (2.03) 26.3 (2.01) 
9 37.4 (1.08, 1.28) 37.4 (1.08, 1.28) 39.3 (1.95) 39.8 (2.00) 39.8 (2.00) 39.8 (1.99) 39.8 (2.00) 40.0 (1.98) 
10 31.2 (2.17) 30.8 (2.16) 135.9 135.9 135.9 135.9 135.9 135.1 
11 36.8 (1.09, 1.27) 36.8 (1.09, 1.27) 124.1 (5.15) 124.2 (5.15) 124.2 (5.15) 124.3 (5.15) 124.3 (5.15) 124.8 (5.13) 
12 25.4 (1.39) 25.4 (1.39) 25.5 (1.99) 26.7 (2.09) 26.7 (2.09) 26.8 (2.06) 27.2 (2.03) 27.2 (2.06) 
13 40.0 (1.96) 40.0 (1.96) 40.0 (1.96) 39.8 (2.00) 39.8 (2.00) 39.8 (1.99) 39.8 (2.00) 27.2 (2.06) 
14 135.9 135.9 135.9 135.9 135.9 135.9 135.9 124.8 (5.13) 
15 124.0 (5.15) 124.1 (5.15) 124.1 (5.15) 124.2 (5.15) 124.2 (5.15) 124.3 (5.15) 124.3 (5.15) 135.1 
16 28.3 (2.04) 28.3 (2.04) 28.3 (2.04) 28.3 (2.04) 28.3 (2.04) 28.3 (2.04) 28.3 (2.04) 40.0 (1.98) 
17 28.3 (2.04) 28.3 (2.04) 28.3 (2.04) 28.3 (2.04) 28.3 (2.04) 28.3 (2.04) 28.3 (2.04) 24.4 (1.62) 
18 124.0 (5.15) 124.1 (5.15) 124.1 (5.15) 124.2 (5.15) 124.2 (5.15) 124.3 (5.15) 124.3 (5.15) 37.7 (1.06, 1.24) 
19 135.9 135.9 135.9 135.9 135.9 135.9 135.9 33.0 (1.36) 
20 40.0 (1.96) 40.0 (1.96) 40.0 (1.96) 39.8 (2.00) 39.8 (2.00) 39.8 (1.99) 39.8 (2.00) 37.7 (1.06, 1.24) 
21 25.4 (1.39) 25.4 (1.39) 25.4 (1.39) 25.4 (1.39) 26.7 (2.09) 26.8 (2.06) 27.2 (2.03) 25.1 (1.21) 
22 36.8 (1.09, 1.27) 36.8 (1.09, 1.27) 36.6 (1.08, 1.28) 36.6 (1.08, 1.28) 124.2 (5.15) 124.3 (5.15) 124.3 (5.15) 37.7 (1.06, 1.24) 
23 31.2 (2.17) 30.8 (2.16) 30.8 (2.16) 31.0 (2.23) 135.9 135.9 135.9 33.0 (1.36) 
24 37.4 (1.08, 1.28) 37.4 (1.08, 1.28) 37.4 (1.08, 1.28) 37.4 (1.08, 1.28) 39.8 (2.00) 39.4 (1.96) 39.8 (2.00) 37.7 (1.06, 1.24) 
25 24.5 (1.20, 1.34) 24.5 (1.20, 1.34) 24.5 (1.20, 1.34) 24.5 (1.20, 1.34) 24.5 (1.20, 1.34) 24.5 (1.20, 1.34) 27.2 (2.03) 24.8 (1.19, 1.32) 
26 37.4 (1.08, 1.28) 37.4 (1.08, 1.28) 37.4 (1.08, 1.28) 37.4 (1.08, 1.28) 37.4 (1.08, 1.28) 36.6 (1.08, 1.28) 124.3 (5.15) 39.6 (1.13) 
27 32.8 (1.40) 32.7 (1.40) 32.7 (1.40) 32.8 (1.40) 32.7 (1.40) 32.8 (1.40) 135.9 28.2 (1.52) 
28 37.4 (1.08, 1.28) 37.4 (1.08, 1.28) 37.4 (1.08, 1.28) 37.4 (1.08, 1.28) 37.4 (1.08, 1.28) 37.4 (1.08, 1.28) 39.8 (2.00) 22.9 (0.86) 
29 24.7 (1.29) 24.7 (1.29) 24.7 (1.29) 24.7 (1.29) 24.7 (1.29) 24.7 (1.29) 27.2 (2.03) 17.9 (1.61) 
30 39.4 (1.16) 39.4 (1.16) 39.4 (1.16) 39.4 (1.16) 39.4 (1.16) 39.4 (1.16) 124.3 (5.15) 16.3 (1.61) 
31 28.0 (1.54) 28.0 (1.54) 28.0 (1.54) 28.0 (1.55) 28.0 (1.55) 28.0 (1.55) 135.9 16.3 (1.61) 
32 22.7 (0.89) 22.7 (0.89) 22.7 (0.89) 22.7 (0.89) 22.7 (0.89) 22.7 (0.89) 25.7 (1.71) 16.3 (1.61) 
33 22.7 (0.89) 17.6 (1.63) 17.6 (1.63) 17.7 (1.63) 17.7 (1.63) 17.7 (1.63) 17.7 (1.63) 20.0 (0.83) 
34 19.7 (0.87) 19.7 (0.87) 19.7 (0.87) 16.0 (1.62) 19.8 (0.87) 16.0 (1.61) 16.0 (1.62) 20.0 (0.83) 
35 19.7 (0.87) 19.7 (0.87) 15.9 (1.61) 16.0 (1.62) 16.0 (1.62) 16.0 (1.61) 16.0 (1.62) 22.9 (0.86) 
36 15.9 (1.61) 15.9 (1.61) 15.9 (1.61) 16.0 (1.62) 16.0 (1.62) 16.0 (1.61) 16.0 (1.62)  
37 15.9 (1.61) 15.9 (1.61) 15.9 (1.61) 16.0 (1.62) 16.0 (1.62) 16.0 (1.61) 16.0 (1.62)  
38 19.7 (0.87) 19.7 (0.87) 19.7 (0.87) 19.8 (0.87) 16.0 (1.62) 16.0 (1.61) 16.0 (1.62)  
39 19.7 (0.87) 19.7 (0.87) 19.7 (0.87) 19.8 (0.87) 19.8 (0.87) 19.8 (0.87) 16.0 (1.62)  
40 22.7 (0.89) 22.7 (0.89) 22.7 (0.89) 22.7 (0.89) 22.7 (0.89) 22.7 (0.89) 17.7 (1.63)  
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Figure 18. NMR analysis of lycopadiene. 2D-13C-HSQC spectrum of lycopadiene. 
Positive (red) contours represent -CH or -CH3 correlations, while negative (green) 
contours indicate -CH2. Peaks originating from the molecule of interest are marked with 
resonance assignment, while those from impurities are left unmarked. Peaks aliased on 
13C axis are shown in a dashed line box. 
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Figure 19. NMR analysis of lycopatriene. Positive (red) contours represent -CH or -
CH3 correlations, while negative (green) contours indicate -CH2. Peaks originating from 
the molecule of interest are marked with resonance assignment, while those from 
impurities are left unmarked. Peaks aliased on 13C axis are shown in a dashed line box. 
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Figure 20. NMR analysis of lycopatetraene. 2D-13C-HSQC spectrum of 
lycopatetraene. Positive (red) contours represent -CH or -CH3 correlations, while 
negative (green) contours indicate -CH2. Peaks originating from the molecule of interest 
are marked with resonance assignment, while those from impurities are left unmarked. 
Peaks aliased on 13C axis are shown in a dashed line box. 
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Figure 21. NMR analysis of lycopapentaene. 2D-13C-HSQC spectrum of 
lycopapentaene. Positive (red) contours represent -CH or -CH3 correlations, while 
negative (green) contours indicate -CH2. Peaks originating from the molecule of interest 
are marked with resonance assignment, while those from impurities are left unmarked. 
Peaks aliased on 13C axis are shown in a dashed line box. 
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Figure 22. NMR analysis of lycopapentaene isomer. Positive (red) contours represent 
-CH or -CH3 correlations, while negative (green) contours indicate -CH2. Peaks 
originating from the molecule of interest are marked with resonance assignment, while 
those from impurities are left unmarked. Peaks aliased on 13C axis are shown in a dashed 
line box. 
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Figure 23. NMR analysis of lycopahexaene. 2D-13C-HSQC spectrum of 
lycopahexaene. Positive (red) contours represent -CH or -CH3 correlations, while 
negative (green) contours indicate -CH2. Peaks originating from the molecule of interest 
are marked with resonance assignment, while those from impurities are left unmarked. 
Peaks aliased on 13C axis are shown in a dashed line box. 
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Figure 24. NMR analysis of C35H64. 2D-13C-HSQC spectrum of C35H64. Positive (red) 
contours represent -CH or -CH3 correlations, while negative (green) contours indicate -
CH2. Peaks originating from the molecule of interest are marked with resonance 
assignment, while those from impurities are left unmarked. Peaks aliased on 13C axis are 
shown in a dashed line box. 
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Figure 25. NMR analysis of lycopaoctaene. 2D-13C-HSQC spectrum of lycopaoctaene. 
Positive (red) contours represent -CH or -CH3 correlations, while negative (green) 
contours indicate -CH2. Peaks originating from the molecule of interest are marked with 
resonance assignment, while those from impurities are left unmarked. Peaks aliased on 
13C axis are shown in a dashed line box. 
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Figure 26. Hydrocarbon-related enzyme activities in B. braunii race L.  
A. Radioactive enzyme assays were conducted using different protein fractions of race L 
cell lysates to test the two possible lycopadiene biosynthetic pathways. Enzyme 
activities were calculated based on the incorporation of 3H-GGPP into lycopaoctaene, 
3H-PPP into lycopadiene, and 3H-FPP into squalene. Squalene synthase enzyme activity 
is used as a positive control. Values shown are the mean ± standard error obtained from 
three independent experiments (n = 3). B. Lycopaoctaene synthase (LOS) enzyme 
activity, growth rate (dry biomass accumulation), and total hydrocarbon production in 
race L over a 39-day culture period. Race L shows a rapid increase in growth rate after 
12 days of inoculation into new medium, and a direct correlation between LOS enzyme 
activity and hydrocarbon accumulation was observed, with LOS activity increasing 
rapidly after day 30 of the culture cycle. 
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localized to a membrane system, possibly the ER as is seen for SS82. Tellingly, LOS 
activity in these assays was detected when using the same cofactor and divalent metal 
cation as those used for SS activity measurement. These results suggest direct 
lycopadiene biosynthesis from PPP is not a significant contributor to C40 hydrocarbon 
production in race L, while conversion of GGPP into lycopaoctaene occurs readily, as 
proposed in the second hypothetical route (Figure 9B). Correspondingly, LOS enzyme 
activity directly correlated with lycopadiene accumulation over the growth cycle, 
suggesting this activity is related to hydrocarbon biosynthesis (Figure 26B). Detection of 
LOS activity from an algal homogenate in an assay similar to that of SS supports the 
notion that an LOS enzyme may be similar to a typical SS enzyme. 
2.2b GGPP is a precursor for tetraterpenoid hydrocarbons in race L 
To investigate whether GGPP is incorporated into lycopaoctaene, which would 
act as the precursor for lycopadiene and its unsaturated homologues, we conducted a 
pulse-chase experiment using 14C-geranylgeraniol (GGOH) instead of 14C-GGPP. 
GGOH was used for two reasons; first, GGPP will not be taken up by cells due to the 
highly charged diphosphate moiety, and second prenyl alcohols such as GGOH and FOH 
have been shown to be converted to their mono and diphosphate versions once taken up 
by plant cells111 including B. braunii, race B112. We confirmed that enzyme activities 
exist in B. braunii race L for the conversion of GGOH first to GGP and subsequently to 
GGPP (Figure 27A) as has been seen in tobacco111. After a 48-hour 14C-GGOH pulse, 
algae cells were transferred to fresh media containing non-labelled GGOH, samples 
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Figure 27. Geranylgeraniol kinase assay and radioactive feeding experiment. 
GGOH = Geranylgeraniol. A. The kinase assay shows incorporation of 14C-GGOH into 
14C-geranylgeranyl monophosphate (GGP) and 14C-geranylgeranyldiphosphate (GGPP) 
by a microsomal protein fraction of race L. B. Pulse-Chase experiments were conducted 
to analyze relationships between precursor and intermediate levels related to lycopadiene 
biosynthesis. Algae cells were pulsed with 14C-GGOH and chased with nonlabelled 
GGOH for 72-hours followed by determination of 14C incorporation into individual 
hydrocarbons. Data shown in (A) and (B) are an representatives from three independent 
experiments (n = 3). 
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collected over a 72 hour chase, hydrocarbons extracted and separated by thin layer 
chromatography (TLC), and radioactive incorporation into each hydrocarbon molecule 
determined (Figure 27B). Incorporation of 14C into lycopaoctaene was determined based 
on the TLC spot with an identical Rf value to a lycopaoctaene standard (generated in yeast 
as described below). 14C incorporation into lycopahexaene and lycopatetraene could not 
be separated due to TLC comigration. Except for lycopapentaene and lycopadiene, 14C 
incorporation into lycopaoctaene, lycopahexaene/lycopatetraene, and lycopatriene was 
low and remained constant over the 72-hour chase (Figure 27B) suggesting rapid reduction 
of these molecules to their respective higher saturated homologues. In contrast, 14C 
incorporation into lycopapentaene increased over the chase and eventually surpassed the 
radioactivity incorporated into lycopadiene (Figure 27B). This was surprising since 
lycopapentaene accounts for only 3% of the total hydrocarbon fraction (Figure 10) 
suggesting reduction of lycopapentaene as a rate-limiting step in lycopadiene biosynthesis. 
Furthermore, 14C incorporation into lycopadiene increased until 12-hours and then 
declined until 72-hours after the chase (Figure 27B). This is consistent with previous 
studies showing lycopadiene is further utilized to make the cross-linked hydrocarbon 
network forming the race L extracellular matrix113, 114. Altogether, the feeding experiments 
show GGPP is the direct precursor for lycopaoctaene production, with lycopahexaene, 
lycopapentaene, lycopatetraene and lycopatriene as intermediates in lycopadiene 
biosynthesis. 
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2.2c Identification of a lycopaoctaene synthase enzyme 
To identify the gene(s) responsible for lycopaoctaene biosynthesis, we generated 
and computationally screened an L race transcriptomic database for SS-like sequences. 
Two SS-like cDNAs were identified and named based on the function of their encoded 
proteins as detailed below; SS from race L (LSS) and lycopaoctaene synthase (LOS). 
Both the LSS and LOS proteins contain all five conserved activity domains, the 
transmembrane domain, and the NADPH binding residues found in typical SS enzymes 
(Figures 28 and 29)79. Comparison of the encoded amino acid sequences showed 57.5% 
and 49.2% identity to SS from race B (BSS)57 for LSS and LOS, respectively (Figure 
29). Additionally, comparison of LOS with other SS and SS-like enzymes showed 
52.5% identity to LSS, 47.3% identity to the Solanum lycopersicum (tomato) SS (SlSS), 
44.6%, 61.7%, and 44.1% identity to the squalene synthase-like enzymes (SSL) 1, 2, and 
3 from the B race of B. braunii, and 33.9% identity to the human SS (HSS; Figure 29). 
Several studies79, 81, 92, 93, including the recent determination of the crystal structure of 
HSS94, have elucidated the catalytic mechanism of the SS reaction. These studies have 
shown the FLAP domain, domains I – V, and the JK loop of HSS form the SS active 
site94. Furthermore, several HSS residues (Ser51, Ser53, Tyr171, Gln212), two DXXED 
motifs in domains II and IV, and the NADPH-binding residues were determined to be 
key for catalytic activity (Figure 29)94. All of these catalytic residues and motifs are also 
conserved in both the LSS and LOS enzymes (Figure 29), making it difficult at this time  
to determine which domains/residues are specific for LOS activity in a comparison of 
LSS and LOS. 
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Figure 28. Protein domain alignment of SS-like cDNAs from B. braunii. SS= 
squalene synthase, BSS = race B SS, LSS = race L SS, LOS = lycopaoctaene synthase 
from race L. 
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Figure 29. Amino acid sequence alignment of SS and SS-like proteins.  FLAP region, 
five conserved domains and putative NADPH binding residues (indicated in red) found 
in typical squalene synthase are labeled and shown in bold. Possible transmembrane 
region(s) predicted by TMpred for each protein are underlined. HSS = human squalene 
synthase, LOS = lycopaoctaene synthase, LSS = race L SS, BSS = race B SS, SlSS = SS 
from Solanum lycopersicum, and SSL-1, SSL-2, SSL-3, SS-like enzymes from race B. 
 
Protein % identity to LOS
LSS 52.5
BSS 49.2
SlSS 47.3
SSL-1 44.6
SSL-2 61.7
SSL-3 44.1
HSS 33.9
Supplementary Figure 18. Amino acid sequence alignment and percent identity of SS and SS-like proteins using Clustal Omega.  FLAP 
region, five conserved domains and putative NADPH binding residues (indicated in red) found in typical squalene synthase are labeled and 
shown in bold. Possible transmembrane region(s) predicted by TMpred for each protein are underlined. HSS = human squalene synthase, 
LOS = lycopaoctaene synthase, LSS = race L SS, BSS = race B SS, SlSS = SS from Solanum lycopersicum, and SSL-1, SSL-2, SSL-3, 
SS-like enzymes from race B.
FLAP
Domain I Domain II
Domain III
Domain IV
Domain V JK loop
HSS    AVTLMMDATNMPAVKAIIYQYMEEIYHRIPD---SDPSSSKTRQIISTIRTQNLPNCQ--------L 376 
        . :.        .          :  :       **  : * : :  :          
 
LOS    AKGP-STAMVLAGALLIAALAYFAYVYSAGGTSLKA-LPLFG--VVIILAIGLFGRNLALKTV---- 444 
LSS    AATPLSDDFI-SKLVLVLGLGYCVYAFNLLPLLWKSALIPGPPPPALTSSLGLPHQIIAVFCVLTAG 452 
BSS    -----FDELRSRLLALTGGSFYLAWTYNFLDLRGPGDLPTFLSVTQHWWSILIFLISIAV------- 446 
SlSS   RNEPNYSPVLIVVI-------FIILAIILAQLFGSRS------------------------------ 411 
SSL-1  SFCAAPTPTK--------------------------------------------------------- 403 
SSL-2  SGSALTDDPAIRLLLLVGVVAYFAYAFNLGDVRGEHGVRALG--SILD--L--SQKGLAVASVALLL 446 
SSL-3  GA----------------------------------------------------------------- 383 
HSS    ISRSHYSPIYLSFVMLLAAL---SWQYLTTLSQVTEDYVQTGEH----------------------- 417 
  
 
LOS    ------------------- 444 
LSS    YQVFLRGGLA--------- 462 
BSS    --FFIPSRPSPRPTLSA-- 461 
SlSS   ------------------- 411 
SSL-1  ------------------- 403 
SSL-2  LVLLARSRLPLLTSASSKQ 457 
SSL-3  ------------------- 383 
HSS    ------------------- 417 
                                                                     
LOS    -------MKYTDFLAHPDEIIPTIRMMYADYRLK----NMEIKDPSVRFCYNMLNRVSRSFAMVIQQ 56 
LSS    ------MGKLQEVLKHPDELVPLMQMLVSDYYTK----I-VPRDPGLGFCYRMLNKVSRSFAIVIQQ 56 
BSS    ---MGMLRWGVESLQNPDELIPVLRMIYADKFGK----I-KPKDEDRGFCYEILNLVSRSFAIVIQQ 59 
SlSS   ------MGTLRAILKNPDDLYPLIKLKLAARHAE----KQIPPEPHWGFCYLMLQKVSRSFALVIQQ 57 
SSL-1  MTMHQDHGVMKDLVKHPNEFPYLLQLAATTYGSPA---APIPKEPDRAFCYNTLHTVSKGFPRFVMR 64 
SSL-2  ------MVKLVEVLQHPDEIVPILQMLHKTYRAK----R-SYKDPGLAFCYGMLQRVSRSFSVVIQQ 56 
SSL-3  -------MKLREVLQHPGEIIPLLQMMVMAYRRK----R-KPQDPNLAWCWETLIKVSRSYVLVIQQ 55 
HSS    -------MEFVKCLGHPEEFYNLVRFRIGGKRKVMPKMDQDSLSSSLKTCYKYLNQTSRSFAAVIQA 60 
                    : .* ::   :::                 .     *:  *  .*:.:  .:   
 
LOS    LPVELRDATCVFYLILRALDTVEDDMAIPKEVKIPMLRTFHEHLSDRSWKIKCGY-GPYVDLMDNYP 122 
LSS    LPELLRDPICVFYLVLRALDTVEDDMALPNDIKLPLLRAFHKKIYDRKWSMKCGY-GPYVQLMEEYP 122 
BSS    LPAQLRDPVCIFYLVLRALDTVEDDMKIAATTKIPLLRDFYEKISDRSFRMTAGDQKDYIRLLDQYP 126 
SlSS   LPVELRDAVCIFYLVLRALDTVEDDTSIPTDVKVPILISFHQHVYDREWHFACGT-KEYKVLMDQFH 123 
SSL-1  LPQELQDPICIFYLLLRALDTVEDDMNLKSETKISLLRVFHEHCSDRNWSMKSDY-GIYADLMERFP 130 
SSL-2  LPDELRHPICVFYLILRALDTVEDDMNLPNEVKIPLLRTFHEHLFDRSWKLKCGY-GPYVDLMENYP 122 
SSL-3  LPEVLQDPICVNYLVLRGLDTLQDDMAIPAEKRVPLLLDYYNHIGDITWKPPCGY-GQYVELIEEYP 121 
HSS    LDGEMRNAVCIFYLVLRALDTLEDDMTISVEKKVPLLHNFHSFLYQPDWRFMESK-EKDRQVLEDFP 126 
       *   ::.  *: **:**.***::**  :    :: :*  ::.   :  :            ::: : 
 
LOS    LVTDVYLRFDEGTKAVIKDITRRMGNGMADFIDLDEVLTIPQYDLYCHYVAGLCGIGMCKLFVDSGL 189 
LSS    MVTGVFLKLDPGPREVITEICRKMGAGMAEFIPK-EVLTVKDYDQYCHYAAGLVGEGLSKLAVGSGL 188 
BSS    KVTSVFLKLTPREQEIIADITKRMGNGMADFVHKGVPDTVGDYDLYCHYVAGVVGLGLSQLFVASGL 193 
SlSS   HVSTAFLELGKLYQQAIEDITMRMGAGMAKFICK-EVETTDDYDEYCHYVAGLVGLGLSKLFHASGK 189 
SSL-1  LVVSVLEKLPPATQQTFRENVKYMGNGMADFIDK-QILTVDEYDLYCHYVAGSCGIAVTKVIVQFNL 196 
SSL-2  LVTDVFLTLSPGAQEVIRDSTRRMGNGMADFIGKDEVHSVAEYDLYCHYVAGLVGSAVAKIFVDSGL 189 
SSL-3  RVTKEFLKLNKQDQQFITDMCMRLGAEMTVFLKR-DVLTVPDLDLYAFTNNGPVAICLTKLWVDRKF 187 
HSS    TISLEFRNLAEKYQTVIADICRRMGIGMAEFLDK-HVTSEQEWDKYCHYVAGLVGIGLSRLFSASEF 192 
        :      :    :  : :    :*  *: *:      :  : * *..   *  .  : :: 
 
LOS    EKEDLVAEEDLANQMGLFLQKNNIVRDYLEDINELPAPRMFWPKEIWGNYAKQLDEFKDPKNLDKAM 256 
LSS    ENPVLLQKEDLSNHMGLFLQKTNIVRDYLEDINEEPAPRMFWPKEIWGKYTKDLADFKDPANEKGAV 255 
BSS    QSPSLTRSEDLSNHMGLFLQKTNIIRDYFEDINELPAPRMFWPREIWGKYANNLAEFKDPANKAAAM 260 
SlSS   ED---LASDSLSNSMGLFLQKTNIIRDYLEDINEVPKCRMFWPREIWSKYVNKLEDLKYEENSVKAV 253 
SSL-1  ATPE-ADSYDFSNSLGLLLQKANIITDYNEDINEEPRPRMFWPQEIWGKYAEKLADFNEPENIDTAV 262 
SSL-2  EKENLVAEVDLANNMGQFLQKTNVIRDYLEDINEEPAPRMFWPREIWGKYAQELADFKDPANEKAAV 256 
SSL-3  ADPKLLDREDLSGHMAMFLGKINVIRDIKEDVLEDP-PRIWWPKEIWGKYLKDLRDIIKPEYQKEAL 253 
HSS    EDPLVGEDTERANSMGLFLQKTNIIRDYLEDQQ---GGREFWPQEVWSRYVKKLGDFAKPENIDLAV 256 
                . :  :. :* * *:: *  **       * :**:*:*..* :.* ::        *: 
 
LOS    LCLNHMVTDALRHCEVGLRSLSLLHNPNILRAVLIPQVMGVRTLTLVYNNPEVFRG---VVKMRRGE 320 
LSS    QCLNHMVTDALRHGEHALKYMALLRDPQYFNFCAIPQVMAFGTLSLCYNNPQVFKG---VVKLRKGE 319 
BSS    CCLNEMVTDALRHAVYCLQYMSMIEDPQIFNFCAIPQTMAFGTLSLCYNNYTIFTGPKAAVKLRRGT 327 
SlSS   QCLNDMVTNALSHVEDCLTYMFNLHDPAIFRFCAIPQVMAIGTLAMCYDNIEVFRG---VVKMRRGL 317 
SSL-1  KCLNHMVTDAMRHIEPSLKGMVYFTDKTVFRALALLLVTAFGHLSTLYNNPNVFKE---KVRQRKGR 326 
SSL-2  QCLNHMVTDALRHCEIGLNVIPLLQNIGILRSCLIPEVMGLRTLTLCYNNPQVFRG---VVKMRRGE 320 
SSL-3  ACLNDILTDALRHIEPCLQYMEMVWDEGVFKFCAVPELMSLATISVCYNNPKVFTG---VVKMRRGE 317 
HSS    QCLNELITNALHHIPDVITYLSRLRNQSVFNFCAIPQVMAIATLAACYNNQQVFKG---AVKIRKGQ 320 
        ***.::*:*: *    :  :  . :   :.   :    ..  ::  *:*  :*      *: *:*  
 
LOS    TAKIFVTTTSKLSFFRTYLQFANEMEQKCLTEAKNDPMVALTLKRVQGVQAACRAAIVKAEIAE--G 385 
LSS    SAKLMTTVKSMPALYRTFLRMADDMVARCKGEARQDPNVATTLKRLQAIQAVCKTGLRSSIKSRKKQ 386 
BSS    TAKLMYTSNNMFAMYRHFLNFAEKLEVRCNTETSEDPSVTTTLEHLHKIKAACKAGLARTKDDT--- 391 
SlSS   TAKVIDRTKTMADVYGAFFDFSCMLKSKVNN---NDPNATKTLKRLDAILKTCRDSGTLNKRKSYII 381 
SSL-1  IARLVMSSRNVPGLFRTCLKLANNFESRCKQETANDPTVAMTIKRLQSIQATCRDGLAKYDTPSGLK 393 
SSL-2  TAKLFMSIYDKRSFYQTYLRLANELEAKCKGEASGDPMVATTLKHVHGIQKSCKAALSSKELLA--K 385 
SSL-3  TAKLFLSVTNMPALYKSFSAIAEEMEAKCVR---EDPNFALTVKRLQDVQALCKAGLAKSNGKVSAK 381 
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For initial characterization of the enzymatic activity of LSS and LOS, both 
proteins were expressed in E. coli and the purified recombinant proteins tested for 
enzyme activity. LSS was shown to yield squalene as its sole product in an in vitro assay 
with FPP as the substrate, as expected (Figures 30A and 30B, panel I). However, 
purified recombinant LOS incubated with GGPP in an in vitro assay showed 
lycopaoctaene as the sole reaction product (Figures 30A and 30B, panel II). Since LOS 
may have arisen from an SS paralogue that evolved to accept GGPP as substrate for 
lycopaoctaene production, we considered that LOS may have retained the ability to 
utilize FPP to produce squalene. Indeed, squalene production was detected when LOS 
was incubated with FPP in an in vitro reaction (Figures 30A and 30B, panel III). More 
surprising, LOS incubation with PPP yielded lycopadiene, albeit at levels much lower 
than lycopaoctaene or squalene (Figures 30A and 30B, panel IV). Similar in vitro 
incubations of LSS with GGPP or PPP did not result in lycopaoctaene or lycopadiene 
production (see below). Because LOS can utilize three different substrates, steady state 
kinetic experiments were performed with FPP, GGPP, and PPP to analyze LOS substrate 
specificity. The LOS enzyme shows higher substrate affinity (Km) for GGPP compared 
to that of FPP and PPP, and the turnover number (kcat) and catalytic efficiency (Kcat/Km) 
for PPP are an order of magnitude less than for FPP and GGPP (Figure 31). 
To further characterize LOS, it was coexpressed in yeast with Arabidopsis 
thaliana GGPP synthase-11 (AtGGPPS11)115 since unlike FPP, yeast GGPP biosynthesis  
is limited and considered a bottleneck for GGPP-derived isoprenoid production116. 
Coexpression of LOS and AtGGPPS11 in yeast resulted in lycopaoctaene production 
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Figure 30. Functional characterization of SS-like enzymes from race L. A. Diagram 
of reactions showing substrates and products for the analysis in B and D. B. GC-MS 
profiles of LSS and LOS in vitro reaction products: I, LSS products using FPP as 
substrate to produce squalene (1); II, LOS products using GGPP as substrate to produce 
lycopaoctaene (3); III, LOS products using FPP as substrate to produce squalene (1); and 
IV, LOS products using PPP as substrate to produce lycopadiene (2). C. GC-MS profiles 
of LOS yeast in vivo reaction products: I, n-hexane extractable metabolites of yeast 
expressing AtGGPPS11 and LOS to make lycopaoctaene (3); or II, yeast expressing 
AtGGPPS11 alone. D. Expression of LSS and LOS in the SS (ERG9) yeast knockout 
strain: I, in the presence of ergosterol; or II, absence of ergosterol to test restoration of 
ergosterol prototrophy. The control carries the expression vector without a transgene. 
Data shown in (B), (C) and (D) are an representatives from three independent 
experiments (n = 3). 
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Figure 31. Kinetics of the LOS enzyme reaction with different substrates. A. LOS 
kinetics using geranylgeranyl diphosphate (GGPP) as substrate. B. LOS kinetics using 
farnesyl diphosphate (FPP) as substrate. C. LOS kinetics using phytyl diphosphate (PPP) 
as substrate. Values shown are the mean ± standard error obtained from three 
independent measurements. 
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(Figure 30C, panel I), which was undetectable when AtGGPPS11 was expressed without 
LOS (Figure 30C, panel II). Furthermore, when expressed in a yeast SS knockout strain, 
LOS restored ergosterol prototrophy indicating its ability to produce squalene in vivo 
(Figure 30D, panel I and II). LSS was also able to restore ergosterol prototrophy as 
expected (Figure 30D, panel I and II). Taken together, the results in Figure 30 suggest 
LSS is a true SS enzyme, whereas LOS appears to be a promiscuous SS-like enzyme 
with broader substrate chain length and saturation specificity. 
Previous studies have reported the production of lycopaoctaene (a.k.a. 
lycopersene) in vitro from protein extracts during studies conducted to decipher the 
carotenoid biosynthetic pathway32-34, but subsequent studies determined lycopaoctaene 
could not be an intermediate in carotenoid biosynthesis35,36 raising the possibility that 
lycopaoctaene production in these studies was an in vitro artifact. A more relevant study 
reported the ability of purified yeast SS to utilize GGPP for lycopaoctaene production in 
vitro, at levels much lower than native squalene production37. Importantly, we did not 
detect any lycopaoctaene production when AtGGPPS11 was expressed alone in wild-
type yeast (Figure 30C, panel II), suggesting that yeast SS does not utilize GGPP in vivo 
under the conditions employed. Similarly, the ability of LOS to catalyze the conversion 
of PPP to lycopadiene may not have biological significance as we did not detect 
lycopadiene production using PPP as the substrate ex vivo in race L cell lysates (Figure 
26A), and the efficiency of LOS to use PPP as a substrate is quite low (Figure 31). 
Together, these results suggest that the relevant in vivo route to lycopadiene production 
is unlikely to involve the condensation of two PPP molecules by LOS, but rather, as we 
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contend, the condensation of two GGPP molecules to form lycopaoctaene, for eventual 
conversion to lycopadiene. 
2.2d LOS is promiscuous towards prenyl substrates 
The LOS enzyme was further characterized using combinations of FPP, GGPP 
and PPP as substrates in in vitro reactions. Interestingly, in the presence of FPP and 
GGPP LOS produced significant amounts of squalene and a C35H58 molecule, and lesser 
amounts of lycopaoctaene (Figure 32, panel I). The C35H58 molecule is a chimera 
produced from head-to-head condensation of one FPP molecule and one GGPP 
molecule, and its identity was confirmed by GC-MS (Figure 33). Next, when LOS was 
supplied with FPP and PPP, squalene production predominated with small amounts of 
C35H64 and lycopadiene (Figure 32, panel II). C35H64, also a chimeric hydrocarbon, is 
produced as a result of head-to-head condensation of one molecule each of FPP and PPP. 
Finally, LOS incubation with GGPP and PPP produced lycopadiene and lycopapentaene 
as minor products and lycopaoctaene as the major product (Figure 32, panel III). 
To the best of our knowledge, this is the first report where a wild type, non-
mutated eukaryotic SS or SS-like enzyme has been shown to be able to utilize three 
naturally occurring prenyl diphosphate substrates to yield hydrocarbon products in all 
possible combinations. To support this notion, several SS and SS-like enzymes were 
tested for their ability to utilize FPP, GGPP, and PPP as substrates (Figure 34). The 
enzymes tested included LOS and three typical SS enzymes; LSS, BSS, and SlSS.  
Additionally, SS-like enzymes SSL-1, SSL-2, and SSL-3 from race B were chosen 
because of their SS-like activities. SSL-1 utilizes FPP to produce PSPP, which is then 
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Figure 32. Characterization of substrate use of LOS enzyme. Diagram of reactions 
showing substrates and products and GC-MS profiles of LOS enzyme assay products 
with: I, Farnesyl diphosphate (FPP) and geranylgeranyl diphosphate (GGPP) substrates 
to produce squalene (1), C35H58 (3) and lycopaoctaene (6); II, FPP and phytyl 
diphosphate (PPP) substrates to make squalene (1), C35H64 (2) and lycopadiene (4); and 
III, GGPP and PPP substrates to produce lycopadiene (4), lycopapentaene (5) and 
lycopaoctaene (6). Data shown are representatives from three independent experiments 
(n = 3).  
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Figure 33. Analysis of C35H58 by GC-MS. The mass spectrum and structure of the 
C35H58 molecule produced by the LOS enzyme when FPP and GGPP are used in 
combination as substrate. Molecular ion in box corresponds to the parent ion of the 
molecule. 
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Figure 34. Characterization of substrate use for SS & SS-like enzymes. Radioactive 
enzyme assays using 3H substrates geranylgeranyl diphosphate (GGPP), farnesyl 
diphosphate (FPP) and phytyl diphosphate (PPP) with selected SS or SS-like enzymes. 
SSL-1 produces presqualene diphosphate (PSPP) from FPP substrate, however, PSPP 
was not analyzed for in this assay. LOS, lycopaoctaene synthase; LSS, race L SS; BSS, 
race B SS; SlSS, SS from Solanum lycopersicum (tomato); and SSL-1, SSL-2, SSL-3, 
SS-like enzymes from the B race of B. braunii. Values shown are the mean ± standard 
error obtained from three independent measurements (n = 3). 
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converted by SSL-2 to squalene, or by SSL-3 to C30-botryococcene as the major product 
and squalene as a minor product38. As shown in figure 34, the typical SS enzymes 
display SS activity as their main catalytic function, with BSS and SlSS also utilizing PPP 
to produce minute amounts of lycopadiene. In contrast, the B race SSL enzymes have 
limited substrate flexibility, allowing SSL-2 and SSL-1 plus SSL-2 to use GGPP to 
generate minor amounts of lycopaoctaene (Figure 34). However, LOS is the only 
enzyme tested that is able to utilize all three substrates and to produce significant 
amounts of lycopaoctaene, squalene, and lycopadiene (Figure 34). 
2.2e The LOS reaction uses a cyclopropyl intermediate 
We next conducted enzyme assays to determine if the LOS reaction mechanism 
with GGPP as substrate is similar to that of SS, i.e. utilizes a PSPP-like cyclopropyl 
diphosphate intermediate, which is termed prelycopaoctaene diphosphate (PLPP; Figure 
35A). First, assays were conducted with or without a dinucleotide reducing agent, which 
would be required to convert PLPP to lycopaoctaene (Figure 35A). LOS successfully 
utilized both NADH and NADPH as reducing agents for lycopaoctaene production, with 
preference for NADPH (Figure 35B). In the absence of a dinucleotide reducing agent 
LOS activity was lost (Figure 35B), suggesting the presence of the PLPP reaction 
intermediate. This result is consistent with previous reports where yeast SS utilized 
GGPP in vitro to produce lycopaoctaene; however, without NADH or NADPH only the 
reaction intermediate PLLPP accumulated117. Next, we showed that LOS is strongly 
inhibited by squalestatin (Figure 35C), a potent SS inhibitor that mimics PSPP 
binding105, 118-120. Finally, we identified PLPP as a reaction intermediate by conducting a  
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Figure 35. Characterization of the lycopaoctaene synthase reaction intermediate. A. 
Proposed LOS reaction mechanism to produce the prelycopaoctaene diphosphate (PLPP) 
intermediate and lycopaoctaene final product. B. Radioactive LOS enzyme assays 
conducted with 3H-GGPP substrate with or without NADH or NADPH reducing agents. 
Values shown are the mean ± standard error obtained from three independent 
measurements (n = 3). C. GC-MS profiles of LOS enzyme assay with GGPP as substrate 
to produce lycopaoctaene (1): I, in the absence; or II, presence of 20 nM squalestatin. D. 
GC-MS profile of products from LOS enzyme assay with GGPP substrate in the absence 
of NADPH to produce PLPP, which was hydrolyzed by acid phosphatase to yield 
prelycopaoctaene alcohol (PLOH) for GC-MS analysis. Data shown in (C) and (D) are 
representatives from three different experiments (n = 3). 
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Figure 36. GC-MS analysis of prelycopaoctaene alcohol (PLOH). A. Expected mass 
spectral fragmentation pattern of PLOH. Mass fragmentation pattern of PLOH shown 
above is adapted from Quershi et al, J. Biol. Chem. 248:2755-2767 (1973). B. The mass 
spectrum of PLOH molecule when analyzed in chemical ionization mode.  Molecular 
ion in box corresponds to the parent ion of the PLOH molecule and other ionic species in 
red correspond to fragments of PLOH molecule as shown above in A. 
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GGPP-based LOS assay in the absence of NADPH, followed by acid phosphatase 
treatment to convert PLPP to prelycopaoctaene alcohol (PLOH). Analysis by GC-MS 
showed the presence of PLOH (Figure 35D) with a fragmentation pattern consistent with 
previous reports of PLOH (Figure 36)37. Taken together, these results are consistent with 
a two-step LOS reaction to produce lycopaoctaene. By analogy to SS, LOS catalyzes the 
condensation of two GGPP units in the first half reaction to form the 
cyclopropylcarbinyl diphosphate intermediate PLPP, with concomitant release of one 
molecule of inorganic pyrophosphate (PPi; Figure 35A). In the second half reaction, the 
PLPP cyclopropyl ring is cleaved and rearranged to form a 1-1’ linkage, and further 
reduction by NADPH forms lycopaoctaene (Figure 35A). 
2.2f Characterization of geranylgeranyl reductase-like genes from race L 
Altogether our data supports the second possibility of lycopadiene biosynthesis 
where the LOS enzyme catalyzes the dimerization of two GGPP molecules to produce 
the eight double bond containing lycopaoctaene in the first step, which would then be 
sequentially reduced to produce lycopahexaene, lycopapentaene, lycopatetraene, 
lycopatriene, and lycopadiene (Figure 37). These multiple reductions could be catalyzed 
by a multifunctional reductase or multiple reductases with each enzyme catalyzing a 
stepwise reduction to form lycopadiene as the final product. The pulse-chase experiment 
with 14C-GGOH showed reduction of lycopapentaene to lycopatetraene as the rate 
limiting step of the lycopadiene biosynthetic pathway (Figure 27B). This data suggests 
that at least two reductase enzymes could be involved in the reduction of lycopaoctaene  
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Figure 37. Proposed pathway for lycopadiene biosynthesis. The lycopaoctaene 
synthase (LOS) enzyme utilizes geranylgeranyl diphosphate (GGPP) in a two-step 
reaction to produce lycopaoctaene, which is further reduced by an unknown enzyme(s) 
to produce lycopahexaene, lycopapentaene, lycopatetraene, lycopatriene and finally 
lycopadiene. 
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to lycopadiene (Figure 37). The first putative reductase enzyme could reduce 
lycopaoctaene to lycopapentaene in a multi-step reduction reaction (Figure 37).  
Similarly, double bond reduction of lycopapentaene to lycopadiene could be catalyzed 
by second putative reductase enzyme in the pathway (Figure 37). This hypothesis is 
further supported by the structures of the lycopadiene intermediates. As shown in figure 
37, reduction from lycopaoctaene to lycopapentaene shows reduction of the double 
bonds on one half of the molecule, and the reduction from lycopapentaene to 
lycopadiene involves the other half of the molecule. 
Since each half of lycopaoctaene is made from a prenyl moiety of GGPP, the 
putative reductase(s) catalyzing the reduction of lycopaoctaene to lycopadiene could be 
similar to geranylgeranyl reductase (GGR). In plants such as Arabidopsis thaliana, a 
single multifunctional GGR (AtGGR) enzyme catalyzes sequential reduction of three of 
the four double bonds of GGPP to produce dihydroGGPP, tetrahydroGGPP and phytyl 
diphosphate (PPP), in the chloroplast (Figure 38)121. PPP is used as the tail of the 
chlorophyll molecule and as a substrate for the biosynthesis of tocopherols and 
phylloquinone in photosynthetic organisms121, 122. Similarly, the AtGGR enzyme also 
catalyzes sequential reduction of geranylgeranyl-chlorophyll to dihydrogeranylgeranyl-
chlorophyll, tetrahydrogeranylgeranyl-chlorophyll and phytyl-chlorophyll, in etioplasts 
(Figure 38)121. Homologues of plant GGR found in archaea and bacteria also catalyze 
the sequential reduction of three of the four double bonds present in the geranylgeranyl 
side chain, and are involved in the biosynthesis of archaeal membrane lipids and 
bacteriochlorophyll123, 124.  
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Figure 38. Reduction reaction catalyzed by AtGGR enzyme. AtGGR = 
geranylgeranyl reductase from Arabidopsis thaliana. GGPP = geranylgeranyl 
diphosphate, GG-Chl = geranylgeranyl-chlorophyll, DihydroGG-Chl = 
dihydrogeranylgeranyl-chlorophyll, TetrahydroGG-Chl = tetrahydrogeranylgeranyl-
chlorophyll and Phytyl-Chl = phytyl-chlorophyll. The reactions shown above is drawn 
based on the study from Keller et al, Eur. J. Biochem. 251:413-417 (1998). 
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To investigate the role of GGR-like enzymes in the reduction of lycopadiene 
biosynthetic intermediates, GGR-like cDNA sequences were searched for within the  
transcriptome of race L using BLAST and the GGR (AtGGR) from Arabidopsis thaliana 
as a query. Two GGR-like cDNAs (GGR-1 and GGR-2) were identified and cloned from 
race L. Alignment of the deduced amino acid sequence shows GGR-1 to be 66.8% and 
GGR-2 to be 21.6 % identical to AtGGR (Figure 39). Both GGR-1 and GGR-2 contain a 
dinucleotide binding sequence motif found in typical GGR enzymes as they utilize the 
dinucleotide NADPH as an electron source for the reaction (Figure 39)125. Like AtGGR, 
GGR-1 contains a chloroplast transit peptide (cTP) at its N-terminus suggesting plastid 
localization, and that GGR-1 could be a true GGR enzyme from race L (Figure 39). In 
contrast, GGR-2 does not contain a cTP but shows the presence of a predicted signal 
peptide and a transmembrane region at the N-terminus of the protein (Figure 39). For 
initial characterization of enzyme activity, we decided to express in E. coli cells 
engineered to produce lycopaoctaene molecule N-terminally truncated versions of GGR-
1 and GGR-2 to delete the cTP for GGR-1 and the signal peptide and predicted 
transmembrane domain for GGR-2. An in vivo approach for characterization of GGR-1 
and GGR-2 was chosen instead of an in vitro assay with purified enzymes for several 
reasons. First, lycopaoctaene, a potential substrate of the putative reductase is a highly 
hydrophobic molecule and is not soluble in an aqueous reaction environment. Second, 
the enzyme assay conditions such as cofactors and buffer conditions required for the 
reduction of lycopadiene biosynthetic intermediates is not known. Our initial strategy to  
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Figure 39. Amino acid sequence alignment of GGR-like sequences. GGR= 
geranylgeranyl reductase. GGR-1 and GGR-2 are from B. braunii race L and AtGGR is 
from Arabidopsis thaliana. A chloroplast transit peptide predicted by the ChloroP 1.1 
software for GGR-1 and AtGGR is shown in green. A signal peptide predicted by the 
TargetP 1.1 software for GGR-2 is shown in blue. A possible transmembrane region 
predicted by TMpred for GGR-2 is underlined. Conserved dinucleotide binding 
sequences for each protein are highlighted in red. 
 
 
GGR-1      MASTGLNLASVSGVSAKARNVCPAKAVPVMMAAAPQALSCKRASSFAGRSIVESVRQS-- 58 
GGR-2      -------MSSTSDNNVLLVAACGA-----------------AAAAVAGAAFYAGRRSGLS 36 
AtGGR      -MATTVTLKSFTGL---------------------------RQSSTEQTNFVSHVPSSLS 32 
                  : * :.                              ::     :     ..   
 
GGR-1      VTKGRVSQLQV-SAVKDGAVLDRPLRVAVIGGGPSGACCAETLAQGGVETYLIER-KMDN 116 
GGR-2      QAGR-------EVPRKYTSLPADAFDAAIVGAGPSGSACAFYLARAGARVALLEKEKFPR 89 
AtGGR      LPQRR-TSLRVTAARATPKLSNRKLRVAVIGGGPAGGAAAETLAQGGIETILIER-KMDN 90 
                              :    : .*::*.**:*...*  **:.* .. *:*: *: . 
 
GGR-1      CKPCGGAIPL---CMVDEFDIPPEIIDRKVTKMK----MISPSNRE-VDVGKTLSETEYI 168 
GGR-2      DKYCGDAVCTPAIRVLEEMGVLKELMDNDEAKFADEGGFVSPAGLTYIGVSKEKLGEAAC 149 
AtGGR      CKPCGGAIPL---CMVGEFNLPLDIIDRRVTKMK----MISPSNIA-VDIGRTLKEHEYI 142 
            * **.*:      :: *:.:  :::*.  :*:     ::**:.   :.:.:         
 
GGR-1      GMCRREVMDDYLRKRASKFGADVINGLYLKMEQKDS-EGPITVFFNRYKE-G-DKVGTPD 225 
GGR-2      CAVKRIILDERMAKAATRAGANLYEGFEVSGS---------NLIFDKLSGLWTVTSAEGK 200 
AtGGR      GMVRREVLDAYLRERAEKSGATVINGLFLKMDHPENWDSPYTLHYTEYDGKT-GATGTKK 201 
              :* ::*  : : * : ** : :*: :. .         .: : . .       .  . 
 
GGR-1      KVEVDLVIGAEGANSRVATEMGAGEYDYAIAFQERIRIPDD------KMAYYVD-----L 274 
GGR-2      SVRARVLVIADGATSKLATELGYCTEPPKGVCSRAFIEPGSHNVLFDGVCFYSPDSLPGY 260 
AtGGR      TMEVDAVIGADGANSRVAKSIDAGDYDYAIAFQERIRIPDE------KMTYYED-----L 250 
           .:..  :: *:**.*::*..:.        . .. :  *..       : :*         
 
GGR-1      AEMIVGDDVSPDFYGWVFPKYD-----HVAVGTGTVVNKTAIKQYQQATRDRSKVKTEGG 329 
GGR-2      SAIFKHPKDELNFCYYLIPCGKDGMCGDVKESDLKRLHEGAIKKDPFISKA----LGPNP 316 
AtGGR      AEMYVGDDVSPDFYGWVFPKCD-----HVAVGTGTVTHKGDIKKFQLATRNRAKDKILGG 305 
           : :    . . :*  :::*  .     .*  .  .  ::  **:    ::        .  
 
GGR-1      KIIRVEAHP--IPEHPRPNRARGRVTLVGDAAGYVTKCSGEGIYFAAKSGRMAAEAIVED 387 
GGR-2      KVERMRAAPLRLGSQGVPQSYDDHLLIVGDAAGHIDPLTGEGIHTAMMGGKAAAETILDM 376 
AtGGR      KIIRVEAHP--IPEHPRPRRLSKRVALVGDAAGYVTKCSGEGIYFAAKSGRMCAEAIVEG 363 
           *: *:.* *  : .:  *.    :: :******::   :****: *  .*: .**:*::  
 
GGR-1      SLNGKRMVGEATLRKYLDRFDRKYWSTYKVLDILQKVFYRSNPAREAFVEM-------CA 440 
GGR-2      RASGDY--SKAATKAYENRWMRAYGHDFGMSKAFAELIYRYPILLDATANEMGRVGDTMM 434 
AtGGR      SQNGKKMIDEGDLRKYLEKWDKTYLPTYRVLDVLQKVFYRSNPAREAFVEM-------CN 416 
             .*.   .:.  : * ::: : *   : : . : :::**     :* .:           
 
GGR-1      SE---YVQKMTFDSYLYKTVVPGNPVDDVKLLVGTVASLLRGNALRSAAPKTVNFGIREE 497 
GGR-2      SKWAEIMTNMRPKTYFLRPD------VAIPLTFALLREIWQQKVLKRPSAYVKP-----S 483 
AtGGR      DE---YVQKMTFDSYLYKRVAPGSPLEDIKLAVNTIGSLVRANALRREIEKLSV------ 467 
           .:    : :*  .:*: :          : * .  : .: : :.*:               
 
GGR-1      EKVAA- 502 
GGR-2      D----- 484 
AtGGR      ------ 467 
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produce lycopaoctaene in E.coli by overexpressing LOS did not yield any lycopaoctaene 
but resulted in the production of squalene and a small amount of C35H58 (Figure 40,  
panel I). This result is consistent with the previous report of low levels of intracellular 
GGPP precursors present in E.coli126. To overcome this limitation, GGPPsynthase-11 
(AtGGPPS11)115 from Arabidopsis thaliana was overexpressed along with LOS in 
E.coli, and the analysis of n-hexane extracts show the production of high levels of 
lycopaoctaene but very low amounts of squalene and C35H58, suggesting robust turnover 
of FPP to GGPP by AtGGPPS11 and GGPP to lycopaoctaene by LOS (Figure 40, panel 
II). Next, we overexpressed GGR-1 and GGR-2 separately in the E.coli line producing 
lycopaoctaene to test their ability to reduce lycopaoctaene into the higher saturated 
homologues, however, no lycopahexaene, lycopapentaene, lycopatetraene, lycopatriene, 
or lycopadiene were detected (Figure 41, panel IV and Figure 42, panel IV). Expression 
of both GGR-1 and GGR-2 slightly decreased the level of lycopaoctaene and increased 
the level of squalene and C35H58 (compare panel II and IV in Figures 41 and 42). It is 
possible that both GGR-1 and GGR-2 possess typical GGR enzyme activity and reduce 
GGPP to PPP, thus decreasing the level of the GGPP pool available for LOS to produce 
lycopaoctaene. Phytyl-PP production in the E.coli lines expressing GGR-1 and GGR-2 
was not analyzed in these experiments and should be done in near future. It is difficult to 
speculate at this time on why the levels of squalene and C35H58 increases when GGR-1 
and GGR-2 were coexpressed with AtGGPPS11 and LOS. This preliminary data 
suggests that GGR-1 and GGR-2 may not be the reductase enzyme hypothesized to be 
involved in the reduction of the lycopaoctaene molecule. Further characterization of  
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Figure 40. Generation of a lycopaoctaene producing E.coli line. Shown are GC-MS 
profiles of n-hexane extractable metabolites of E.coli cells expressing different gene 
constructs. I, LOS expression. II, AtGGPPS11 and LOS expression. III, Empty vector 
expression. IV, Hydrocarbon standards. LOS = lycopaoctaene synthase; AtGGPPS11 = 
geranylgeranyl diphosphate synthase 11 from Arabidopsis thaliana. 
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Figure 41. Characterization of GGR-1 in E.coli. Shown are GC-MS profiles of n-
hexane extractable metabolites of E.coli cells expressing different gene constructs. I, 
Empty vector expression. II, AtGGPPS11 and LOS expression. III, GGR-1 expression. 
IV, AtGGPPS1, LOS and GGR-1 expression. AtGGPPS11 = geranylgeranyl diphosphate 
synthase 11 from Arabidopsis thaliana, LOS = lycopaoctaene synthase and GGR-1 = 
geranylgeranyl reductase like-1. 
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Figure 42. Characterization of GGR-2 in E.coli. Shown are GC-MS profiles of n-
hexane extractable metabolites of E.coli cells expressing different gene constructs. I, 
Empty vector expression. II, AtGGPPS11 and LOS expression.  III, GGR-2 expression. 
IV, AtGGPPS1, LOS and GGR-2 expression. AtGGPPS11 = geranylgeranyl diphosphate 
synthase 11 from Arabidopsis thaliana, LOS = lycopaoctaene synthase and GGR-2 = 
geranylgeranyl reductase like-2. 
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GGR-1 and GGR-2 is necessary before ruling them out as a putative reductase enzyme 
of the lycopadiene biosynthetic pathway. 
2.3 Discussion 
Our studies identified the first committed step in lycopadiene biosynthesis in race 
L of Botryococcus braunii, and describe a new SS-like enzyme, LOS, that carries out 
this reaction. Importantly, this enzyme may be used to engineer the effective production 
of hydrocarbon biofuel feedstocks in other photosynthetic or heterotrophic organisms in 
the future. This novel enzyme produces the tetraterpenoid lycopaoctaene from GGPP in 
a reaction analogous to that of squalene synthase. Lycopaoctaene would then undergo 
sequential reduction by a yet-to-be identified reductase enzyme(s) to form 
lycopahexaene, lycopapentaene, lycopatetraene, lycopatriene, and finally lycopadiene as 
the major hydrocarbon product of the pathway (Figure 37). Furthermore, we show that 
the wild type LOS enzyme displays remarkable substrate flexibility, and can utilize at 
least three different, naturally occurring C15 and C20 prenyl diphosphate substrates in 
vivo and in vitro for the combinatorial biosynthesis of hydrocarbons belonging to three 
terpene classes; triterpenes, sesquarterpenes, and tetraterpenes. 
When used under artificial reaction conditions, other SS-like enzymes have been 
described to show relaxed substrate flexibility and to yield products of varying lengths. 
One such enzyme is CrtM, a dehydrosqualene synthase from Staphylococcus aureus that 
is involved in C30 carotenoid biosynthesis42-44. In S. aureus and also when overexpressed 
in E. coli, CrtM uses two FPP molecules to produce dehydrosqualene, a C30 squalene-
like molecule with a cis double bond at the 1-1’ linkage of the two FPP molecules45. 
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Expression of a GGPP synthase in E. coli also expressing CrtM led to the depletion of 
FPP and the overproduction of GGPP42. Under these conditions, CrtM was found to 
generate its native C30 product, a C35 homolog, and C40 phytoene, indicating the ability 
of CrtM to accept GGPP as a substrate when the natural FPP substrate is limiting42. 
CrtM was further engineered through mutations to accept C25 farnesylgeranyl 
diphosphate (FGPP), yielding C40, C45 and C50 homologs of dehydrosqualene in the 
presence of FPP, FGPP, and GGPP127, 128. In another study, squalene synthases from 
yeast, pig, and rat have been shown to accept non-natural derivatives of FPP to generate 
several unnatural terpene products in vitro129, 130. Additionally, yeast SS has been shown 
to yield alternative products in vitro from FPP as a substrate under various non-
physiological reaction conditions, such as in the absence of NADPH with extended 
incubation times, or in the presence of an unreactive NADPH analog48-50. Irrespective of 
these examples, the promiscuity of LOS is still remarkable, considering that the wild-
type LOS enzyme is able to accept three naturally occurring prenyl diphosphate 
substrates and produce the chimeric hydrocarbons described here without the need for 
mutations or altered, non-physiological reaction conditions. Such remarkable intrinsic 
substrate promiscuity has not been documented for any other eukaryotic SS or SS-like 
enzyme up until now. 
Ours and other studies38,51 raise the question about how SS-like enzymes arise. 
LSS and LOS from B. braunii share >50% sequence identity and both contain the 
important catalytic residues and conserved domains of SS enzymes (Figure 29), but they 
still have different substrate preferences and product formation. Thus, we hypothesize 
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that an ancient SS gene may have undergone gene duplication in race L. The paralogue 
that gave rise to LSS maintained the ability to produce squalene as its sole product to 
support sterol biosynthesis for primary metabolism. However, the paralogue that yielded 
LOS developed the use of alternative substrates for hydrocarbon oil production, while 
also preserving SS activity. A similar scenario has been suggested as a possible 
mechanism for generating new secondary metabolites that may provide a fitness benefit 
to the host organism127, 131. For B. braunii, it has been proposed that hydrocarbon oils 
and their derivatives increase the buoyancy of colonies for increased exposure to 
sunlight51,53,54. Similar gene diversifications have also been proposed in the B race of B. 
braunii for botryococcene production, and in some bacteria for squalene generation. For 
botryococcene production, SS duplications gave rise to the SSL-1 and SSL-3 
genes/enzymes responsible for botryococcene production while retaining a residual 
ability to produce squalene38. For bacteria, a three-enzyme system for squalene 
production arose from successive gene duplication events51. 
LOS produces a variety of terpenes in vitro when offered a mixture of substrates, 
and also do so in vivo in race L. In the in vitro mixed substrate assays with LOS (Figure 
32), a C35H64 molecule was observed from FPP and PPP condensation. This product has 
the exact same GC retention time and mass spectrum as the C35H64 hydrocarbon detected 
in the total hydrocarbon pool (Figure 10, panel VII; Figure 32, panel II). This suggests 
that LOS is also promiscuous in B. braunii cells, but at best has limited access to the FPP 
and PPP pools since the C35H64 product only comprises 0.15% of the total hydrocarbons 
(Figure 10, panel VII). The FPP-GGPP condensation product C35H58 seen in these in 
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vitro assays (Figure 32, panel I) is not detected in the total hydrocarbon pool, possibly 
because this molecule is reduced to C35H64 in vivo. It should be noted that two previous 
studies described several C35 squalene-like isoprenoids from Methanococcus jannaschii 
and Thermococcus barophilus, including the C35H58 and C35H64 molecules identified 
here55,56, although the enzymatic basis for the biosynthesis of these products remains 
uncharacterized. Additionally, the ability of LOS to produce lycopapentaene as an 
observed in vitro condensation product of GGPP and PPP (Figure 32, panel III) and 
accumulation high level of radioactivity during pulse-chase experiment (Figure 27B) 
may indicate the existence of an alternative in vivo biosynthetic route to this molecule, 
and may be partially responsible for the relative prevalence of lycopapentaene (3% of 
total hydrocarbons; Figure 10, panel IV) amongst the minor hydrocarbons of race L. 
This would suggest that LOS can also utilize PPP in vivo. However, LOS does not 
appear to utilize PPP as a single substrate for lycopadiene production in vivo as we were 
not able to detect lycopadiene synthesis activity in cell fractions using PPP as substrate 
(Figure 26A). 
The promiscuous LOS described in this work is nevertheless utilized by B. 
braunii race L to produce lycopaoctaene preferentially over squalene, as shown by the 
large amounts of hydrocarbon oils produced by this alga, and the absence of detectable 
amounts of squalene or non-sterol squalene derivatives in the total hydrocarbon pool. In 
contrast, accumulation of the non-sterol squalene derivatives methylsqualenes in race B 
are thought to arise from squalene produced by the additional SS-like enzyme SSL-238. 
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Thus, detection of non-sterol squalene derivatives in race L would be expected if LOS 
was producing squalene in vivo. 
We hypothesize that the observed preference of LOS for C40 lycopaoctaene 
biosynthesis over C30 squalene production in vivo may result from an increased flux from 
GGPP over FPP, as seen for E.coli cells producing lycopaoctaene (Figure 40), due to 
metabolic channeling to form a biosynthetic metabolon specific for lycopadiene 
production. Formation of such metabolons is common in plants, and is used for 
channeling substrates and intermediates required for the biosynthesis of different classes 
of plant natural products, including isoprenoids57-59. When expressed in yeast, LOS may 
produce squalene presumably due to a lack of this proposed metabolon, thus giving LOS 
access to the FPP pool. We therefore conclude that LOS is responsible for synthesizing 
lycopaoctaene as the first committed step towards lycopadiene hydrocarbon biosynthesis 
in race L of B. braunii. 
2.4 Methods 
2.4a Reagents  
[1-3H]-FPP (specific activity, 18.2 Ci/mmol) was purchased from PerkinElmer. 
[1-3H]-GGPP (specific activity, 20.0 Ci/mmol), [1-3H]-phytyl-PP (specific activity, 20.0 
Ci/mmol), and nonradiolabeled phytyl-PP were purchased from American Radiolabeled 
Chemicals. When required, specific activities of radiolabeled chemicals were adjusted 
with non-labeled chemicals. Solvents and chemicals were purchased from VWR. All 
other reagents were purchased from Sigma unless otherwise noted. 
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2.4b Culturing of Botryococcus braunii  
B. braunii, race L, Songkla Nakarin strain16 was obtained from Algobank-Caen 
Microalgal Culture Collection, University of Caen Basse-Normandie, France and grown 
in a modified Chu 13 medium, pH 7.560 at 22°C under continuous aeration of filter-
sterilized air enriched with 2.5% CO2. The concentrations of chemicals in modified Chu 
13 medium were as follows; KNO3 (0.4 g/L), MgSO4•7H2O (0.1 g/L), K2HPO4 
(0.052g/L), CaCl2•2H2O (0.054 g/L), FeNa EDTA (0.01 g/L), H3BO4 (2.86 mg/L), 
MnSO4•H2O (1.54 mg/L), ZnSO4•7H2O (0.22 mg/L), CuSO4•5H2O (0.08 mg/L), 
NaMoO4•2H2O (0.06 mg/L) and CoSO4•7H2O (0.09 mg/L). The cultures were grown 
under a 12:12 hr light:dark cycle with a light intensity of 120 µEm-2s-1. Algae cells were 
subcultured by inoculation of 100 mL of a floating six-week-old culture to 750 mL of 
fresh medium. 
2.4c Hydrocarbon staining and microscopy 
Nile red (Sigma) staining of L race hydrocarbons was done by treating 500 µL 
of B. braunii L race colonies in medium at early phase (5 day) density with 2.5 µL of a 
stock solution of Nile red dissolved in acetone (0.15 mg/mL) for a final concentration of 
Nile red of 0.375 g/mL and acetone of 0.25%. Samples were kept in the dark and 
incubated at room temperature for 15 min prior to imaging. Confocal microscopy images 
were obtained using an Olympus IX83-FV1200 inverted confocal microscope with 
spectral detection unit using an Olympus UPLSAPO 60X oil immersion objective 
(NA=1.35). The confocal aperture diameter was set to 1 Airy disk unit, and Z-series 
images were acquired with voxel dimensions of 101x101x490 (nm; X-Y-Z, 
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respectively). Nile Red and chlorophyll were excited using a 488 nm laser and detected 
using 540-590 nm and 655-755 nm barrier filter settings, respectively. Bright-field 
images were acquired via the transmitted detector using the 488 nm laser. Maximum 
intensity projections and brightness/contrast adjustments were completed using the 
Olympus FV-ASW software version 4. 
2.4d Hydrocarbon purification 
Hydrocarbons were purified as described previously38, 132 and as follows. Algal 
cells were harvested by vacuum filtration using a 10 µm nylon-mesh filter, freeze-dried, 
extracted twice with n-hexane for 2 hours to recover extracellular hydrocarbons, and 
then twice with CHCl3:MeOH (2:1) for 12 hours stirring at room temperature to recover 
intracellular hydrocarbons. Both extracts were concentrated separately using a rotary 
evaporator and resuspended in a small amount of n-hexane before running through 
separate gravity-fed silica gel columns with n-hexane as solvent. The n-hexane eluent 
prior to the pigment front was collected as the hydrocarbon fraction. Both extracellular 
and intracellular hydrocarbon fractions were combined and evaporated to dryness to 
recover the total hydrocarbon pool of the algae. Individual hydrocarbon molecules were 
purified by injecting the total hydrocarbon sample onto an HPLC Develosil 60 silica 
column (20 mm × 250mm) using n-hexane as a mobile phase at a flow rate of 6 ml/min 
and detection at 210nm. An aliquot of the purified hydrocarbons were analyzed by GC-
MS for purity analysis. 
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2.4e GC-MS conditions 
Enzyme assays products, purified hydrocarbons, and yeast extracts were 
analyzed by GC-MS (Bruker 436-GC-SCION SQ Premium) using a 5% Phenyl BR-5ms 
capillary column (30 m × 0.25 mm, film thickness: 0.25 µm) in electron ionization (70 
eV) mode. Initial oven temperature was 220°C, held for 1 min, then increased to 280°C 
at the rate of 5°C/min, and then ramped to 300°C at a rate of 2°C/min, and held for 20 
min. Helium was used as a carrier gas at a flow rate of 2.58 mL/min. Temperatures of 
injection port, interface, and ion source were, 280ºC, 250ºC and 200ºC, respectively. 
2.4f Hydrocarbon NMR analysis 
1D NMR spectra of race L hydrocarbons molecules suffer from severe spectral 
overlap and the data interpretation is further complicated by degenerate chemical shifts 
as a result of symmetry planes in the lycopadiene structure. Consequently, hetero-
nuclear 2D experiments were used for unambiguous structural characterization of each 
entity. NMR experiments were performed at 25°C on purified samples dissolved in 
deuterated chloroform using a 500 MHz Bruker Avance III HD spectrometer equipped 
with an inverse detection TXI probe. We have relied on 2D hetero-nuclear experiments 
acquired at natural abundance of 13C nuclei to deduce structures of these molecules. 
Multiplicity-edited 2D HSQC spectrum was acquired for each compound and the 
resonances were assigned using a combination of 2D H2BC, 2D HMBC and 2D 
HSQCTOCSY experiments. The 13C chemical shifts obtained for lycopadiene match 
those previously obtained16. 
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2.4g Spectral data for hydrocarbons analyzed  
Lycopadiene: 1H NMR (500 MHz, CDCl3): δ 0.87, 0.89, 1.08, 1.09, 1.16, 1.2, 1.29, 
1.39, 1.4, 1.54, 1.61, 1.96, 2.04, 2.17, 5.15; 13C NMR (125 MHz, CDCl3): δ 15.9, 19.7, 
22.7, 24.5, 24.7, 25.4, 28.0, 28.3, 31.2, 32.8, 36.8, 37.4, 39.4, 40.0, 124.0, 135.9; MS 
(m/z): [M+] calcd. for C40H78, 558.61; found, 558.70. Lycopatriene: 1H NMR (500 
MHz, CDCl3): δ 0.87, 0.89, 1.08, 1.09, 1.13, 1.16, 1.2, 1.29, 1.29, 1.39, 1.4, 1.54, 1.61, 
1.63, 1.71, 1.96, 1.98, 2.04, 2.16, 5.12, 5.15; 13C NMR (125 MHz, CDCl3): δ 15.9, 17.6, 
19.7, 22.7, 24.5, 24.7, 24.7, 25.4, 25.6, 25.7, 28.0, 28.3, 30.8, 32.7, 36.8, 37.1, 37.4, 
39.4, 40.0, 124.1, 125.1, 131.1, 135.9; MS (m/z): [M+] calcd. for C40H76, 556.59; found, 
556.70. Lycopatetraene: 1H NMR (500 MHz, CDCl3): δ 0.87, 0.89, 1.08, 1.08, 1.13, 
1.16, 1.2, 1.29, 1.39, 1.4, 1.54, 1.61, 1.63, 1.71, 1.95, 1.96, 1.99, 2.04, 2.16, 5.12, 5.15; 
13C NMR (125 MHz, CDCl3): δ 15.9, 17.6, 19.7, 22.7, 24.5, 24.7, 25.4, 25.5, 25.7, 28.0, 
28.3, 30.8, 32.7, 36.6, 37.1, 37.4, 39.3, 39.4, 40.0, 124.1, 125.2, 131.1, 135.9; MS (m/z): 
[M+] calcd. for C40H74, 554.58; found, 554.60. Lycopapentaene: 1H NMR (500 MHz, 
CDCl3): δ 0.87, 0.89, 1.08, 1.08, 1.16, 1.2, 1.29, 1.39, 1.4, 1.55, 1.62, 1.63, 1.71, 2, 2.04, 
2.09, 2.23, 5.15; 13C NMR (125 MHz, CDCl3): δ 16.0, 17.7, 19.8, 22.7, 24.5, 24.7, 25.4, 
25.7, 26.7, 28.0, 28.3, 31.0, 32.8, 36.6, 37.4, 39.4, 39.8, 124.2, 131.1, 135.9; MS (m/z): 
[M+] calcd. for C40H72, 552.56; found, 552.70. Lycopapentaene isomer: 1H NMR (500 
MHz, CDCl3): δ 0.87, 0.89, 1.08, 1.08, 1.13, 1.16, 1.2, 1.29, 1.4, 1.55, 1.62, 1.63, 1.71, 
1.99, 2, 2.04, 2.09, 5.1, 5.15; 13C NMR (125 MHz, CDCl3): δ 16.0, 17.7, 19.8, 22.7, 
24.5, 24.7, 25.5, 25.7, 26.7, 28.0, 28.3, 32.7, 36.6, 37.1, 37.4, 39.4, 39.8, 124.2, 124.8, 
131.1, 135.9; MS (m/z): [M+] calcd. for C40H72, 552.56; found, 552.90. Lycopahexaene: 
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1H NMR (500 MHz, CDCl3): δ 0.87, 0.89, 1.08, 1.08, 1.16, 1.2, 1.29, 1.4, 1.55, 1.61, 
1.63, 1.71, 1.96, 1.99, 2.04, 2.06, 5.15; 13C NMR (125 MHz, CDCl3): δ 16.0, 17.7, 19.8, 
22.7, 24.5, 24.7, 25.7, 26.8, 28.0, 28.3, 32.8, 36.6, 37.4, 39.4, 39.4, 39.8, 124.3, 131.1, 
135.9; MS (m/z): [M+] calcd. for C40H70, 550.55; found, 550.60. Lycopaoctaene: 1H 
NMR (500 MHz, CDCl3): δ 1.62, 1.63, 1.71, 2, 2.03, 2.04, 5.15; 13C NMR (125 MHz, 
CDCl3): δ 16.0, 17.7, 25.7, 27.2, 28.3, 39.8, 124.3, 131.1, 135.9; MS (m/z): [M+] calcd. 
for C40H66, 546.52; found, 546.70. C35H64: 1H NMR (500 MHz, CDCl3): δ 0.83, 0.86, 
1.06, 1.13, 1.19, 1.21, 1.24, 1.32, 1.36, 1.52, 1.61, 1.68, 1.98, 2.01, 2.06, 5.13; 13C NMR 
(125 MHz, CDCl3): δ16.3, 17.9, 20.0, 22.9, 24.4, 24.8, 25.1, 26.0, 26.3, 27.2, 28.2, 33.0, 
37.7, 39.6, 40.0, 124.8, 131.4, 135.1; MS (m/z): [M+] calcd. for C35H64, 484.50; found, 
484.70. 
2.4h Ozonolysis experiments 
Due to the limited amount of minor hydrocarbons in the total L race 
hydrocarbon pool, ozonolysis experiments were conducted only on those hydrocarbons 
that could be purified to obtain at least 10mg; lycopadiene, lycopatriene and 
lycopapentaene. These hydrocarbons were separately dissolved in dichloromethane and 
submitted to ozone cleavage for 5 min at -78ºC. Each product from reductive cleavage of 
the resulting ozonide was directly subjected to GC-MS (electron ionization) analyses 
without purification. GC-MS analysis was carried out using a GCMS-QP2010 Ultra 
spectrometer (Shimadzu, Kyoto, Japan) equipped with a capillary column (InertCap 
1MS, GL Science; 60 m x 0.25 mm, film thickness: 0.25 µm). The column temperature 
was programmed as follows: 50ºC for 1 min, raised at 10ºC/min from 50ºC to 220ºC, 
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then at 2ºC/min from 220ºC to 260 ºC, and held for 22 min at the final temperature. 
Helium was used as a carrier gas at a flow rate of 41.2 cm/sec. Temperatures of injection 
port, interface, and ion source were, 260 ºC, 250 ºC and 200 ºC, respectively. 
2.4i Preparation of algal cell lysate 
Algae from the rapid growth phase were harvested, snap frozen with liquid 
nitrogen and stored at -80°C for future use. In a typical preparation, 200 mg of frozen 
algae was added to 8 individual tubes containing 0.8 mL extraction buffer (50 mM Mops 
(pH 6.8), 20 mM MgCl2, 5mM β-mercaptoethanol, 5 mM EGTA and 20% (v/v) 
glycerol) with 200 µL of stainless steel metal beads (mixture of 0.9 - 2 mm diameter 
beads), and then homogenized using a Bullet Blender Storm 24 (Next Advance, Inc., 
USA) for 10 min at a speed of 10. The algal homogenates were centrifuged at 9,000 × g 
for 10 min at 4°C. The 9,000 × g supernatants were pooled and then centrifuged at 
100,000 × g for 1 hour to obtain the soluble fraction. The pellet was washed with 4 mL: 
extraction buffer and centrifuged again at 100,000 × g. This process was repeated twice, 
and the pellet was resuspended in 0.5 mL extraction buffer to obtain a microsomal 
fraction. An aliquot of each protein fraction was used for enzyme assays. 
2.4j Enzyme assays 
Radioactive enzyme assays were conducted in a 50 µL total reaction volume as 
described previously58, 105 and as follows. Reactions were initiated by adding 10 µg algal 
lysate or 1 µg of recombinant enzyme purified from E. coli to a reaction buffer 
containing 50mM MOPS (pH 6.8), 2.5 mM β-mercaptoethanol, 20 mM MgCl2, 2 mM 
NADPH or NADH and 10 µM [1-3H]-prenyl-PP substrate (specific activity = 0.25 
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Ci/mmol). Enzyme assays were incubated at 37°C for 60 minutes and terminated by 
adding 60 µL of n-hexane, followed by brief vortexing and centrifugation. Thirty µL of 
the organic layer was spotted onto silica gel 60 TLC plates along with authentic 
standards of squalene (Rf = 0.17), C30-botryococcene (Rf = 0.2), lycopaoctaene (Rf = 
0.09) and lycopadiene (Rf = 0.5), and then developed with n-hexane. Hydrocarbon 
standards were visualized by iodine vapor and spots corresponding to authentic 
standards were scraped and analyzed by liquid scintillation counter to determine 
radioactive incorporation into the respective hydrocarbons. Squalene synthase and 
botryococcene synthase assays were conducted using 3H-FPP, whereas lycopaoctaene 
synthase and lycopadiene synthase assays were conducted using 3H-GGPP and 3H-PPP, 
respectively. For GC-MS analysis of reaction products, enzyme assays were conducted 
with nonradiolabeled substrates in glass vials by scaling the total reaction volume and 
contents to 500 µL. Two separate 500 µL reactions were each extracted twice with 1 mL 
n-hexane, the extracts pooled, dried under a stream of nitrogen gas, resuspended in 100 
µL n-hexane and a 5 µL aliquot analyzed by GC-MS. 
2.4k Hydrocarbon accumulation and LOS activity over growth cycle 
Several flasks of race L culture were grown over a 39-day culture period. 
Twenty-five mL of culture was collected at indicated times on pre-weighed Whatman 
GF/C filters by vacuum filtration. The filters with algae were dried in an 80°C oven, and 
total hydrocarbons were extracted using the protocol described above. Similarly, 500 mL 
of algae cells were also harvested at indicated times by filtering through a 10 µm nylon-
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mesh and the samples used to determine LOS enzyme activity over the culture period. 
LOS enzyme assays were conducted using 10 µg of 9,000 × g supernatant. 
2.4l 14C-GGOH phosphorylation assays 
Geranylgeraniol (GGOH) phosphorylation assays were conducted as described 
previously111. In brief, a 50µL reaction was initiated by adding 50µg of microsomal 
protein to a reaction buffer containing 5mM Tris-HCl (pH=7.4), 5mM MgCl2, 0.05% 
CHAPS, 20mM sodium orthovanadate, 100µM ATP, 100µM CTP, 100µM UTP, 100µM 
GTP and 136µM 14C-GGOH (specific activity 0.015 Ci/mmol). The reactions were 
incubated for 16 min at 37°C and terminated by adding 200µL of methanol, followed by 
brief vortexing and centrifugation to collect the supernatant. Reaction products were 
further extracted with 200µL methanol:water (4:1). The supernatants were pooled, dried 
under a stream of nitrogen gas, resuspended in 50µL of water-saturated butanol and then 
analyzed on silica gel 60 TLC plates using isopropanol:NH4OH: H2O (6:3:1) as mobile 
phase. 14C incorporation into products was determined by scraping the spots 
corresponding to authentic standards of GGP (Rf = 0.59) and GGPP (Rf = 0.26) followed 
by analysis on a liquid scintillation counter. 
2.4m Pulse-chase experiment 
Feeding experiments in B. braunii race L were conducted as described 
previously55, 112, 133. In brief, a solution containing 9µCi of [1-14C]-geranylgeraniol 
(GGOH) (specific activity, 0.3 Ci/mol) was equally divided and fed to three separate 
625ml 4-day-old race L cultures. After a 45 hour incubation (pulse) with 14C-GGOH, 
algae cells were filtered using a 10µm nylon-mesh, washed thoroughly with fresh media, 
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transferred into fresh media containing 19µM non-radiolabelled GGOH, and incubated 
for three days (chase). During the three days chase, algae cells were harvested at 
different time points by vacuum filtration using Whatman G/FC filters. The filters with 
algae cells were freeze-dried and the total hydrocarbons were extracted using the 
protocol described above. The total hydrocarbon fraction was spotted onto preparative 
silica gel 60 TLC plates along with the authentic standards indicated above plus those of 
lycopahexaene (Rf = 0.32), lycopapentaene (Rf = 0.24), lycopatetraene (Rf = 0.32), and 
lycopatriene (Rf = 0.42). The TLC plate was developed with n-hexane and visualized by 
iodine vapor. Incorporation of 14C into each hydrocarbon molecule was determined by 
scraping the corresponding spot on the TLC plate followed by analysis with a liquid 
scintillation counter. 
2.4n RNA isolation 
Total RNA was isolated as previously described63 and as follows. For B. 
braunii, liquid-nitrogen frozen samples were pulverized using a Tissuelyser II (Qiagen, 
Valencia, CA). Approximately 200 mg of this frozen pulverized B. braunii tissue, or 
frozen leaf tissues of Arabidopsis thaliana and Solanum lycopersicum, were ground in a 
mortar and pestle with liquid nitrogen. The samples were then added to 1 mL of TRIzol 
(Life Technologies, Grand Island, NY) and the total RNA was isolated following the 
manufacturer instructions. The RNA from A. thaliana and S. lycopersicum were used 
directly for gene cloning (see below). For the B. braunii RNA, contaminating 
polysaccharides were removed prior to use for gene cloning as follows. The RNA pellet 
was resuspended in 0.5 mL 2M LiCl, incubated for 5 min, and centrifuged at 12,000 × g 
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for 15 min at 4°C to pellet the total RNA. The polysaccharides remain in the supernatant. 
This process was repeated until the size of RNA pellet remained constant. The RNA 
pellet was then dissolved in 0.5 mL 1x TE, extracted with an equal volume of 
phenol/chloroform/isoamyl alcohol mix (25:4:1), and centrifuged at 12,000 × g for 15 
min at 4°C. The aqueous supernatant phase was removed and extracted with 0.5 mL of 
chloroform followed by centrifugation at 12,000 × g for 15 min at 4°C. The RNA was 
precipitated form the aqueous supernatant by adding 0.1 volume 3M sodium acetate and 
2.5 volumes of 100 % ethanol, incubated for 20 min at -20°C, and centrifuged at 12,000 
× g for 15 min at 4°C. The RNA pellet was washed twice with 0.5 mL 70% ethanol, 
centrifuged at 12,000 × g for 15 min at 4°C, the pellet dried using a speedvac, and the 
RNA resuspended in 50 uL of RNAase free water. 
2.4o LSS, LOS, GGR-1 and GGR-2 cloning 
RNAseq analysis on the L race of B. braunii was carried out as previously 
reported63 and as follows. RNA isolated from days 0, 3, 7, 14, 21, and 28 over the 4-
week culture cycle were kept separate, paired-end libraries were prepared from each 
RNA sample, and each sample was sequenced under the Illumina platform. A 
transcriptome contig library was created using the Trinity software suite. Squalene 
synthase-like sequences were computationally screened for using this transcriptomic 
database with race B squalene synthase (BSS)57 as a query. Similarly, geranylgeranyl 
reductase (GGR)-like sequences were screened for using the Arabidopsis thaliana GGR 
as a query. Two SS-like (LSS and LOS) and two GGR-like (GGR-1 and GGR-2) 
cDNAs, were identified. Total RNA was extracted from a Day-3 race L culture and first 
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strand cDNA was prepared using the SuperScript III first strand synthesis kit 
(Invitrogen). Primers specific to each cDNA based on the transcriptome sequence were 
used to amplify the PCR product from first strand cDNA using GoTaq DNA polymerase 
mix (Promega) for LSS and LOS, and with Phusion DNA polymerase for GGR-1 and 
GGR-2 followed by cloning into the pGEM-T vector (Promega). Gene specific primers 
were as follows: For LSS, forward primer 5’-
ATGGGGAAGCTACAGGAGGTTTTGAAGC-3’ and reverse primer 5’-
TCAGGCAAGGCCGCCGCGAAG-3’; for LOS, forward primer 5’-
ATGAAGTACACAGATTTCCTTGCGC-3’ and reverse primer 5’-
TCACACAGTCTTGAGGGCGAG-3’; for GGR-1, forward primer 5’-
ATGGCTTCCACAGGCTTGAAC-3’and reverse primer 5’-
TTAAGCGGCCACCTTCTCCTC-3’; for GGR-2, forward primer 5’-
ATGAGTAGCACTTCTGATAATAATGTGCTCC-3’and reverse primer 5’-
CTAATCAGAGGGCTTTACGTAAGCGC-3’. 
2.4p AtGGPPS11 and SlSS cloning 
The cDNA sequences for AtGGPPS11 (NR_142395.1)30 and SlSS 
(ACY25092.1) were obtained from the NCBI nucleotide database. Total RNA isolated 
from the leaves of Arabidopsis thaliana and Solanum lycopersicum were used for first 
strand cDNA synthesis and PCR products corresponding to each cDNA were amplified 
using gene specific primers followed by cloning into the pGEM-T vector. Gene specific 
primers were as follows: For AtGGPPS11, forward primer 5’-
ATGGCTTCAGTGACTCTAGGTTC-3’ and reverse primer 5’-
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TCAGTTCTGTCTATAGGCAATG-3’; for SlSS, forward primer 5’-
ATGGGAACATTGAGGGCA-3’ and reverse primer 5’-
CTAAGACCGGCTGCCAAAAAGTTG-3’, were used for PCR amplification. 
2.4q Protein expression and purification 
Except for SSL-1 and SSL-3, DNA sequences encoding the predicted 
transmembrane domain at the C-terminus of each SS or SS-like protein were deleted, 
and then cloned to pET28a to encode for N-terminal 6xHis-tagged proteins. DNA 
templates of BSS, SSL-1, SSL-2 and SSL-3 were received from previous studies25,38. 
The pET28a expression constructs were made using appropriate restriction sites; 
LOSΔ392-444 with NheI and HindIII; LSSΔ399-462, SlSSΔ387-411, BSSΔ399-461, SSL-1, and 
SSL-3 with NdeI and HindIII; SSL-2Δ392-465 with NdeI and SalI. The expression 
constructs were transformed into E. coli BL21(DE3), grown at 37°C to OD600 = 0.8, and 
protein expression for each gene induced by adding 1mM isopropyl-β-D-1-
thiogalactopyranoside. The induced cultures were then grown for an additional 6 hours 
at 25°C. 
His-tagged proteins were purified at 4°C by standard procedures. In a typical 
purification, pellets from a 100mL culture were resuspended in 10mL extraction buffer 
(50 mM sodium phosphate buffer (pH=7.8), 300 mM NaCl, 10 mM imidazole, 1x 
general protease inhibitor cocktail (Sigma), 1 mM MgCl2, and 1% glycerol (v/v)) and 
then sonicated four times for 15 sec at 70% maximum power with 2 min interval 
between each sonication. The sonicated samples were centrifuged at 16,000 × g for 10 
min at 4°C. The supernatants were applied to a gravity-fed column containing Ni-NTA 
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agarose (QIAGEN) and the His-tagged proteins were purified according to the 
manufacturer’s recommendations. The wash buffer (50 mM sodium phosphate buffer 
(pH=7.8), 300 mM NaCl, 60 mM Imidazole, 1 mM MgCl2, and 1% glycerol (v/v)) and 
the elution buffer (50 mM sodium phosphate buffer (pH=7.8), 300 mM NaCl, 400 mM 
imidazole, 1 mM MgCl2, and 1% glycerol (v/v)) were used for protein purification. The 
eluted fractions were dialyzed using storage buffer (300 mM NaCl, 20 mM Tris-HCl 
(pH=7.5), 5 mM DTT and 2 mM MgCl2), concentrated with an Amicon Ultra centrifugal 
filter (0.5 mL, 30 kDa cutoff; EMD Millipore) to desired protein concentration, an equal 
amount of 100% glycerol added, and stored at -20°C for 1-2 months without a loss of 
enzyme activity. 
2.4r LOS steady-state kinetic experiments 
Michaelis-Menten enzyme kinetics experiments with the LOS enzyme were set 
up using the protocol described previously64 and as follows. Pilot experiments were 
initially conducted using radioactive enzyme assays to determine the reaction conditions 
where reaction velocity is linear (less that 10% turnover) with respect to enzyme 
concentration. For steady-state kinetics experiments, enzyme assays (50 µL total reaction 
volume) were conducted with 100 nM of purified LOS enzyme at the indicated 
concentration of 3H-GGPP, 3H-FPP, or 3H-PPP for a set time interval. Kinetics for the 
NADPH cofactor were not determined and this factor was held constant at 2 mM in all 
assays. The reaction velocities were plotted against substrate concentrations to generate 
Michaelis-Menten curves and the kinetics parameters of LOS enzyme for GGPP, FPP, 
PPP were determined by analyzing the data using GraphPad Prism 6 software. 
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2.4s Yeast expression 
The DNA sequence encoding the 56 N-terminal amino acids for the plastid-
targeting signal of AtGGPPS11 were deleted resulting in AtGGPPS11Δ57, which was 
cloned into pESC-TRP using BamHI and SalI restriction sites for expression under the 
inducible GAL1 promoter. For coexpression studies, the DNA sequences encoding the 
predicted C-terminal transmembrane domain of LOS was deleted resulting in LOSΔ392-
444, which was cloned into the second multiple cloning site of AtGGPPS11Δ57:pESC-TRP 
using EcoRI and SpeI restriction sites for expression under the inducible GAL10 
promoter. The yeast expression constructs, AtGGPPS11Δ57:pESC-TRP and 
AtGGPPS11Δ57 + LOSΔ392-444:pESC-TRP, were introduced into yeast strain CKY457 
(MATa, leu2Δ1, ura3-52, trp1Δ63, his3Δ200, lys2-128∂) via lithium acetate 
transformation followed by selection on yeast synthetic drop-out medium (SC-TRP). 
Positive transformants were grown at 30°C in 150 mL SC-TRP media to mid-log phase, 
induced with 2% final galactose concentration, and grown for an additional 130 hours. 
Yeast cells were harvested, freeze-dried, and extracted with n-hexane for 2 hours by 
stirring at room temperature. The organic extracts were centrifuged at 1,000 × g, the 
supernatant dried using a rotary evaporator, resuspended in 500 µL n-hexane, and a 5µL 
aliquot analyzed by GC-MS to evaluate for the production of lycopaoctaene. 
2.4t Purification of lycopaoctaene standard 
A 3-liter culture of yeast strain CKY457 expressing AtGGPPS11Δ57 + LOSΔ392-
444:pESC-TRP was grown and the metabolites were extracted with n-hexane using the 
protocol described above. The organic extracts were applied to a silica gel gravity-fed 
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column, and metabolites eluted sequentially with two different solvent systems, n-
hexane and 1% diethyl ether in n-hexane. The 1% diethyl ether in n-hexane eluent 
fraction containing lycopaoctaene and other metabolites was concentrated and 
resuspended in a small volume of n-hexane before injecting the samples onto a 10 mm × 
250 mm Cosomil 5C18-AR-II HPLC column. Lycopaoctaene was purified by RP-HPLC 
using methanol:acetone (60:40) as a mobile phase at a flow rate of 3 mL/min and 
detection at 210 nm. Identity of lycopaoctaene molecule was confirmed by GC-MS 
(Figure 13) and NMR (Table 1 & Figure 25). 
2.4u LSS and LOS complementation of yeast SS knockout strain 
The yeast strain ZX 178-08 (MATa, his3, leu2, met15, ura3, SUE, 
erg9Δ::HPH) which has a knockout of the endogenous squalene synthase gene (ERG9) 
was used for complementation experiments65. The expression vector XURA used in our 
study was made by replacing the GAL1 and GAL10 promoters in pESC-URA vector 
backbone with constitutive promoters TEF1 and GPD, respectively66. Full-length LSS 
was cloned into XURA using Not1 and SpeI restriction sites. Full-length LOS was 
cloned into EcoRI and SpeI sites of XURA vector. The expression constructs, 
LSS:XURA, LOS:XURA and XURA were transformed into ZX 178-08 yeast strain via 
lithium acetate transformation followed by selection on yeast synthetic drop-out medium 
supplement with ergosterol (SCE-URA). The positive transformants were further 
characterized by streaking on selection media with or without ergosterol to test the 
ability of individual genes to restore ergosterol prototrophy of ZX 178-08 yeast. 
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2.4v GC-MS analysis of prelycopaoctaene alcohol (PLOH) 
The enzyme assay for prelycopaoctaene diphosphate (PLPP) was conducted 
following the protocol described previously for analysis of presqualene diphosphate38,51 
and as follows. The PLPP assay contained 50 mM MOPS (pH 6.8), 2.5 mM β-
mercaptoethanol, 20 mM MgCl2, 180 µM GGPP and 750 µg of purified LOS enzyme in 
a 2.5 mL total reaction volume. The reaction mixture was incubated at 37°C for 2 hours 
and terminated by snap freezing with liquid nitrogen followed by lyophilization. For 
hydrolysis of PLPP to PLOH, the white residue obtained after lyophilization was 
resuspended in 2 mL phosphatase solution  (20% 1-propanol, 100mM sodium acetate pH 
4.7, 0.1% Triton-X-100, 50 units of sweet potato acid phosphatase) and then incubated 
for 16 hours in a 28°C shaker. The dephosphorylation reaction mixture was extracted 
three times with 4 mL of MTBE, the extracts pooled, dried under a stream of nitrogen 
gas, resuspended in 100 µL n-hexane and a 5 µL aliquot analyzed by GC-MS as under 
the conditions described above with the following differences. Chemical ionization using 
methane gas at 20 psi was employed for analysis of the PLOH molecule as electronic 
ionization did not result in a molecular ion of PLOH. Initial oven temperature was 70°C, 
held for 1 min, then increased to 200°C at the rate of 8°C/min, and then ramped to 
300°C at a rate of 20°C/min, and held for 20.75 min. Temperatures of injection port, 
interface, and ion source were, 260ºC, 250ºC and 200ºC, respectively. 
2.4w Hydrocarbon production analysis in E.coli 
The expression constructs, LOS∆392-444:pET28a and AtGGPPS11∆57:pET22b 
were made using the NheI and HindIII, and NdeI and SalI restriction sites, respectively. 
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The DNA sequences encoding the 57 N-terminal amino acids of GGR-1 for the 
chloroplast targeting signal was deleted resulting in GGR-1∆58, which was then cloned 
into the pACYCDuet-1 vector using the BamHI and HindIII restriction sites. Similarly, 
the DNA sequences corresponding to a signal peptide and the N-terminal transmembrane 
domain were deleted from GGR-2 to yield GGR-2∆33, which was then cloned into the 
pACYCDuet-1 vector using the BamHI and HindIII restriction sites. The expression 
constructs, pET28a, AtGGPPS11∆57:pET22b, LOS∆392-444:pET28a, GGR-
1∆58:pACYCDuet-1 and GGR-2∆33:pACYCDuet-1 were transformed into E.coli BL21 
(DE3) cells and the positive transformants were selected using standard procedures. The 
E.coli line harboring the desired construct(s) was grown in 100 ml of terrific broth media 
at 37°C to OD600 = 0.8 and expression of the corresponding genes was induced by 
adding 1mM isopropyl-β-D-1-thiogalactopyranoside (IPTG). After induction, cells were 
grown for 6 hrs at 25°C, harvested by centrifugation, snap frozen with liquid nitrogen 
and lyophilized. Freeze-dried cells were extracted with n-hexane by stirring with a 
magnetic stir bar in a glass beaker for 2 hrs. The n-hexane extracts were centrifuged at 
1,000 × g, the supernatant dried, resuspended in 200µL n-hexane, and a 5µL aliquot 
analyzed by GC-MS to evaluate the production of hydrocarbons. 
  110 
CHAPTER III  
SUBSTRATE AND PRODUCT SPECIFICITY FOR A TETRATERPENOID 
SYNTHASE FROM BOTRYOCOCCUS BRAUNII RACE L 
 
3.1 Background and rationale 
Isoprenoids (a.k.a. terpenes) are one of the largest groups of structurally diverse 
natural products produced by all domains of life63. All isoprenoids are biosynthesized via 
either the mevalonate pathway or the methylerythritol phosphate (MEP) pathway 
depending on the organism in question, and based on the number of C5 isoprene units 
present isoprenoids are classified as monoterpenes (C10), sesquiterpenes (C15), diterpenes 
(C20), triterpenes (C30) or tetraterpenes (C40)63. Beside critical roles in primary and 
secondary metabolism, isoprenoids and their derivatives have a wide range of 
applications including use as medicines, nutraceuticals, agricultural chemicals, 
fragrances, flavorings, and industrial chemicals65. More recently, there has been 
significant interest in the use and development of isoprenoid-based chemicals as a direct 
substitute for petroleum-derived fuels34, 134. The highly branched and cyclic nature of 
isoprenoids provides these molecules with properties such as high energy density, high 
ignition stability, and a low freezing temperature, which are physiochemical 
characteristics desired in an ideal combustion fuel34, 134. However, low yields in natural 
hosts have directed isoprenoid-based biofuel research toward metabolic engineering for 
overproduction of isoprenoid chemicals in industrial microorganisms such as yeast and 
E. coli135. For example, the sesquiterpene farnesene, a potential diesel and jet-fuel 
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alternative, has been commercially produced by utilizing metabolically engineered yeast 
and sugarcane-derived carbohydrates as an energy source134. 
The colony-forming green microalga Botryococcus braunii is an exception to low 
isoprenoid yielding organisms as it naturally produces large amounts, 30-50% of dry 
weight, of liquid hydrocarbon oils, which are stored in the colony extracellular matrix 
(Figure 1)36. Furthermore, these hydrocarbons can be catalytically cracked to produce 
petroleum-equivalent combustion engine fuels4, 136, thus making B. braunii hydrocarbons 
a promising renewable biofuel feedstock4, 5. There are three chemical races of B. braunii, 
each producing distinct types of hydrocarbons (Figure 2)36. Race A produces fatty acid 
derived C23-C33 alkadienes and alkatrienes (Figure 2)41. Race B and race L produce 
isoprenoid hydrocarbons derived from the MEP pathway36, with race B producing the 
triterpene C30-C37 botryococcenes and C31-C34 methylsqualenes39-41, and race L, the 
focus of this study, producing the C40 tetraterpenoid hydrocarbon lycopadiene as the 
predominant hydrocarbon (Figure 2)42, 132. 
The lycopadiene biosynthetic pathway has been recently elucidated59. Early 
studies suggested lycopadiene could be generated via a squalene synthase (SS) like 
reaction since lycopadiene resembles a C40 version of the triterpene squalene (Figure 
43)42, 132. The SS enzyme carries out the head-to-head condensation of two C15 farnesyl 
diphosphate (FPP) molecules in a two-step reaction to form squalene for use in sterol 
production (Figure 43)97, 137. The first step of the SS reaction generates the intermediate 
presqualene diphosphate (PSPP), which is reductively rearranged to squalene in the  
 
  112 
 
 
 
 
 
Figure 43. Squalene and lycopadiene biosynthesis in race L. Two molecules of 
farnesyl diphosphate (FPP) are condensed by squalene synthase (SS) to produce the 
presqualene diphosphate (PSPP) intermediate followed by reductive rearrangement to 
produce squalene. Lycopaoctaene synthase (LOS) catalyzes the condensation of two 
molecules of geranylgeranyl diphosphate (GGPP) to produce the prelycopaoctaene 
diphosphate (PLPP) intermediate followed by reductive rearrangement to produce 
lycopaoctaene, which is subsequently reduced to produce lycopadiene. 
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second reaction step (Figure 43)97, 137. An SS-like enzyme called lycopaoctaene synthase 
(LOS) was identified from the L race of B. braunii that, like SS, catalyzes a two-step 
reaction where two molecules of C20 geranylgeranyl diphosphate (GGPP) undergo head-
to-head dimerization to produce the prelycopaoctaene diphosphate (PLPP) intermediate 
in the first step, followed by reductive arrangement to produce C40 lycopaoctaene in the 
second step (Figure 43)59. Production of lycopaoctaene represents the committed step in 
lycopadiene biosynthesis, and is subsequently reduced to lycopadiene by a yet to be 
identified enzyme(s) (Figure 43)59. 
The LOS enzyme also shows unusual substrate promiscuity not previously 
observed in eukaryotic SS or SS-like enzymes59. LOS is capable of utilizing three prenyl 
diphosphate substrates FPP, GGPP, and C20 phytyl diphosphate (PPP) individually or in 
combination to produce six different hydrocarbons with C30, C35, and C40 chain lengths 
(Figure 32)59. For example, when FPP and GGPP are provided as equimolar substrates 
LOS produces three of these hydrocarbons: squalene from combining two FPP 
molecules, C35H58 from joining one FPP and one GGPP, and lycopaoctaene from the 
condensation of two GGPP molecules (Figure 32)59. The remaining three hydrocarbons 
are produced when LOS is incubated with FPP and PPP, or GGPP and PPP (Figure 
32)59. This discovery provides a unique opportunity to engineer the LOS enzyme for 
robust production of individual hydrocarbons with specific chain lengths for possible 
industrial uses such as fuel production. 
In order to accomplish this, the mechanism underlying LOS substrate promiscuity 
needs to be understood. It has been proposed that LOS and the B. braunii L race SS 
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(LSS) arose from the duplication of an ancient SS gene in this alga59. LSS maintained the 
original SS activity to provide carbon flux towards sterol biosynthesis, while LOS 
evolved the novel catalytic function to produce lycopaoctaene leading to hydrocarbon 
production59. The promiscuous activity of LOS is likely due to preservation of the 
original SS activity following the gene duplication event59. Thus, conversion of LOS to 
an SS enzyme, or an enzyme that produces only one C30, C35, or C40 hydrocarbon 
product for potential industrial use could be accomplished by understanding how LOS 
binds substrate for product formation.  In this chapter, we pursued X-ray crystallography 
to obtain the structure of LOS protein for structure-function study. Furthermore, we used 
protein alignments between LOS and SS proteins, as well as a comparison of a predicted 
LOS 3D-strucure with the human SS (HSS) crystal structure to conduct rational site-
directed mutagenesis in order to identify the critical LOS residues important for 
conferring substrate and product specificity. 
3.2 Results and discussion 
3.2a Purification of LOS enzyme for protein crystallization 
3.2a1 Structural comparison of LOS with HSS 
Among many eukaryotic SS enzymes, HSS has been extensively studied due to 
consideration as a drug target for reducing cholesterol in humans92-94, 138. Initial attempts 
to obtain soluble and catalytically active form of HSS faced many challenges as HSS is 
an endoplasmic reticulum associated enzyme, and contains a C-terminal membrane 
spanning domain138. Although deletion of the C-terminal membrane domain of HSS 
yielded catalytically active protein in E.coli extracts, purification of highly soluble, 
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Figure 44. Amino acid sequence alignment of LOS with other SS proteins. 
Conserved domains and regions found in a typical squalene synthases are highlighted 
indicated above the sequence. The substrate binding motifs are shown in blue, NADPH 
binding residues are highlighted in green, and the residues of LOS chosen for 
mutagenesis and the corresponding residues in the SS proteins are shown in red and 
orange. Transmembrane domain predicted by TMpred for each protein are underlined. 
SS, squalene synthase; LOS, lycopaoctaene synthase; LSS, SS from Botryococcus 
braunii race L; BSS, SS from Botryococcus braunii race B; AtSS, SS from Arabidopsis 
thaliana; YSS, SS from Saccharomyces cerevisae; and HSS, Human SS. 
 
FLAP
Domain I Domain II
Domain III Domain IV
Domain V JK loop
HSS      EEIYHR---IPDSDPSSSKTRQIISTIRTQNLPN-----------------CQLISRSHY 382 
           :  :      .**        :  :.                                 
 
LOS      A--KGPSTA-------MVLAG-AL-LIAALAYFAYVYSAGGTS-LKALPLFG-------V 426 
LSS      KQAATPLSD-------DFISKLVL-V-LGLGYCVYAFNLLPLL--------------WKS 421 
BSS      D---------------ELRSRLLA-LTGGSFYLAWTYNFLDLRGPGDLPTFLSVTQHWWS 436 
AtSS     VNDKGQPNS-------VFIIMVVILLAIVFAYLRAN------------------------ 410 
YSS      DDELVPTQQEEEYKFNMVLSIILS-VLLGFY---YIYTLHRA------------------ 444 
HSS      -------SP-------IYLSFVML-----LAALSWQYLTTLSQVTED---YVQTGEH--- 417 
                                                                      
 
LOS      VIILAIG--LF---GRNLALKTV---------------------------- 444 
LSS      ----------ALIPGPPPPALTSSLGLPHQIIAVFCVLTAGYQVFLRGGLA 462 
BSS      ILIFLISIAVFFIPSRPSPRPTLSA-------------------------- 461 
AtSS     --------------------------------------------------- 410 
YSS      --------------------------------------------------- 444 
HSS      --------------------------------------------------- 417	
LOS      ----MKYTDFLAHPDEIIPTIRMMYADYRLK----NMEIKDPSVRFCYNMLNRVSRSFAM 52 
LSS      MG---KLQEVLKHPDELVPLMQMLVSDYYT-----KIVPRDPGLGFCYRMLNKVSRSFAI 52 
BSS      MGMLRWGVESLQNPDELIPVLRMIYADKFG-----KIKPKDEDRGFCYEILNLVSRSFAI 55 
AtSS     MG---SLGTMLRYPDDIYPLLKMKRAIEKAE----KQIPPEPHWGFCYSMLHKVSRSFSL 53 
YSS      MG---KLLQLALHPVEMKAALKLKFCRTP--LFSIYDQSTSPYLLHCFELLNLTSRSFAA 55 
HSS      ----MEFVKCLGHPEEFYNLVRFRIGGKRKVMPKMDQDSLSSSLKTCYKYLNQTSRSFAA 56 
                      * ::   :::                 .     *:  *: .****:  
 
LOS      VIQQLPVELRDATCVFYLILRALDTVEDDMAIPKEVKIPMLRTFHEHLSDRSWKIKCGY- 111 
LSS      VIQQLPELLRDPICVFYLVLRALDTVEDDMALPNDIKLPLLRAFHKKIYDRKWSMKCGY- 111 
BSS      VIQQLPAQLRDPVCIFYLVLRALDTVEDDMKIAATTKIPLLRDFYEKISDRSFRMTAGDQ 115 
AtSS     VIQQLNTELRNAVCVFYLVLRALDTVEDDTSIPTDEKVPILIAFHRHIYDTDWHYSCGT- 112 
YSS      VIRELHPELRNCVTLFYLILRALDTIEDDMSIEHDLKIDLLRHFHEKLLLTKWSFDGNAP 115 
HSS      VIQALDGEMRNAVCIFYLVLRALDTLEDDMTISVEKKVPLLHNFHSFLYQPDWRFMESK- 115 
         **: *   :*:   :***:******:***  :    *: :*  *:  :   .:    .   
 
LOS      -GPYVDLMDNYPLVTDVYLRFDEGTKAVIKDITRRMGNGMADFIDLD-----EVLTIPQY 165 
LSS      -GPYVQLMEEYPMVTGVFLKLDPGPREVITEICRKMGAGMAEFIPKE-----VL-TVKDY 164 
BSS      -KDYIRLLDQYPKVTSVFLKLTPREQEIIADITKRMGNGMADFVHKG-----VPDTVGDY 169 
AtSS     -KEYKILMDQFHHVSAAFLELEKGYQEAIEEITRRMGAGMAKFICQE-----VE-TVDDY 165 
YSS      DVKDRAVLTDFESILIEFHKLKPEYQEVIKEITEKMGNGMADYILDENYNLNGLQTVHDY 175 
HSS      -EKDRQVLEDFPTISLEFRNLAEKYQTVIADICRRMGIGMAEFLDKH-----VT-SEQEW 168 
               :: ::  :   : .:    :  * :* .:** ***.::           :  :: 
 
LOS      DLYCHYVAGLCGIGMCKLFVDSGLEKEDLVAEEDLANQMGLFLQKNNIVRDYLEDINELP 225 
LSS      DQYCHYAAGLVGEGLSKLAVGSGLENPVLLQKEDLSNHMGLFLQKTNIVRDYLEDINEEP 224 
BSS      DLYCHYVAGVVGLGLSQLFVASGLQSPSLTRSEDLSNHMGLFLQKTNIIRDYFEDINELP 229 
AtSS     DEYCHYVAGLVGLGLSKLFLAAGSEVLT-PDWEAISNSMGLFLQKTNIIRDYLEDINEIP 224 
YSS      DVYCHYVAGLVGDGLTRLIVIAKFANESLYSNEQLYESMGLFLQKTNIIRDYNEDLV--- 232 
HSS      DKYCHYVAGLVGIGLSRLFSASEFEDPLVGEDTERANSMGLFLQKTNIIRDYLEDQQ--- 225 
         * ****.**: * *: :*   :              : *******.**:*** **      
 
LOS      APRMFWPKEIWGNYAKQLDEFKDPKNLDKAMLCLNHMVTDALRHCEVGLRSLSLLHNPNI 285 
LSS      APRMFWPKEIWGKYTKDLADFKDPANEKGAVQCLNHMVTDALRHGEHALKYMALLRDPQY 284 
BSS      APRMFWPREIWGKYANNLAEFKDPANKAAAMCCLNEMVTDALRHAVYCLQYMSMIEDPQI 289 
AtSS     KSRMFWPREIWGKYADKLEDLKYEENTNKSVQCLNEMVTNALMHIEDCLKYMVSLRDPSI 284 
YSS      DGRSFWPKEIWSQYAPQLKDFMKPENEQLGLDCINHLVLNALSHVIDVLTYLASIHEQST 292 
HSS      GGREFWPQEVWSRYVKKLGDFAKPENIDLAVQCLNELITNALHHIPDVITYLSRLRNQSV 285 
           * ***:*:*..*. .* ::    *   .: *:*.:: :** *    :  :  :.: .  
 
LOS      LRAVLIPQVMGVRTLTLVYNNPEVFRG---VVKMRRGETAKIFVTTTSKLSFFRTYLQFA 342 
LSS      FNFCAIPQVMAFGTLSLCYNNPQVFKG---VVKLRKGESAKLMTTVKSMPALYRTFLRMA 341 
BSS      FNFCAIPQTMAFGTLSLCYNNYTIFTGPKAAVKLRRGTTAKLMYTSNNMFAMYRHFLNFA 349 
AtSS     FRFCAIPQIMAIGTLALCYNNEQVFRG---VVKLRRGLTAKVIDRTKTMADVYGAFYDFS 341 
YSS      FQFCAIPQVMAIATLALVFNNREVLHG---NVKIRKGTTCYLILKSRTLRGCVEIFDYYL 349 
HSS      FNFCAIPQVMAIATLAACYNNQQVFKG---AVKIRKGQAVTLMMDATNMPAVKAIIYQYM 342 
         :.   *** *.. **:  :**  :: *    **:*:* :  ::    .             
 
LOS      NEMEQKCLTEAKNDPMVALTLKRVQGVQAACRAA-----------------IVKAEIAEG 385 
LSS      DDMVARCKGEARQDPNVATTLKRLQAIQAVCKTG-----------------LRSSIKSRK 384 
BSS      EKLEVRCNTETSEDPSVTTTLEHLHKIKAACKAG-----------------LARTKDDTF 392 
AtSS     CMLKTK---VDKNDPNASKTLNRLEAVQKLCRDA-----------------GVLQNRKSY 381 
YSS      RDIKSK---LAVQDPNFLKLNIQISKIEQFMEEMYQDKLPPNVKPNETPIFLKVKERSRY 406 
  116 
pure and active HSS required removal of 30 amino acids at the N-terminus and 47 amino 
acids at the C-terminus138. Several crystal structures of HSS have now been solved, but 
the crystallization of double truncated form of HSS (HSS31-370) protein was only possible 
in the presence of either farnesyl thiodiphosphate (FSPP; an analog of substrate FPP), 
PSPP intermediate or inhibitors of the SS reaction92-94, 138. As mentioned earlier, LOS is 
an SS-like enzyme and shares high amino acid sequence similarity at the conserved 
catalytic regions of HSS enzyme (Figure 44). Thus, our approach to obtain protein 
crystal of LOS is similar to that used for the HSS31-370 protein. LOS encodes 444 amino 
acids with two predicted transmembrane domains at the C-terminus, one of the domain 
corresponds to amino acids 392 to 409 and the other corresponds to amino acids 420 to 
441 (Figure 44). The three-dimensional structure of LOS was generated using the 
Iterative Threading ASSEmbly Refinement (I-TASSER) bioinformatics program139-141. 
The predicted 3-D structure shows LOS as an α-helical protein with several regions 
matching previous SS structures such as a large central catalytic channel running 
through the center of the protein (dashed box in Figure 45A), an N-terminal flexible 
region (green in Figure 45A) and a C-terminal transmembrane domain (magenta in 
Figure 45A). 
As we previously reported59, removal of the 53 C-terminal amino acids encoding 
the transmembrane domain, producing LOS1-391, was sufficient to achieve soluble, pure 
and catalytically active form of this enzyme. In order to match the HSS31-370 structure, 
the first 32 N-terminal amino acids of LOS1-391 were truncated plus an additional nine C- 
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Figure 45. 3D-Structures of LOS and HSS. A. A model of LOS structure as predicted 
by the I-TASSER program. The N-terminal flexible region is shown in green and a 
double pass transmembrane domain predicted by TMPred software is shown in magenta. 
B. Comparison of the crystal structure of HSS31-370 (light blue) bound to two molecules 
of farnesylthiol diphosphate (FSPP) and a computationally truncated model of LOS33-
381(light brown). LOS = lycopaoctaene synthase and HSS = human squalene synthase.  
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terminal amino acids were removed to generate LOS33-381 (Figure 45B). The comparison 
of the FSPP bound HSS31-370 structure with that of the predicted LOS33-381 structure 
showed that both structures aligned well with very close matches of all α-helices and the 
active site (Figure 45B). To check whether LOS33-381 is biologically active, two 
constructs of LOS designed to encode for 6xHis-LOS1-391 and 6xHis-LOS33-381 were 
made, expressed in E.coli, protein samples purified and the enzymatic activity tested. As 
shown in Figure46A, both LOS1-391 and LOS33-381 were successfully purified, but their 
apparent protein size as analyzed by SDS-PAGE is smaller than the predicted molecular 
weight. It should be noted that purified HSS also migrated lower than its predicted 
molecular weight when analyzed by SDS-PAGE138. When the LOS enzyme assay was 
conducted with purified LOS1-391 and LOS33-381, both samples successfully produced 
lycopaoctaene using GGPP as a substrate (Figure 46B). Similarly, when activities were 
tested using the FPP/GGPP mixed substrate assay, both LOS protein samples produced 
hydrocarbons of all possible combinations; squalene, C35H58 and lycopaoctaene (Figure 
46C). Although the absolute values of enzymatic activities of LOS33-381 are lower when 
compared to LOS1-391, both LOS constructs can be purified and are catalytically active, 
and will be used for future crystallization experiments (Figure 46). 
3.2a2 Purification of 6xHis-LOS1-391 protein for crystal screening 
Unlike enzyme assays, protein crystallization requires large amounts (~10 mg) of 
highly pure protein as most of the protein sample will be used to screen conditions 
optimal for obtaining crystals of the desired protein. For optimization of large-scale  
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Figure 46. Characterization of LOS1-391and LOS33-381 proteins. A. Approximately 
5µg of purified protein for each sample was analyzed by SDS-PAGE. Predicted 
molecular weight for 6xHis-LOS1-391and 6xHis-LOS33-381 is shown. B. LOS enzyme 
assay for lycopaoctaene production using LOS1-391 and LOS33-381 with GGPP given as a 
substrate. C. Enzyme activities of LOS1-391 and LOS33-381 in the FPP/GGPP mixed 
substrate assay showing production of squalene, C35H58, and lycopaoctaene. GGPP = 
geranylgeranyl diphosphate and FPP = farnesyl diphosphate. 
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protein purification, we decided to focus on the construct encoding 6xHis-LOS1-391. 
Initial purification of the LOS1-391 protein was conducted to determine the optimal 
imidazole concentration required in the washing step of protein purification. Four 
different imidazole concentrations (20, 30, 40 and 50 mM) were tested, and the 
purification for each sample was conducted using the E.coli cell pellet from a 200 mL 
culture expressing the LOS1-391 construct (Figure 47A). Samples washed with 40 mM 
and 50 mM imidazole yielded protein with higher purity despite a significant loss in 
protein yield when compared to treatment with 20 mM and 30 mM imidazole (Figure 
47A). Although there is no significant difference in the purity between the 40 mM and 
50 mM imidazole washes, protein yield was reduced by more than 60% when treated 
with the 50 mM imidazole wash (Figure 47A). In order to obtain a good yield along with 
pure protein, the 40 mM imidazole wash step was used in future purification 
experiments. 
Next, the protein purification was scaled up using the cell pellet from a 750 mL 
E.coli culture. About 2.9 mg of purified protein from nickel affinity chromatography was 
loaded into a gel filtration column (Figure 47B). Two peaks were observed, the large 
peak with earlier elution time corresponded to aggregated protein, and the small peak 
corresponded to the LOS monomer (Figure 47B). Analysis by SDS-PAGE showed the 
aggregation sample contained LOS protein as the major component and a small amount 
of other contaminants. In case of the monomer peak, the LOS protein is relatively pure 
except for the presence of a 25kDa protein band (Figure 47B). Protein recovery for the  
  121 
 
Figure 47. Purification of 6xHis-LOS1-391. Approximately 20µg of purified protein was 
analyzed by SDS-PAGE. A. LOS protein purification optimization using different 
concentrations of imidazole in the wash buffer. The amount of purified protein recovered 
after each wash treatment is expressed as mg of protein per liter of E.coli culture. B. 
Protein purified from nickel affinity chromatography as analyzed by SDS-PAGE on the 
left was loaded into the gel filtration column. Two samples were collected and analyzed 
by SDS-PAGE as shown in right. C. Sample 1 from B was loaded onto the gel filtration 
column, sample A was collected and then analyzed by SDS-PAGE gel. LOS = 
lycopaoctaene synthase. 
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LOS monomer sample from the gel filtration column was 20%. To check whether the 
LOS monomer sample was stable over time, sample 2 from figure 47A was stored at -
80°C for two weeks, and then loaded onto a gel filtration column (Figure 47C). The LOS 
monomer sample did not show any aggregation peak suggesting it is stabile over time 
(Figure 47C). Interestingly, a shoulder peak was observed for sample A in the gel 
filtration analysis and may correspond to the small protein band observed around 25 kDa 
in the SDS-PAGE analysis (Figure 47C). Further analysis of sample A by western blot 
using an α-His antibody detected this 25 kDa band suggesting it is a C-terminal 
degradation product of the 6xHis-LOS1-391 protein (data not shown). It should be noted 
that the 25 kDa band is present in all purification steps and becomes more prevalent after 
purification through gel filtration (Figure 47). When purification was scaled up using the 
cell pellet from a ~1.5 liter E.coli culture, LOS purity decreased (data not shown). Due 
to this reason, we repeated purification using the cell pellet from a ~750 mL E.coli 
culture. This was carried out five independent times and generated 3.3 mg of the LOS1-
391 monomer sample, which was given it to our collaborator Su Tang (Dr. James 
Sacchettini’s lab at Texas A&M University) for crystal screening. Unfortunately, 
screening under 480 crystallization conditions did not yield protein crystals. It is possible 
that the small band of LOS protein could have interfered the crystallization process. 
The LOS enzyme shows optimal enzyme activity in a MOPS based reaction 
buffer59. However, the large scale purification of LOS1-391 conducted so far utilized a 
sodium phosphate based buffer. The detail information on the composition of sodium 
phosphate and MOPS based buffer is provided in the method section of this chapter. In 
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order to test the effect of a MOPS based buffer on protein purification, we conducted 
nickel affinity chromatography purification using a cell pellet from a ~750 mL E.coli 
culture and analyzed the purified protein using gel filtration (Figure 48A). As shown in 
the gel filtration chromatograph (Figure 48A), the MOPS based buffer did not change 
the profile of aggregated versus LOS monomer peaks, but shifted the shoulder peak of 
the LOS monomer peak towards left (sample 1) when compared to the shoulder peak 
observed on the right in the previous purification with the sodium phosphate based 
buffer (compare figures 47C and 48A). We also collected the fractions corresponding to 
the left shoulder (sample 1) and the main peak (sample 2), and then analyzed the protein 
samples by SDS-PAGE (Figure 48A). Interestingly, sample 1 contained 6xHis-LOS1-391 
as a major protein band and the 25 kDa small protein band corresponding to a C-terminal 
degraded or truncated form of LOS (Figure 48A). It seems that the 25 kDa protein band 
of LOS interacts with 6xHis-LOS1-391 protein, and eventually results in the shoulder peak 
and earlier elution of sample 1 from the gel filtration column (Figure 48A). In the case of 
sample 2, the 25 kDa protein band was not present and the 6xHis-LOS1-391 accounted for 
most of the protein in the sample (Figure 48A). Based on this data, only sample 2 was 
collected and used for future crystal screening experiments. 
Further purification optimization using 0.1% Triton X-100 in the MOPS based 
lysis buffer increased the yield of the purified protein from affinity chromatography by 
2.5-fold; 10.3 mg versus 4.1 mg per ~750 mL E.coli culture with or without Triton X-
100, respectively (Figure 48B). This result is consistent with the hydrophobic nature of 
LOS and suggests increased solubility of the LOS protein by the non-ionic detergent   
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Figure 48. Purification of 6xHis-LOS1-391 using MOPS based buffer. Approximately 
20 µg of purified protein was analyzed by SDS-PAGE. Sample P = protein purified from 
nickel affinity chromatography was loaded onto the gel filtration column. Sample 1 and 
sample 2 were collected from the LOS monomer peak. A. Purification using the MOPS 
based buffer. B. Purification using the MOPS based buffer containing 0.1% Triton X-
100 in the lysis buffer. LOS = lycopaoctaene synthase. 
Sample     1   2 
Sample    P       1        2                
Aggregation peak
46
kDa
58
75
 32
100
 25
Monomer peak
Sample     1   2 
Aggregation peak
Sample    P      1       2                
46
kDa
58
75
 32
100
 25
A
B
Monomer peak
A
bs
or
ba
nc
e 
(m
A
u)
 a
t 2
80
 n
m
0 40 80 12020 60 100 140 160 180
380
340
300
260
220
180
140
100
60
20
0
Retention time (min)
A
bs
or
ba
nc
e 
(m
A
u)
 a
t 2
80
 n
m
0 40 80 12020 60 100 140 160 180
800
700
600
500
400
300
200
100
0
Retention time (min)
  125 
Triton X-100. However, analysis of the 10.3 mg of purified protein by gel filtration did 
not show any change in the chromatograph profile (compare figures 48A and 48B). 
Approximately 2.5 mg of sample 2 (LOS monomer) was recovered from the gel 
filtration column and analysis by SDS-PAGE showed a highly pure protein band for 
6xHis-LOS1-391 (Figure 48B). This process was repeated several times to generate 10.6 
mg of highly pure LOS1-391 monomer (sample 2 in figure 48B). As mentioned earlier, 
generating protein crystals of HSS was only possible when HSS was co-incubated with 
either FSPP, PSPP, or the inhibitor molecules92-94, 138. Since LOS can utilize FPP to 
produce squalene, crystal screening was conducted with the LOS1-391 monomer sample 
by incubating with FSPP. However, crystal screening under 600 different solution 
conditions with 4 mM FSPP did not result in any protein crystals. There could be many 
factors contributing to the unsuccessful crystallization of the LOS1-391 protein. It should 
be noted the 6xHis tag was not cleaved from the LOS1-391 monomer sample used in the 
crystal screening experiment. It was assumed the 6xHis tag may not affect the LOS1-391 
crystallization since the enzyme activity of LOS1-391 was not compromised by the 6xHis 
tag and the monomer sample of 6xHis-LOS1-391 was stable and did not aggregate over 
time. Furthermore, several protein structures containing 6xHis tags have been reported in 
the literature142. However, many crystallographers do not recommend the use of 6xHis 
or any other tags during crystallization as they are known to increase the aggregation of 
the purified protein and hinder the protein crystallization process142. Although highly 
pure and stable LOS1-391 monomer was obtained, unsuccessful crystallization of this 
protein could have resulted due to the presence of the 6xHis tag at the N-terminus. 
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3.2a3 Purification of 6xHis-SUMO-TEV-LOS1-391 protein for crystal screening 
In order to purify a tag free version of LOS, a new LOS construct was designed 
to encode for 6xHis-SUMO-TEV-LOS1-391. The N-terminal 6xHis tag was added in 
order to purify protein using nickel affinity chromatography, whereas the small 
ubiquitin-like modifier (SUMO) protein was fused to LOS as it is known to significantly 
increase the solubility and stability of fusion proteins143. The cleavage site for tobacco 
etch virus nuclear-inclusion-a endopeptidase (TEV protease) was also added after the 
6xHis-SUMO tag to facilitate the removal of both tags from the LOS1-391 fusion protein. 
Purification of 6xHis-SUMO-TEV-LOS1-391 using a cell pellet from a ~750 mL E.coli 
culture yielded approximately 32.5 mg of pure protein after nickel affinity 
chromatography (sample 1, Figure 49). This is three times higher yield than previously 
observed for 6xHis-LOS1-391. Next the 6xHis-SUMO-TEV-LOS1-391 protein was treated 
with 6xHis-TEV protease to remove the 6xHis-SUMO tag, the protein sample incubated 
with nickel resin to bind any uncleaved LOS fusion protein and the 6xHis-TEV protease, 
and the flow through (sample 4, Figure 49) containing LOS1-391 analyzed by gel filtration 
(Figure 49). Out of the 32.5 mg of protein used in the cleavage reaction with 6xHis-TEV 
protease, only 4.3 mg of tag free LOS1-391 was recovered in the flow through (sample 4, 
Figure 49) whereas most of the tag free LOS1-391 remained on the nickel column as an 
aggregate (sample 3, Figure 49). 
Interestingly, the gel filtration chromatograph of LOS1-391 showed a change in 
the profile of the aggregation and monomer peaks when compared to the profile  
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Figure 49. Purification of 6xHis-SUMO-TEV-LOS1-391. Except for sample 3, 
approximately 10µg of protein sample was analyzed by SDS-PAGE. The predicted 
molecular weight of each protein is shown. Protein purification was done using MOPS 
based buffer containing 0.1% Triton X-100 in the lysis buffer. LOS = lycopaoctaene 
synthase. 
  
Sample 1 = purified protein from nickel affinity chromatography  
Sample 2 = protein sample after cleavage with TEV protease for 17.5 hrs at 4℃ 
Sample 3 = aliquot of nickel resin after collecting flow through of cleaved sample  
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Sample 5 = LOS monomer protein collected from gel filtration column
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observed for 6xHis-LOS1-391; the peak size of the aggregated protein decreased whereas 
the peak size of LOS monomer increased (compare figures 48B and 49). Analysis of the 
LOS monomer sample by SDS-PAGE showed a highly pure protein band corresponding 
to the LOS1-391 protein (sample 5, Figure 49). Unlike purification of 6xHis-LOS1-391, the 
LOS1-391 monomer peak does not contain the small protein band around 25 kDa 
(compare Figures 48B and 49). It is possible the SUMO tag increased protein solubility 
as well as the stability of LOS1-391. Protein purification for 6xHis-SUMO-TEV-LOS1-391 
was repeated several times to generate 10.3 mg of tag free LOS1-391 monomer protein. 
Unfortunately, crystal screening using the LOS1-391 protein conducted with or without 
geranylgeranylthiol diphosphate (GGSPP), a GGPP substrate analog, under many 
crystallization conditions did not yield protein crystals. Extensive screening of 
crystallization conditions should be done in the future in order to obtain a crystal of the 
LOS1-391 protein. 
3.2a4 Purification using 6xHis-LOS33-381 & 6xHis-SUMO-TEV-LOS33-381 constructs 
The LOS33-381 construct, which was designed based on the published crystal 
structure of HSS, is soluble and catalytically active (Figure 46). In order to use LOS33-381 
for crystal screening experiments, test purification using two different constructs was 
conducted; 6xHis-LOS33-381 and 6xHis-SUMO-TEV-LOS33-381. Purification of 6xHis-
LOS33-381 using a cell pellet from a ~750 mL E.coli culture yielded approximately 3.3 
mg of purified protein after nickel affinity chromatography (sample P, Figure 50). This 
is 3-fold less protein yield when compared to purification of the 6xHis-LOS1-391 protein  
  
  129 
 
 
 
 
Figure 50. Purification of 6xHis-LOS33-381. Approximately 20 µg of purified protein 
was analyzed by SDS-PAGE. The predicted molecular weight of 6xHis-LOS33-381 
protein is shown. Sample P = protein purified from nickel affinity chromatography was 
loaded onto the gel filtration column. Sample 1 and sample 2 were collected from the 
LOS monomer peak. Protein purification was done using MOPS based buffer containing 
0.1% Triton X-100 in the lysis buffer. LOS = lycopaoctaene synthase. 
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Figure 51. Purification of 6xHis-SUMO-TEV-LOS33-381. Approximately 10µg of each 
protein sample was analyzed by SDS-PAGE. The predicted molecular weight of each 
protein is shown. Protein purification was done using MOPS based buffer containing 
0.1% Triton X-100 in the lysis buffer. LOS = lycopaoctaene synthase. 
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under same conditions. In contrast to 6xHis-LOS1-391, analysis of purified 6xHis-LOS33-
381 protein by gel filtration showed increased peak size of the LOS monomer whereas the 
peak size of the aggregated LOS protein is decreased (compare figures 48B and 50). 
Although a shoulder peak was not observed for the LOS monomer, two fractions 
(sample 1 and 2) from the monomer peak were collected. Analysis of these samples by 
SDS-PAGE showed a major protein band corresponding to 6xHis-LOS33-381 along with 
several small protein bands of sizes below 25kDa (Figure 50). 
In the case of 6xHis-SUMO-TEV-LOS33-381, protein purification using a cell 
pellet from a ~750 mL E.coli culture yielded approximately 11.4 mg of purified protein 
after nickel affinity chromatography (sample 1, Figure 51). This is 3-fold less protein 
yield when compared to purification of 6xHis-SUMO-TEV-LOS1-391 under the same 
conditions. Next the 6xHis-SUMO tag of 6xHis-SUMO-TEV-LOS33-381 was cleaved 
using TEV protease, and the tag free LOS33-381 was loaded onto the gel filtration column 
(Figure 51). Surprisingly, most of the LOS33-381 protein aggregated as shown by the 
prominent aggregation peak and a small peak was observed for the LOS33-381 monomer 
(Figure 51). Further analysis of the monomer peak (sample 3) by SDS-PAGE showed 
decreased purity of LOS33-381 as it contained several protein contaminants of smaller 
sizes (Figure 51). It is possible that the small protein bands seen in sample 3 could result 
from the degradation of the LOS33-381 protein. In summary, protein purity of the double 
truncated constructs (6xHis-LOS33-381 and 6xHis-SUMO-TEV-LOS33-381) is less when 
compared to the C-terminal truncated constructs (6xHis-LOS1-391 and 6xHis-SUMO-
TEV-LOS1-391). Further optimization of LOS33-381 protein purification should be 
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conducted in order to obtain highly pure and stable monomer samples suitable for crystal 
screening experiments. 
3.2b Mutagenesis experiment with LOS enzyme 
3.2b1 Identification of LOS residues for mutagenesis 
 Our attempts to obtain the crystal structure of LOS for structure-function 
studies were unsuccessful. Thus, for rational mutagenesis experiments LOS was 
compared to LSS and four other SS enzymes from other organisms to determine regions 
of similarity or dissimilarity and to identify mutational targets for understanding LOS 
substrate specificity. The reaction catalyzed by SS has been extensively investigated and 
the role of important catalytic residues verified using protein crystal structures, site-
directed mutagenesis, and enzyme assays81, 92-94. From these studies seven functional SS 
domains have been identified: domains I-V for substrate binding and catalysis, and a 
FLAP domain and a J-K loop involved in NADPH binding (Figure 44)79, 81, 94. An amino 
acid alignment of LOS with the five SS proteins shows conservation of all these domains 
in LOS as well as two domain II and IV DXXED motifs involved in FPP/PSSPP 
diphosphate binding81, 94, and the positively charged residues R52, R218, K315, R317 
and K318 that are involved in NADPH binding94 (Figure 44). From this analysis it is 
obvious LOS shows high sequence conservation with SS proteins, making it difficult to 
use these alignments to identify residues that may confer LOS substrate specificity. 
Additionally, residues that dictate the novel catalytic activity and promiscuity of LOS 
may lie outside these conserved regions. 
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Thus, we found identifying the amino acid differences that control LOS substrate 
binding to be most straightforward using a structural comparison. Based on the HSS31-370 
- LOS33-381 structural comparison, five LOS amino acids appear to be important for 
substrate interaction: T65, M180, S276, A288 and V289 (Figure 52A). Except for S276, 
all residues are located within the conserved functional SS enzyme domains I, III, and 
IV, and all five LOS residues are different from their corresponding amino acids in the 
other SS proteins (Figure 52A). For instance, the corresponding amino acids in HSS are 
V69, L183, Y276, F288 and C289 (Figure 52A), and are located in the hydrophobic 
region that forms the bottom of the central cavity for the active site of HSS (Figure 
52B)94. Previous HSS structure studies have shown that these five amino acids form a 
hydrophobic floor in the substrate binding pockets for interaction with the non-polar tail 
of the FSPP substrates94; the hydrophobic side chains of V69, L183, and F288 form the 
hydrophobic floor for the substrate 1 (S1) pocket, whereas the hydrophobic portions of 
the Y276 and C289 side chains form the hydrophobic floor for the substrate 2 (S2) 
pocket (Figure 52B). The corresponding five LOS residues are also located in the same 
hydrophobic region of the LOS active site, with the T65, M180, and A288 side chains 
contributing to the hydrophobic floor for the S1 substrate pocket, and V289 and S276 
contributing to the hydrophobic floor for the S2 substrate pocket (Figure 52C). However, 
the replacement of HSS F288 with A288 in LOS and HSS Y276 with S276 in LOS 
appears to enlarge the S1 and S2 substrate binding pockets, respectively, to 
accommodate the larger GGPP substrate (Figure 52C). We therefore hypothesized that 
LOS A288 and S276 were key mutations that arose during gene duplication to allow   
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Figure 52. Alignment of amino acid and structures. For clarity, structures are focused 
on the active site of both enzymes. A. Amino acid sequence alignment of LOS with SS 
proteins focusing on the regions around the residues analyzed in this study. The five 
LOS residues chosen for mutagenesis and the corresponding residues in the SS proteins 
are shown in red. LOS, lycopaoctaene synthase; LSS, B. braunii L race SS; BSS, B. 
braunii B race SS; AtSS, Arabidopsis thaliana SS; YSS, yeast SS; HSS, human SS. B. 
Superposition of HSS (light blue) and LOS (light brown) showing the five amino acids 
of HSS located on the hydrophobic floor of the two substrate binding sites highlighted in 
magenta. C. Superposition of HSS (light blue) and LOS (light brown) showing the five 
amino acids of LOS located on the hydrophobic floor of two substrate binding sites 
highlighted in magenta. 
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S2 FSPP
B
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C
S276
V289 A288
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S1 FSPP
S1 FSPP
S2 FSPP
FLAP Domain I
Domain III
Domain V
 
LOS   45 RVSRSFAMVIQQLPVELRDATCVFYL 70 
LSS   45 KVSRSFAIVIQQLPELLRDPICVFYL 70 
BSS   48 LVSRSFAIVIQQLPAQLRDPVCIFYL 73 
AtSS  46 KVSRSFSLVIQQLNTELRNAVCVFYL 71 
YSS   48 LTSRSFAAVIRELHPELRNCVTLFYL 73 
HSS   49 QTSRSFAAVIQALDGEMRNAVCIFYL 74 
          .****: **: *   :*:   :***   
 
LOS  166 DLYCHYVAGLCGIGMCKLFVDSGLEK 191 
LSS  165 DQYCHYAAGLVGEGLSKLAVGSGLEN 190 
BSS  170 DLYCHYVAGVVGLGLSQLFVASGLQS 195 
AtSS 166 DEYCHYVAGLVGLGLSKLFLAAGSEV 191 
YSS  176 DVYCHYVAGLVGDGLTRLIVIAKFAN 201 
HSS  169 DKYCHYVAGLVGIGLSRLFSASEFED 194 
         * ****.**: * *: :*   :  
 
LOS  276 SLSLLHNPNILRAVLIPQVMGVRTLT 301 
LSS  275 YMALLRDPQYFNFCAIPQVMAFGTLS 300 
BSS  280 YMSMIEDPQIFNFCAIPQTMAFGTLS 305 
AtSS 275 YMVSLRDPSIFRFCAIPQIMAIGTLA 300 
YSS  283 YLASIHEQSTFQFCAIPQVMAIATLA 308 
HSS  276 YLSRLRNQSVFNFCAIPQVMAIATLA 301 
         :  :.: .  :.   *** *.. **:  
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binding of GGPP while still retaining FPP binding. Thus, A288 and S276 plus the three 
other residues (T65, M180, V289) forming the LOS S1 and S2 substrate pocket 
hydrophobic floors were chosen for mutational studies to decipher their roles in substrate 
binding and product specificity. 
3.2b2 Characterization of LOS mutants in vitro  
In order to determine the roles of LOS T65, M180, S276, A288 and V289 in 
substrate binding and product formation these amino acids were mutated to their 
corresponding residues in HSS individually and in combinations (Table 2). The mutated 
proteins were purified, enzyme activities characterized in a mixed substrate assay 
(Figure 53A) containing equimolar 3H-FPP and 3H-GGPP, and the enzymatic activity 
quantified based on 3H incorporation into the products lycopaoctaene, C35H58, and 
squalene (Figure 53B). The FPP/GGPP mixed substrate assay was chosen over the 
FPP/PPP or GGPP/PPP mixed substrate assays because the FPP/GGPP assay is more 
robust in terms of product formation59. 
The results from these assays indicate that for the M1 to M5 single amino acid 
mutations, M1, M2, and M5 retained their ability to produce lycopaoctaene, whereas the 
replacement of S276 and A288 with the aromatic amino acids Tyr and Phe in M3 and 
M4, respectively, lead to a significant loss of lycopaoctaene production activity (Figure 
53B). When compared to wild-type (WT), M3 retained 47% of lycopaoctaene 
production, and M4 had a substantial reduction retaining only 29% of lycopaoctaene 
production activity (Figure 53B). In the case of C35H58 production, all single mutants at 
least retained WT activity (Figure 53B). Interestingly, the M3 mutant showed a 
  136 
substantial increase in C35H58 production to 183% of that of WT LOS (Figure 53B). 
Except for M3, all single mutants retained at least WT activity levels for squalene 
production (Figure 53B). The observed activity for M3 and M4 suggests the increased 
residue size in these mutants blocks GGPP biding in the S1 pocket by the M4 A288F 
mutation and in the S2 pocket by the M3 S276Y mutation. This indicates the importance 
of LOS S276 and A288 in binding of GGPP substrate. Further support for this is seen in 
the increased C35H58 production in M3 (Figure 53B) suggesting favorable binding of one 
GGPP in the S1 pocket and one FPP in the S2 pocket. Additionally, the decreased 
lycopaoctaene production, but no change in C35H58 and squalene production in M4 
(Figure 53B) suggests limited binding of two GGPP molecules and preferable binding of 
one FPP in the S1 pocket and one GGPP in the S2 pocket (Figures 53A and B). 
Next, the LOS double mutants M6 to M9 (Table 2) were characterized for 
enzymatic activity using the same mixed substrate assay (Figure 53A). As shown in 
Figure 53B, the enzyme activity of M6 is similar to that of WT. When comparing the 
M7 double mutant to the parent M4 mutant background, M7 did not show a difference in 
lycopaoctaene production, but C35H58 production was slightly increased and squalene 
formation was significantly reduced (Figure 53B). For the M9 double mutant, which has 
a V289C substitution in the S276Y M3 background, a small increase in C35H58 
production was observed, whereas the activities for lycopaoctaene and squalene 
production remained the same as that of M3 background (Figure 53B). Most 
interestingly, the M8 double mutant, which has both the M3 S276Y mutation and the M4  
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Table 2. List of lycopaoctaene synthase (LOS) mutants characterized in this study.  
Mutant name Mutation
M1 T65V
M2 M180L
M3 S276Y
M4 A288F
M5 V289C
M6 T65V M180L
M7 T65V A288F
M8 S276Y A288F
M9 V289C S276Y
M10 T65V  M180L A288F
M11 T65V  M180L  S276Y A288F 
M12 T65V M180L S276Y A288F V289C
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Figure 53. Characterization of LOS mutants in vitro. A. Reaction scheme showing 
LOS products from the FPP/GGPP mixed substrate assay. B. Enzyme activities of the 
LOS mutants in the FPP/GGPP mixed substrate assay showing production of squalene, 
C35H58, and lycopaoctaene. Numbers on top of each bar indicate the activity percentage 
based on WT LOS activity as 100%. Data shown are from three independent experiments 
(n = 3). 
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A288F mutation, showed a drastic reduction in the ability to produce lycopaoctaene and 
C35H58 when compared to WT (Figure 53B). Moreover, the SS activity for M8 is 
substantially increased more than 3-fold over the WT enzyme (Figure 53B). These 
results for M8 further support our hypothesis that S276 and A288 are important for 
controlling LOS substrate binding, and replacing these residues with bulky aromatic 
amino acids blocks the binding of GGPP in both substrate binding pockets. This is 
further supported by a previous study where F288 was shown to be essential in the SS 
reaction94. The HSSF288A crystal structure showed mutation to the smaller Ala resulted in 
a deeper cleft in the S1 substrate pocket94. Thus, having Ala at position 288 in LOS 
would expand the S1 substrate pocket to allow for GGPP binding. Additionally, F288 
was proposed to be involved in PSPP diphosphate ionization during the second half 
reaction, and the HSSF288A structure indicated the expanded S1 substrate pocket caused 
misorientation of the PSPP intermediate in the active site94. Accordingly the F288A 
mutation in HSS significantly reduced the HSS enzyme activity to 22.7% of WT 
activity94. Since the WT LOS with A288 is fully active this would suggest there are 
additional LOS residues that are different from SS that would allow for proper PLPP 
diphosphate orientation and ionization. 
Finally, the M10 triple mutant, the M11 quadruple mutant, and the M12 
quintuple mutant (Table 2) were analyzed for enzymatic activity using the mixed 
substrate assay. The M10 mutant showed activity similar to that of the M4 parent 
background (Figure 53B). For the M11 and M12 mutants, the activity is very similar to 
each other. But in comparison to the M8 parent background, both M11 and M12 showed 
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a further reduction in C35H58 production and no significant change in lycopaoctaene and 
squalene formation (Figure 53B). These results suggest that mutation of the five LOS 
amino acids studied here to their corresponding HSS residues is sufficient to change 
LOS substrate binding specificity to mainly FPP binding and thus product specificity to 
squalene production (compare WT and M12 in Figure 53B). It should be noted the M12 
mutant retained residual activity for lycopaoctaene and C35H58 production (Figure 53B), 
indicating low levels of GGPP binding and suggesting further modification is required in 
the M12 mutant background to completely abolish GGPP binding (Figure 53B). 
3.2b3 Analysis of LOS and LOS mutants in vivo 
To further support our in vitro assay data we attempted to characterize the activity 
of WT LOS and the LOS mutants using Escherichia coli as an in vivo expression system 
since the native host, B. braunii, cannot be transformed. Like B. braunii, E. coli utilizes 
the MEP pathway for isoprenoid biosynthesis144. Most importantly, E. coli does not 
naturally produce the lycopaoctaene, C35H58, or squalene hydrocarbons under 
investigation in our study (Figure 54, panel I). Thus, the E. coli expression system 
allows for a straightforward platform to characterize LOS and the LOS mutants in vivo. 
As mentioned earlier, the in vitro mixed substrate assay used for characterization 
of the LOS mutants contained equal concentrations of FPP and GGPP. Thus, an E. coli 
line generating equal and high amounts of FPP and GGPP is desired for characterization 
of LOS and the LOS mutants in vivo. However, when LOS was overexpressed in E. coli, 
only a small amount of squalene was produced with no detection of C35H58 or 
lycopaoctaene (Figure 54, panel II). This result is consistent with the limited FPP   
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Figure 54. GC-MS analysis of E. coli cells expressing different gene constructs. (I) 
Empty vector expression. (II) LOS expression. (III) EcFPS and LOS expression. (IV) 
EcDXS, EcFPS, and LOS expression. (V) EcFPS, AtGGPPS11, and LOS expression. 
(VI) EcDXS, EcFPS, AtGGPPS11, and LOS expression. (VII) Hydrocarbon standards. 
Shown to the right of the GC-MS profiles is quantitation of each hydrocarbon based on 
the GC-MS data and expressed in nanograms. The GC-MS data shown are 
representatives from three independent experiments (n = 3) and each experiment was 
used for quantitation. Numbers shown in the quantitation are the average value for each 
hydrocarbon. The large amount of squalene and lycopaoctaene in panels IV, V, and VI 
caused the altered migration of these peaks compared to the standards. 
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amounts and even lower GGPP levels present in E. coli126. To overcome this limitation, 
we overexpressed FPP synthase from E. coli (ispA, referred to here as EcFPS) to 
increase FPP levels. Overexpression of EcFPS with LOS showed squalene production 
almost doubled and a roughly equal amount of C35H58 was detected (Figure 54, panel 
III). This would suggest EcFPS overexpression slightly increased intracellular FPP 
levels, and GGPP levels were high enough to contribute to C35H58 production. However, 
lycopaoctaene was not detected in this line (Figure 54, panel III) indicating the available 
GGPP pool is small and not sufficient for LOS-mediated lycopaoctaene production. 
To further boost FPP and GGPP production, deoxyxylulose-5-phosphate synthase 
from E. coli (EcDXS) was overexpressed along with EcFPS and LOS. The DXS enzyme 
catalyzes the first reaction of the MEP pathway, and is considered a rate limiting step of 
the MEP pathway61. Expression of EcDXS with EcFPS and LOS generated high levels 
of squalene and increased the amount of C35H58 (Figure 54, IV), suggesting an increase 
in the carbon flux through the MEP pathway to further boost FPP production. However, 
production of lycopaoctaene was still not detected (Figure 54, panel IV), arguing that 
while EcDXS and EcFPS overexpression significantly increased intracellular FPP pools, 
GGPP pools were not increased to a level required for lycopaoctaene biosynthesis. 
In order to enhance the GGPP pool, GGPP synthase from Arabidopsis thaliana 
(AtGGPPS11115) was overexpressed along with EcFPS and LOS. Analysis of 
hydrocarbon production in this line showed detection of a prominent peak for 
lycopaoctaene, whereas only a trace amount of C35H58 was observed (Figure 54, panel 
V). Surprisingly, no squalene was produced in this line (Figure 54, panel V), indicating 
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AtGGPPS11 converted most of the FPP pool into GGPP, which was utilized by LOS to 
produce lycopaoctaene, and the available FPP was used to produce the low level of 
C35H58 (Figure 54, panel V). To further boost FPP production, we overexpressed 
EcDXS, EcFPS, and AtGGPPS11 in one line with LOS and analyzed the hydrocarbon 
profile in this line. The analysis showed lycopaoctaene production was further enhanced 
and remained the predominant product (Figure 54, panel VI). A trace amount of 
squalene was detected and C35H58 production was slightly increased (Figure 54, panel 
VI), suggesting an enhanced level of intracellular FPP pools as a result of EcDXS 
overexpression in this line. However, the level of FPP may still not be sufficient to 
support increased C35H58 or squalene production. Low FPP pool levels in this line can be 
supported by two theories; the AtGGPPS11 is a very efficient enzyme that rapidly 
converts available FPP to GGPP, or the use of GGPP by LOS creates a pull on the MEP 
pathway that rapidly converts the FPP pool to GGPP by AtGGPPS11. 
Interestingly, this product specificity of LOS for lycopaoctaene over C35H58 and 
squalene as observed in E. coli (Figure 54, panel VI) could mirror hydrocarbon 
metabolism in B. braunii race L. Our past studies have shown that while lycopaoctaene 
is rapidly converted to lycopadiene there is no detectable squalene production and low 
levels of C35H64, a reduced product of C35H5859. This would suggest in the L race there is 
a small FPP pool available to LOS for C35H64 production, and mainly a large GGPP pool 
available for lycopaoctaene production. In B. braunii race L this may come about by 
metabolic channeling145 of the MEP pathway towards lycopadiene biosynthesis via 
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lycopaoctaene production by LOS. As we saw in E. coli, the use of GGPP by LOS 
would create a pull that would reduce FPP pools as FPP is used to generate more GGPP.  
Next we investigated the in vivo activity of several select LOS mutants by 
coexpression in the EcDXS, EcFPS, and AtGGPPS11 expressing E. coli line. Our initial 
goal was to create an E. coli screening platform producing approximately equal FPP and 
GGPP levels that would give rise to roughly equal levels of lycopaoctaene, C35H58 and 
squalene from WT LOS expression similar to WT LOS in the in vitro mixed substrate 
assay. This line could then be used for comparing the LOS mutants in vivo. Even though 
the EcDXS, EcFPS, and AtGGPPS11 expressing E. coli line does not appear to produce 
equal FPP and GGPP levels, we still expressed the LOS mutants in this E. coli line to 
assess in vivo function of these mutants. This allowed us to generate valuable 
information as discussed below that can support some aspects of the in vitro data. 
The mutants selected for expression in the EcDXS, EcFPS, and AtGGPPS11 
expressing E. coli line were M3, M4, and M8 (Table 2). Each of these mutants are 
focused on the LOS S276 and A288 residues, which appear to have the biggest influence 
on substrate binding and product formation based on the in vitro studies (Figure 53B). 
Additionally, the M12 mutant (Table 2) was chosen because M12 contains the full set of 
five LOS mutations based on the HSS sequence. As previously seen in Figure 54, WT 
LOS expression in this E. coli line predominantly produced lycopaoctaene, a small 
amount of C35H58, and trace amounts of squalene (Figure 55, panel I). Expression of the 
S276Y M3 mutant showed a reduced level of lycopaoctaene, a large increase in C35H58 
production, and no change in squalene levels in comparison to WT LOS (Figure 55,   
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Figure 55. Characterization of LOS mutants in vivo. Shown are GC-MS profiles and 
quantitation of n-hexane extractable metabolites from E. coli cells expressing WT LOS 
or select LOS mutants with EcDXS, EcFPS, and AtGGPPS11. (I) WT LOS expression. 
(II) LOS M3 mutant expression. (III) LOS M4 mutant expression. (IV) LOS M8 mutant 
expression. (V) LOS M12 mutant expression. (VI) Hydrocarbon standards. Shown to the 
right of the GC-MS profiles is quantitation of each hydrocarbon based on the GC-MS 
data and expressed in nanograms. The GC-MS data shown are representatives from three 
independent experiments (n = 3) and each experiment was used for quantitation. 
Numbers shown in the quantitation are the average value for each hydrocarbon. The 
large amount of lycopaoctaene in panels I and II caused the altered migration of these 
peaks compared to the standard. 
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panel II). This is similar to what was seen in the in vitro assays for M3 (Figure 53B) 
where the C35H58 levels were increased and the lycopaoctaene levels were reduced 
compared to WT LOS. Similarly, in comparison to WT LOS the A288F M4 mutant in 
vivo showed a reduction in lycopaoctaene production and increased C35H58 and squalene 
production (Figure 55, panel III). These data are also similar to the in vitro data for M4 
(Figure 53B), which showed decreased lycopaoctaene levels, maintenance of squalene 
levels, but no change in C35H58 levels. For the M8 S276Y/A288F double mutant, its 
ability to produce lycopaoctaene in vivo was drastically reduced, whereas production of 
C35H58 and squalene was increased compared to WT LOS (Figure 55, panel IV). Again, 
this is similar to what was seen for M8 in vitro (Figure 53B) where lycopaoctaene 
production was drastically reduced and the squalene levels were increased compared to 
WT LOS. However, the in vivo level of C35H58 for M8 went up while the in vitro level of 
C35H58 went down compared to WT LOS (Figure 53B). This would indicate some level 
of GGPP binding by this mutant when high GGPP pools are present in vivo (Figure 55, 
panel IV). As was seen for the in vitro assays, in vivo the M12 mutant showed a drastic 
reduction in lycopaoctaene production and increased squalene levels in comparison to 
WT LOS (Figure 55, panel V). However, the C35H58 levels were higher than WT LOS in 
vivo (Figure 55, panel V), while in vitro the C35H58 levels decreased compared to WT 
LOS (Figure 53). Again, this could be due to saturating levels of GGPP in vivo. As 
intended, the M12 mutations changed the LOS product specificity from lycopaoctaene to 
squalene both in vitro and in vivo. Overall, while the absolute changes in product 
formation for the mutants in figure 55 do not match that seen for the in vitro data in 
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figure 53, the trends in product formation for the M3, M4, M8, and M12 mutants in vivo 
are consistent with the enzymatic activities observed in the in vitro assays. 
3.2b4 Structural insights into the role of LOS S276 and A288 in GGPP binding 
 The studies presented above indicate LOS residues S276 and A288 play a key 
role in substrate binding and product specificity. To gain more insight into the role of 
these two amino acids in controlling substrate binding, we compared the HSS structure 
in complex with FSPP to the predicted LOS structure focusing on HSS Y276 and F288, 
and LOS S276 and A288 (Figure 56A). The analysis showed the distances in HSS from 
the aromatic ring of F288 and the phenol group of Y276 to the corresponding S1 and S2 
FSPP tails are 3.54Å and 4.35Å, respectively (Figure 56A). This suggests HSS cannot 
bind GGPP as a substrate because the bulky F288 in the S1 binding site and Y276 in the 
S2 binding site would interfere with GGPP binding since GGPP is ~4.00Å longer than 
FPP due to the extra C5 isoprene unit. This notion is further supported by the observed in 
vitro and in vivo enzyme activities of the LOS M8 S276Y/A288F double mutant, which 
showed substantial losses of lycopaoctaene and C35H58 formation, and a large increase in 
squalene production as a result of replacing the small S276 and A288 residues with Tyr 
and Phe, respectively (Figure 53B and Figure 55, panel IV). Further support of S276 and 
A288 controlling GGPP binding in LOS is the 6.76Å distance between the A288 side 
chain and the S1 FSPP tail, and the 7.66Å distance between the S276 hydroxyl group 
and the S2 FSPP tail (Figure 56A). These distances should provide enough room in the 
two LOS substrate binding sites to accommodate the longer hydrophobic tail of GGPP. 
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Figure 56. Structure comparison of HSS and LOS. Position comparison of the key 
residues controlling substrate binding from HSS, LOS, and CrtM in relation to the FSPP 
(A) and GGSPP (B) substrate analogs. A. Superposition of the HSS crystal structure 
bound to two FSPP molecules and the predicted LOS 3D-structure. B. Superposition of 
the CrtM crystal structure bound to two GGSPP molecules, the HSS crystal structure 
(FSPP removed), and the predicted LOS 3D-structure. 
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Additional characterization of the two substrate binding sites was conducted by 
comparing the HSS structure and the predicted LOS structure with the Staphylococcus 
aureus dehydrosqualene synthase (CrtM) structure bound to the GGPP analog 
geranylgeranylthiol diphosphate (GGSPP; Figure 56B)96. CrtM is an SS-like enzyme 
catalyzing the condensation of two FPP molecules to PSPP in the first step, followed by 
NADPH independent rearrangement in the second step to produce dehydrosqualene96, 
which contains a cis double bond at 1-1’ linkage between the two FPP molecules (Figure 
57). Except for the NADPH binding residues, CrtM shares sequence similarity with the 
functionally conserved SS domains127. Most importantly, the substrate binding sites in 
the central cavity of CrtM and HSS are structurally homologous94, 96. Although the 
natural substrate of CrtM is FPP, mutation of the bulky F26 residue to Ala in the S1 
substrate binding site was sufficient to allow binding of the longer GGPP substrate127. It 
should be noted the GGSPP bound CrtM crystal structure was not possible with WT 
CrtM and was obtained only with the F26A mutant96. 
The structural comparison of HSS, LOS, and CrtMF26A complexed with GGSPP 
reveals additional insights into substrate binding. The analysis showed that HSS F288 
would clash with the GGSPP hydrophobic tail in the S1 substrate binding site (Figure 
56B). In contrast, the distances from LOS A288 and CrtM A26 to the GGSPP tail are 
3.04Å and 4.37Å, respectively, and would provide enough room for binding GGPP in 
both enzymes (Figure 56B). In the S2 substrate binding site the GGSPP tail, especially 
the terminal isoprene unit, is in a bent conformation (Figure 56B). The closest distance 
between the HSS Y276 hydroxyl group and GGSPP is to the first carbon of the terminal 
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GGSPP isoprene unit at 3.81Å (Figure 56B), and this distance suggests HSS Y276 
would not interfere with GGPP binding in the S2 binding site if the S2 GGPP took on 
the configuration shown in Figure 56B. However, our data suggest the S2 GGPP may 
assume a more linear conformation in HSS since typical SS enzymes cannot utilize 
GGPP59 indicating interference from S276. Additionally, mutation of the small LOS 
S276 to the bulky Tyr (M3 mutant) resulted in substantial loss of lycopaoctaene 
formation (Figure 53B), corroborating limited binding of GGPP due to interference from 
the Tyr as well as a more linear S2 GGPP conformation. The distance between the LOS 
S276 hydroxyl group and the nearest carbon of GGSPP is 8.74Å (Figure 56B), 
indicating that even with GGPP in the linear conformation there is sufficient room to 
accommodate GGPP in the S2 substrate binding site. This assumption is further 
supported by the 8.62Å distance between GGSPP and CrtM V232 in the S2 substrate 
binding site (Figure 56B). Altogether, our data support the hypothesis that small 
structural changes due to the replacement of the bulky Y276 and F288 residues with 
S276 and A288, respectively, in the substrate binding sites of an ancestral B. braunii 
race L SS enzyme resulted in the neofunctionalized LOS enzyme with the ability to 
utilize GGPP to produce the tetraterpenoid hydrocarbon lycopaoctaene. Although LOS 
evolved larger substrate binding pockets to accept GGPP, these larger substrate pockets 
do not prevent binding of the smaller FPP substrate, thus leading to the substrate 
promiscuity observed for this enzyme. 
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Figure 57. Dehydrosqualene synthase reaction. The two step reaction carried out by 
Staphylococcus aureus dehydrosqualene synthase (CrtM) to produce dehydrosqualene. 
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3.2b5 Additional mutants of the LOS enzyme 
Now that the effect of the LOS M8 mutant (S276Y A288F) on the substrate 
binding sites has been identified, S276 and A288 of LOS were further characterize by 
replacing them with amino acids of different properties. Ten more mutants, five for S276 
(M13-M17) and five for A288 (M18-M22) were made where the substituted amino acids 
are either aromatic, polar neutral, acidic, basic or aliphatic in nature (Table 3). Four 
additional residues L61 and Y69 at the S1 binding site, and F184 and I285 at the S2 
binding site for were also selected mutagenesis experiments (Figure 58). These four 
residues of LOS are also conserved in other SS proteins (Figure 44) and the mutations 
are designed to increase specificity of GGPP binding in the substrate binding sites rather 
than eliminating FPP binding. Due to its smaller size compared to GGPP, it will be very 
challenging to limit FPP binding without affecting LOS affinity for GGPP. The L61Y 
(M23) mutation was chosen to create a new hydrophobic floor for the S1 GGPP tail, 
whereas the Y69V (M24) mutation was designed to increase the hydrophobicity of the 
S1 site (Figure 58). The mutation of F184 to leucine (M25) was made to test if this 
mutation increases the size of S2 site as well as increase the hydrophobic interaction 
with the S2 GGPP tail (Figure 58). Another mutation, I285Y, was designed to force the 
tail of GGPP in the direction of the S2 pocket created by S276 (Figure 58). In addition to 
single mutants of L61, Y69, F184 and I285 (M23-M26), mutations were also made in 
combination to yield six double mutants (M27-M32), four triple mutants (M33-M35) 
and one quadruple mutant M36 (Table 3). Due to time limitations these mutants were not  
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Table 3. List of LOS mutants for future study. 
  
Mutant name Mutation
M13 S276F
M14 S276T
M15 S276D
M16 S276K
M17 S276V
M18 A288Y
M19 A288S
M20 A288D
M21 A288H
M22 A288V
M23 L61Y
M24 Y69V
M25 F184L
M26 I285Y
M27 L61Y Y69V
M28 L61Y F184L
M29 L61Y I285Y
M30 Y69V F184L
M31 Y69V I285Y
M32 F184L I285Y
M33 L61Y Y69V F184L
M34 L61Y F184L I285Y
M35 L61Y Y69V I285Y
M35 Y69V F184L I285Y
M36 L61Y Y69V F184L I285Y
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Figure 58. Superposition of the HSS/FSPP and LOS structures. Only FSPP from the 
HSS/FSPP complex is shown. For clarity, the LOS structure is focused on the enzyme 
active site. The four amino acids of LOS chosen for mutagenesis study are located in the 
two substrate binding sites and are highlighted in magenta. FSPP = farnesyl 
thiodiphosphate, HSS = human squalene synthase and LOS = lycopaoctaene synthase. 
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analyzed for activity, and future experiments should involve purification and 
characterization of these mutants in vitro followed by their analysis in E.coli cells 
producing high levels of FPP and GGPP. 
3.3 Methods 
3.3a Reagents 
Radiolabeled substrates [1-3H]-FPP (specific activity, 18.2 Ci/mmol) and [1-3H]-
GGPP (specific activity, 20.0 Ci/mmol) were purchased from PerkinElmer, and non-
labeled FPP and GGPP were purchased from Sigma. All other chemicals were purchased 
from VWR unless otherwise noted. 
3.3b Protein sequences for amino acid comparison 
 The following proteins were used for sequence comparison to LOS (AC# 
KT388101): LSS, B. braunii L race SS (AC# KT388100); BSS, B. braunii B race SS 
(AC# AH009227); AtSS, Arabidopsis thaliana SS (AC# D29017.1); YSS, yeast 
(Saccharomyces cerevisiae) SS (AC# M63979.1); HSS, human SS (AC# Q6IAX1). 
3.3c Structure comparison 
The LOS protein 3-D model was generated using the Iterative Threading 
ASSEmbly Refinement (I-TASSER) bioinformatics program139-141. Among five models 
of LOS predicted by I-TASSER, the model with a high confidence score (C-score = 
0.19) was used for structural analysis in this study. The molecular graphics and structural 
analyses of the predicted LOS structure, the HSS crystal structure (PDB ID; 3WEF), and 
the CrtM crystal structure (PDB ID; 3AE0) were done using the USCF Chimera 
package146. 
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3.3d Protein expression and purification 
The expression constructs, LOS1-391:pET28a designed to encode for 6xHis-
LOS1-391 was made using NheI and HindIII restriction sites and LOS1-391:pET28c SUMO 
designed to encode for 6xHis-SUMO-TEV-LOS1-391 was made using NdeI and HindIII 
restriction sites. Similarly, the double truncated LOS constructs, LOS33-381:pET28a 
designed to encode for 6xHis-LOS33-381 and LOS33-381:pET28c SUMO designed to 
encode for 6xHis-SUMO-TEV-LOS33-381 were made using NdeI and HindIII restriction 
sites. The desired expression construct was transformed into E.coli BL21(DE3), and an 
overnight culture from a single colony was used to inoculate (1.7% v/v) large volume of 
TB medium. The culture was grown at 37°C to OD600 = 0.8, and protein expression 
induced by adding 1 mM isopropyl β-D-thiogalactoside. The induced cultures were then 
grown for an additional 6 hours at 25°C, cells harvested by centrifugation, and the 
pellets were stored at  -80°C for future use. Purification of 6xHis tagged proteins was 
conducted using Ni-NTA agarose resin (QIAGEN) following manufacture’s 
recommendations with some modifications. All steps of purification were done either in 
ice or in a 4°C cold room. In a typical purification, the 750 mL culture pellet was 
suspended in 75 mL of lysis buffer, incubated for 30 min using a rocking table at cold 
room, and the cells were lysed by four successive probe sonication at 70% maximum 
power for 20 sec. DNase I and RNase A (Sigma) at a concentration of 1.2% w/v were 
added to the lysed cells, incubated for 15 min using a rocking table at cold room, and the 
samples were centrifuged at 16,000 x g for 30 min at 4°C. The supernatant was 
incubated with 4 mL of pre-equlibrated Ni-NTA resin for 60 min at 4°C using a rocking 
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table, the sample loaded into a gravity column, and the flow-through was discarded. The 
Ni-NTA column was washed with 80 mL of wash buffer, and the protein bound to nickel 
resin were eluted with 20 mL of elution buffer. The eluted protein sample were dialyzed 
against storage buffer (300 mM NaCl, 20 mM Tris-HCl, pH=7.5, 5 mM DTT and 2 mM 
MgCl2), concentrated using Amicon Ultra centrifugal filter (30kDa cutoff; EMD 
Millipore) to the concentration of ~10mg/mL. The protein sample was loaded into a gel 
filtration column (HiLoad 16/600 Superdex 200pg; GE Helathcare) in ATKA prime plus 
FPLC system, and the sample was run using storage buffer at a flow rate of 0.5 mL/min 
and detection at 210 nm. The fractions corresponding to individual peak were collected, 
concentrated, flash frozen with liquid nitrogen and then stored at -80°C for future use.  
The sodium phosphate based buffer used for purification are lysis buffer (50 
mM sodium phosphate buffer (pH=7.8), 300 mM NaCl, 10 mM imidazole, 1x general 
protease inhibitor cocktail (Sigma), 1 mM MgCl2, and 1% glycerol (v/v)), wash buffer 
(50 mM sodium phosphate buffer (pH=7.8), 300 mM NaCl, 40 mM Imidazole, 1 mM 
MgCl2, and 1% glycerol (v/v)) and the elution buffer (50 mM sodium phosphate buffer 
(pH=7.8), 300 mM NaCl, 400 mM imidazole, 1 mM MgCl2, and 1% glycerol (v/v)). 
Similarly, the MOPS based buffer used for purification are lysis buffer (50 mM MOPS 
(pH=7.8), 300 mM NaCl, 10 mM imidazole, 1x general protease inhibitor cocktail 
(Sigma), 20 mM MgCl2, 2.5 mM DTT and 1% glycerol (v/v)), wash buffer (50 mM 
MOPS (pH=7.8), 300 mM NaCl, 40 mM imidazole, 20 mM MgCl2, 2.5 mM DTT and 
1% glycerol (v/v)), elution buffer (50 mM MOPS (pH=7.8), 300 mM NaCl, 400 mM 
imidazole, 20 mM MgCl2, 2.5 mM DTT and 1% glycerol (v/v)) and the running buffer 
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(50 mM MOPS (pH=7.8), 300 mM NaCl, 20 mM MgCl2 and 5 mM DTT and 1% 
glycerol (v/v)). For purification involving detergent, Triton X-100 at a final 
concentration of 0.1% was added to the lysis buffer.  
The protein samples for enzyme assays were purified using MOPS based buffer 
using the protocol described above and did not utilize any detergents. The wash buffer 
contained higher concentration of imidazole (60mM) to remove non-specifically bounds 
protein to the nickel resin. Furthermore, the eluted protein after dialysis against running 
buffer was concentrated to 1-2 mg/mL, an equal volume glycerol added, and the protein 
sample stored at -20°C for shorter term or at -80°C for future use. For protein samples 
that were subjected to cleavage of 6xHis-SUMO tag, 6xHis-TEV protease was added to 
20mL of eluted proteins (0.15mg of TEV/mg of eluted protein) followed by incubation 
at cold room for 17.5hrs without shaking. The protein samples after cleavage reaction 
were concentrated to ~3mL volume and buffer exchanged with 40mL of MOPS based 
running buffer using Amicon Ultra centrifugal filter (30kDa cutoff; EMD Millipore). 
The protein solution was further concentrated to ~12mL final volume followed by 
incubation with 1.5 mL of pre-equlibrated Ni-NTA resin at 4°C using a rocking table. 
After 60 min incubation, the sample was loaded into a gravity column and the flow-
through was collected. The flow-through, protein samples without 6xHis-SUMO tag, 
was concentrated to desired protein concentration and analyzed by gel filtration 
chromatography as described above.  
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3.3e Site-directed mutagenesis of LOS 
The LOS mutants were generated using LOS1-391:pET28a construct. The desired 
point mutations were created using primers containing the altered nucleotide 
sequence(s). Conditions for PCR-mediated site directed mutagenesis reaction using Pfu 
Turbo DNA Polymerase (Agilent Technologies) were as follows: 98°C initial 
denaturation for 2 min, 17 cycles of denaturation, annealing, and extension (98°C for 30 
sec, 55°C for 30 sec, 72°C for 8 min, respectively), and a final extension at 72°C for 10 
min. All mutants were verified by DNA sequencing. 
3.3f Radioactive in vitro enzyme assays 
The enzyme assays were conducted using the protocol described previously59. In 
brief, a 50 µL reaction was initiated by adding 1 µg of purified protein to a reaction 
buffer containing 50 mM MOPS, pH 6.8, 2.5 mM β-mercaptoethanol, 20 mM MgCl2, 2 
mM NADPH, and 10 µM of 3H-prenyl-PP (0.125 µCi; specific activity = 0.25 Ci/mmol). 
For the mixed substrate assay 10 µM of both 3H-FPP and 3H-GGPP was used (0.125 µCi 
for each substrate; specific activity = 0.25 Ci/mmol). The specific activity for each 
substrate was adjusted by adding non-labeled FPP and/or GGPP. The reactions were 
incubated for 60 min at 37°C and terminated by adding 60µL of n-hexane, followed by 
brief vortexing and centrifugation. Thirty microliters of the supernatant was then 
analyzed on Silica gel 60 TLC plates using n-hexane as the mobile phase. 3H 
incorporation into reaction products was determined by scraping the spots corresponding 
to authentic standards of lycopaoctaene (Rf = 0.09), C35H58 (Rf = 0.12) and squalene (Rf = 
0.17) followed by an analysis on a liquid scintillation counter. 
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3.3g EcDXS and EcFPS cloning 
The cDNA sequences of EcDXS (AC# NP_414954) and EcFPS (a.k.a. ispA; AC# 
NP_414955) were obtained from the NCBI nucleotide database147. Genomic DNA from 
E. coli K-12 strain MG1655 and gene specific primers were used to amplify the PCR 
product using Phusion DNA polymerase followed by cloning into the pGEM-T vector 
(Promega). Gene specific primers were as follows: For EcDXS, forward primer 5’-
ATGAGTTTTGATATTGCCAAATACCCG-3’ and reverse primer 5’-
TTATGCCAGCCAGGCCTTGATTTTG-3’; for EcFPS, forward primer 5’-
ATGGACTTTCCGCAGCAACTC-3’ and reverse primer 5’-
TTATTTATTACGCTGGATGATGTAGTCCGC-3’. 
3.3h EcDXS, EcFPS, and AtGGPPS11 expression constructs 
 The DNA template for AtGGPPS11 was obtained from our previous study59 and 
the DNA sequence encoding the 56 N-terminal chloroplast targeting signal amino acids 
was deleted to yield AtGGPPS1157-371. The expression constructs were made using the 
following restriction sites and vectors: EcDXS in NdeI and XhoI of pET22b, EcFPS in 
BamHI and SalI of pACYDuet-1, and AtGGPPS1157-371 in NdeI and XhoI of 
pACYDuet-1. For experiments involving expression of EcFPS and AtGGPPS1157-371, the 
two cDNAs were expressed using a single expression construct, EcFPS + AtGGPPS1157-
371 in pACYDuet-1, by cloning EcFPS into the second multiple cloning site of 
AtGGPPS1157-371:pACYDuet-1 using the BamHI and SalI restriction sites. 
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3.3i LOS in vivo mutant analysis in E.coli 
The expression construct(s) described above were either transformed individually 
or in combination into E.coli BL21 (DE3) cells and the positive transformants were 
selected using standard procedures. The E.coli line harboring the desired construct(s) 
was grown in 60 mL of TB medium at 37°C to OD600 = 0.8, and gene expression was 
induced by adding 1mM isopropyl β-D-thiogalactoside. After induction, cells were 
grown for 6 hrs at 25°C, 50 mL of cells were harvested by centrifugation, the pellet snap 
frozen with liquid nitrogen, and the pellet lyophilized. Freeze-dried cells were 
transferred to a glass vial and extracted with n-hexane by vortexing vigorously at room 
temperature. The organic extracts were centrifuged at 1,000 x g, the supernatant dried, 
resuspended in 200 µL n-hexane, and a 5 µL aliquot analyzed by GC-MS. 
GC-MS analyses were conducted using 5% Phenyl BR-5ms capillary column (30 m × 
0.25 mm, film thickness: 0.25 µm) in electron ionization (70 eV) mode and utilized 
helium at a flow rate of 2.58mL/min as a carrier gas. The initial oven temperature was 
held at 220°C for 1 min followed by increase in temperature at a rate of 5°C/min to 
280°C, ramped again to 300°C at a rate of 2°C/min, and held for 20 min. The 
temperature for injection port, interface and ion source were set at 280ºC, 250ºC, and 
200ºC, respectively. 
3.3j GC-MS analysis 
A Bruker 436-GC-SCION SQ Premium GC-MS system was used to evaluate 
hydrocarbon production. GC-MS analyses were conducted using a 5% Phenyl BR-5ms 
capillary column (30 m × 0.25 mm, film thickness: 0.25 µm) in electron ionization (70 
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eV) mode using helium as a carrier gas at a flow rate of 2.58 mL/min. The initial oven 
temperature was held at 220°C for 1 min followed by an increase in temperature at a rate 
of 5°C/min to 280°C, ramped again to 300°C at a rate of 2°C/min, and held for 20 min. 
The temperature for the injection port, the interface, and ion source were set at 280ºC, 
250ºC, and 200ºC, respectively. Quantitation for hydrocarbon production in E. coli was 
done based on the calibration curve generated with commercially available squalene 
standard (Sigma). 
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CHAPTER IV  
CONCLUSIONS AND FUTURE DIRECTIONS 
 
Among the three races (A, B and L) of Botryococcus braunii, race L was the 
last one to be isolated and characterized as a chemical race41, 42. Several strains of race L 
were first reported to be isolated from freshwater lakes of Ivory Coast (strains Kossou 
and Yamoussoukro) and Thailand (strain Songkla Nakarin)42. Lycopadiene was 
identified as the sole hydrocarbon produced by this alga accounting for up to 8% of the 
cellular dry weight, and lycopadiene was suggested as a precursor for the formation of 
lycopane fossil deposits found in oil shales and coal deposits42. Although lycopadiene 
was first isolated almost 30 years ago, nothing was known about the hydrocarbon 
biosynthesis until recently. 
In this study, we have elucidated and characterized the biosynthetic pathway for 
the tetraterpenoid hydrocarbon lycopadiene (Figure 37). We have discovered a novel 
enzyme, lycopaoctaene synthase (LOS), that initiates the first committed step of the 
lycopadiene pathway (Figure 37). LOS is a squalene synthase (SS)-like enzyme and 
catalyzes a two-step reaction to produce lycopaoctaene (Figure 35A). The first step 
involves the dimerization of two molecules of geranylgeranyl diphosphate (GGPP) to 
produce prelycopaoctaene diphosphate as the cyclopropyl intermediate, which then 
undergoes NADPH dependent reductive rearrangement reaction to create a 1-1’ (head-
to-head) linkage between the two GGPP molecules to produce lycopaoctaene in the 
second step (Figure 35A). The eight double bond containing lycopaoctaene molecule is 
  164 
sequentially reduced to produce lycopahexaene, lycopapentaene, lycopatetraene and 
lycopatriene as the intermediates, and finally to lycopadiene as the end product of the 
pathway (Figure 37). 
4.1 Identification of reductase enzyme(s) for the lycopadiene biosynthetic pathway 
 The enzyme(s) catalyzing the reduction of lycopaoctaene to lycopadiene is yet 
to be identified and could be similar to geranylgeranyl reductase (GGR); an enzyme that 
catalyzes the sequential reduction of three double bonds of GGPP to produce phytyl 
diphosphate (PPP; Figure 38). Our pulse-chase experiment with 14C labeled GGPP show 
accumulation of a majority of the radioactivity into lycopapentaene and lycopadiene, 
indicating the reduction of lycopapentaene to lycopatetraene as the rate limiting step of 
the pathway (Figures 27B and 37). Furthermore, this data suggests involvement of at 
least two reductase enzymes in the reduction of lycopaoctaene to lycopadiene. In order 
to identify the reductase enzymes in the lycopadiene pathway, two GGR-like cDNAs 
(GGR-1 and GGR-2) from race L were cloned and characterized (Figure 39). The 
reductase activity of two candidate enzymes were tested by overexpressing these cDNAs 
in an E.coli line producing high levels of lycopaoctaene (Figures 41 and 42). However, 
preliminary data showed that the GGR-like enzymes do not reduce lycopaoctaene to its 
higher saturated homologues, indicating lycopaoctaene may not be their putative 
substrate (Figures 41 and 42). 
It is possible that GGR-1 and GGR-2 could be involved in the reduction of 
lycopadiene pathway intermediates other than lycopaoctaene. This hypothesis can be 
tested by conducting in vitro reductase activity assays with purified proteins and one of 
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the lycopadiene intermediates as the substrate. Before testing reductase activity of the 
candidate enzymes in vitro, it may be best to develop the tetraterpenoid reductase assay 
using radiolabeled lycopaoctaene as the substrate and a lysate from race L as the protein 
source. Although commercially unavailable, radiolabeled lycopaoctaene can be 
generated using 3H-GGPP and the LOS enzyme. The radioactive assay is preferred over 
assays with non-labeled substrates due to the high sensitivity of the radioactive assay 
compared to GC-MS analysis. Since we hypothesize the reaction conditions for 
reduction of lycopaoctaene to lycopadiene should be similar to that of GGR, reaction 
conditions for a tetraterpenoid reductase assay should be first optimized using the GGR 
reductase assay conditions as a template121. 
It is possible that GGR-1 and GGR-2 may not be the putative reductase 
enzymes involved in the lycopadiene biosynthetic pathway. It should be noted that 
GGR-1 and GGR-2 characterized in this study were identified from the transcriptome 
database of race L using the Arabidopsis thaliana GGR122 as a query. Since GGR 
enzymes are conserved among all photosynthetic organisms and archaea121-125, DNA 
sequences of GGR and GGR-like genes from these organisms can be used for more 
rigorous bioinformatic searches for candidate genes in the transcriptome as well the 
genome of race L. It is also possible that the current transcriptome data of race L may 
not be sufficient to identidy candidate reductase genes since the transcriptome was 
generated based on the RNA-Seq data from six culture time points (days 0, 3, 7, 14, 21 
and 28) over the 4-week culture cycle. The reasoning for this argument is based on the 
time course analysis of LOS enzyme activity, growth rate and total hydrocarbon 
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production over a 39-day culture period (Figure 26B), which showed a direct correlation 
between LOS enzyme activity and hydrocarbon accumulation in this alga (Figure 26B). 
Furthermore, a rapid increase in the LOS activity was observed after day 30 of the 
culture cycle (Figure 26B). We hypothesize that expression of putative reductases will 
be up-regulated as a result of increased LOS expression. Thus, the current RNA-Seq data 
may not include these candidate genes. Identification of biosynthetic reductase genes 
could be accomplished by generating new transcriptome of race L based on the RNA-
Seq data from multiple time points over the 8-week culture cycle. The genes with a 
similar expression profile to that of LOS can be first filtered from the transcriptome, the 
enzyme activities of new set of genes can be predicted in order to select the potential 
reductase genes, and the candidate genes can be tested both in vitro and in vivo for their 
ability to reduce either lycopaoctaene, lycopahexaene, lycopapentaene, lycopatetraene 
and lycopatriene to their corresponding higher saturated hydrocarbons. A similar 
transcriptome mining approach has been utilized to identify genes involved in the 
biosynthesis of many plant natural products148-150. 
Another approach to identify reductase genes for lycopadiene biosynthesis is by 
expressing a B. braunii race L cDNA library in a yeast line producing high levels of 
lycopaoctaene. Although LOS can make lycopaoctaene in yeast, the amount of 
lycopaoctaene generated in this line is low (Figure 30C) and may not be ideal for 
screening a cDNA library. Thus, a yeast line accumulating large amounts of 
lycopaoctaene should be generated, and could be achieved by overexpressing isoprenoid 
genes from the mevalonate pathway. Yeast should be used as a screening platform 
  167 
instead of E.coli since the putative reductase enzymes are expected to have a membrane 
domain as observed for LOS enzyme. The needed cDNA library for screening of 
reductase enzyme is expected to have at least 106 independent clones. As a result, 
identification of yeast line with the ability to produce reduced forms of lycopaoctaene 
will require extensive screening of cell populations from the expression library, and will 
be labor intensive. Thus a high-throughput single-cell resolution screening platform that 
has the ability to distinguish reduced forms of lycopaoctaene should be developed. A 
high-throughput droplet microfluidics system is an ideal screening platform for this kind 
of study as it allows encapsulation of a single cell (independent line) in a droplet, and 
can function as an independent photobioreactor151. Our recent Raman spectroscopy 
analysis of tetraterpenoid hydrocarbons from race L shows unique Raman signatures of 
each hydrocarbon molecule and allows us to identify and distinguish between 
lycopaoctaene, lycopahexaene, lycopapentaene, lycopatetraene, lycopatriene and 
lycopadiene molecules152. Thus, a high-throughput droplet microfluidics platform 
coupled with Raman spectroscopy could be utilized for screening yeast cells expressing 
a race L cDNA library, and subsequently identify reductase enzymes involved in the 
lycopadiene biosynthetic pathway. Raman spectroscopy integrated with a droplet 
microfluidics platform has been recently developed and was successfully utilized for 
characterization of microalgal lipids153. 
4.2 Substrate and product specificity of the LOS enzyme 
 The LOS enzyme utilizes C20 GGPP as a substrate to produce C40 
lycopaoctaene, the first committed step of the lycopadiene biosynthetic pathway. LOS is 
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promiscuous in its ability to utilize prenyl diphosphate substrates, and can catalyze C15 
FPP to produce C30 squalene and C20 PPP to produce C40 lycopadiene (Figure 32). 
Furthermore, LOS can make chimeric hydrocarbons of all combinations using mixtures 
of the three substrates FPP, GGPP and PPP (Figure 32). To gain structural insights into 
the mechanism of how LOS utilizes three prenyl diphosphate substrates to produce 
combinatorial hydrocarbons of varied chain lengths (C30, C35 and C40), we pursued 
crystallization of the LOS protein as detailed in chapter III. Although we were successful 
in generating large amounts of highly pure, soluble, and active LOS1-391 protein by 
removing the C-terminal transmembrane domain, we were unable to crystallize this 
protein even in the presence of substrate analogs farnesylthiol diphosphate (FSPP) and 
geranylgeranylthiol diphosphate (GGSPP). The double truncated construct of LOS 
(LOS33-381) was also generated based on the comparison of the predicted LOS structure 
and the published human squalene synthase (HSS) crystal structure (Figure 45B)94. 
Although enzymatically active, we were unable to generate large amounts of highly pure 
LOS33-381 protein as previously seen for LOS1-391. Future experiments should involve 
extensive optimization of purification conditions to increase the yield as well the purity 
of LOS33-381, and should be followed by screening of crystallization conditions with 
substrate analogs FSPP and GGSPP. 
 In order to identify the critical amino acids involved in conferring substrate and 
product specificity of LOS, we conducted rational mutagenesis experiments based on the 
sequence alignment of LOS with several SS proteins as well as comparison of the 
predicted LOS structure with the HSS/FSPP complex crystal structure (Figures 44 and 
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52)94. Our analysis of LOS mutants suggests that five residues (T65, M180, S276, A288 
and V289), located on the hydrophobic floor of the two substrate binding sites, control 
the binding of GGPP in this enzyme (Figures 52 and 53). When these five residues of 
LOS were mutated to the corresponding residues found in HSS (V69, L183, Y276, F288 
and C289), the resulting LOS mutant (M12) almost completely lost its ability to produce 
lycopaoctaene whereas SS activity was increased by 3-fold (Figure 53B). Among the 
five residues, S276 and A288 play a dominant role in defining the two substrate binding 
pockets of the LOS enzyme. When the double mutant M8 (S276Y and A288F) was 
designed to resemble the typical SS enzyme, binding of the longer GGPP substrate was 
limited but binding of the smaller substrate FPP was favored as seen by a drastic 
increase in SS activity (Figure 53B). Furthermore, the in vitro enzyme activity of select 
mutants (M3, M4, M8 and M12) were verified by expressing each mutant in E.coli 
engineered to produce high levels of FPP and GGPP (Figure 55). Intriguingly, when 
LOS was expressed along with three isoprenoid synthases (EcDXS, EcFPS and 
AtGGPPS11) in E.coli, lycopaoctaene production was favored over C35H58 and squalene 
suggesting the substrate and product specificity of LOS enzyme in vivo could result by 
metabolic channeling process (Figure 54). 
Altogether, characterization of the LOS mutants in vitro and in vivo along with 
the structural comparison of LOS with the HSS/FSPP complex and a dehydrosqualene 
synthase (CrtM)/GGSPP complex suggests that the small residues S276 and A288 
created larger substrate binding pockets in LOS, allowing for binding of GGPP and 
therefore its novel activity for lycopaoctaene production (Figures 53, 55 and 56). 
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However, the larger substrate binding sites of LOS did not inhibit FPP binding, and thus 
result in its substrate promiscuity. Considering the crystal structure of WT LOS will be 
obtained, future experiments should include crystallization of LOS and its mutants (M3, 
M4, M8 and M12) with FSPP, GGSPP and mixture of both substrate analogs as it will 
provide new structural insights into the substrate binding and product specificity of this 
enzyme. In addition, directed evolution experiments with LOS should also be conducted 
in an E.coli line accumulating high levels of FPP and GGPP substrates. Such 
experiments will not only identify additional residues involved in substrate binding but 
may also result in LOS variants with higher/improved activity for either squalene, 
C35H58 or lycopaoctaene production. Altogether the studies in chapter II extended our 
understanding of the neofunctionalization of the LOS enzyme from the progenitor SS 
enzyme. 
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